University of Massachusetts Amherst

ScholarWorks@UMass Amherst
Doctoral Dissertations

Dissertations and Theses

Winter August 2014

LIGAND-RECEPTOR INTERACTIONS FOR SUPRAMOLECULAR
DISASSEMBLY WITH APPLICATIONS IN SCREENING AND DRUG
DELIVERY
Diego Amado Torres
University of Massachusetts Amherst

Follow this and additional works at: https://scholarworks.umass.edu/dissertations_2
Part of the Amino Acids, Peptides, and Proteins Commons, Biochemistry Commons, Chemical Actions
and Uses Commons, Heterocyclic Compounds Commons, Investigative Techniques Commons,
Laboratory and Basic Science Research Commons, Macromolecular Substances Commons, Materials
Chemistry Commons, Medicinal and Pharmaceutical Chemistry Commons, Medicinal Chemistry and
Pharmaceutics Commons, Medicinal-Pharmaceutical Chemistry Commons, Nanotechnology Commons,
Organic Chemicals Commons, Organic Chemistry Commons, Pharmaceutics and Drug Design Commons,
and the Polymer Chemistry Commons

Recommended Citation
Amado Torres, Diego, "LIGAND-RECEPTOR INTERACTIONS FOR SUPRAMOLECULAR DISASSEMBLY WITH
APPLICATIONS IN SCREENING AND DRUG DELIVERY" (2014). Doctoral Dissertations. 49.
https://doi.org/10.7275/3tjw-g174 https://scholarworks.umass.edu/dissertations_2/49

This Open Access Dissertation is brought to you for free and open access by the Dissertations and Theses at
ScholarWorks@UMass Amherst. It has been accepted for inclusion in Doctoral Dissertations by an authorized
administrator of ScholarWorks@UMass Amherst. For more information, please contact
scholarworks@library.umass.edu.

LIGAND-RECEPTOR INTERACTIONS FOR SUPRAMOLECULAR DISASSEMBLY WITH
APPLICATIONS IN SCREENING AND DRUG DELIVERY

A Dissertation Presented

by
DIEGO FERNANDO AMADO TORRES

Submitted to the Graduate School of the
University of Massachusetts Amherst in partial fulfillment
of the requirements for the degree of
DOCTOR OF PHILOSOPHY

May 2014
Chemistry

© Copyright by Diego Fernando Amado Torres 2014
All Rights Reserved

LIGAND-RECEPTOR INTERACTIONS FOR SUPRAMOLECULAR DISASSEMBLY WITH
APPLICATIONS IN SCREENING AND DRUG DELIVERY

A Dissertation Presented
by
DIEGO FERNANDO AMADO TORRES

Approved as to style and content by:
_______________________________________
Sankaran Thayumanavan, Chair

_______________________________________
V. Adrian Parsegian, Member

_______________________________________
Nathan A. Schnarr, Member

_______________________________________
Gregory N. Tew, Member
____________________________________
Craig T. Martin, Department Head
Chemistry

DEDICATION
To my mother, Adiela Torres Castillo.

ACKNOWLEDGMENTS
The people who have been directly involved with the achievement of my latest
degree are many: family, faculty, lab mates, classmates, friends, and institutions. All of
them are receivers of my eternal gratitude and admiration. However, in the world of
chemistry it is necessary for me to acknowledge those who contributed most
outstandingly in finishing my PhD degree. In an inverse chronological order of
appearance in my life, those remarkable people are Professor Sankaran Thayumanavan,
who formed part of the committee that brought me to UMass and then became my
advisor during my PhD. Under his guidance, I learned and developed my taste for
supramolecular chemistry. Professor Dr. Vladimir V. Kouznetsov, my mentor, advisor,
and teacher during my Masters and Bachelor degrees in chemistry, back in my home
country, Colombia. He taught me how organic chemistry can be frustrating most of the
time, but always fascinating and many times beautiful.
I would have never gotten into chemistry if it was not due to the amazing
teaching skills of Dr. Heriberto Acevedo, a remarkable science teacher during my years
in high school. From him I learned that organic chemistry was the chemistry of life and a
different world worthy of studying in detail. Of course, before all of this chemistry and
science madness began, I had my mother to tell me to keep studying and learning
throughout my childhood “for the best future belongs to those who study hard and
excel at school.” Nothing of what I have achieved would have been achieved if it was
not for her insisting on me to become a better student despite the fact that I was at the
top of the class most years, and among those at the top the other times.

v

ABSTRACT
LIGAND-RECEPTOR INTERACTIONS FOR SUPRAMOLECULAR DISASSEMBLY WITH
APPLICATIONS IN SCREENING AND DRUG DELIVERY
MAY 2014
DIEGO F. AMADO TORRES, B.S., UNIVERSIDAD INDUSTRIAL DE SANTANDER
M.S., UNIVERSIDAD INDUSTRIAL DE SANTANDER
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Sankaran Thayumanavan
Proteins have the capacity to bind specific sets of compounds known as ligands,
these are small molecules with a recurrent theme in their molecular design that is a
characteristic exploited here to (i) identify particular affinities of small molecules for
proteins with the aim of using them as ligands, inhibitors, or targeting moieties in more
complex systems by means of a methodology that screens small molecules based on
protein affinity; (ii) decorate a self-assembling supramolecular system at different
positions, making it responsive to a complementary protein with the aim of exploring
differences in disassembly and sensitivity of the release of encapsulated guest
molecules, depending on the initial location of the ligand upon binding to a specific
protein; (iii) decorate self-assembling and crosslinkable dendrons aiming to introduce a
system incorporating multiple ligands, sequentially responsive to a reducing
environment, and to specific proteins.
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CHAPTER 1
INTRODUCTION

1.1 Protein Binding: from Self-assemblies to Ligands
Synthetic amphiphilic macromolecules that can spontaneously self-assemble in
solution possess the capability of mimicking features of naturally occurring architectures
such as cell membranes and endosomes, and macromolecules, such as proteins, RNA,
and DNA.1 As a result, such systems are of great importance in supramolecular
chemistry. Synthetic supramolecular systems often utilize the same kind of interactions
that nature uses in its own designs, namely hydrophobic interactions, van der Walls
forces, hydrogen bonds, electrostatic interactions, - interactions, and metal-ligand
binding interactions.2 All of these non-covalent interactions are involved in the specific
binding of ligands to proteins, which led to their inclusion by synthetic chemists in
artificial systems in an attempt to emulate designs that evolution has refined over
millions of years.3 Many of those artificial tailored systems include self-assembling
molecules and macromolecules as scaffolds for nanostructures such as micelles,
vesicles, lamellae, and aggregates along with less frequent nanostructures in other
shapes.4 The main characteristics sought in self-assembling systems are often beneficial
in encapsulation of guest molecules for drug delivery purposes and sensing applications.
Artificial self-assembling supramolecular systems are formed by a variety of
molecules, including small molecule surfactants, block copolymers, random copolymers,
and

dendrons.5,6

The

self-assembling

capabilities

1

of

these

molecules

and

macromolecules in an aqueous environment is complemented by the encapsulation
properties, usually of small molecules upon mixing them with the corresponding selfassembling motifs, i.e. small hydrophilic molecules trapped in the aqueous interior of
vesicles, or hydrophobic molecules occupying hydrophobic pockets in a micelle,
lamellae, or aggregate. As in naturally occurring proteins, which suffer conformational
changes when bound to specific molecules, man-made self-assembling systems have
been functionalized with particular features to induce conformational changes upon
stimulation.3,5 A supramolecular system incorporating responsive features becomes
more complex and interesting when a stimulus triggers either disassembly or a
morphological transformation of the system.7 Such disturbances in assembly and
morphology are usually followed by release of encapsulated small molecules, which are
often a pharmacophore or a reporter chromophore. Nevertheless, disassembly and
morphology changes are sought to be reversible in many cases, as a more accurate
emulation of protein features.
The proteins’ capacity for binding to specific sets of compounds known as
ligands, small molecules with a recurrent theme in their molecular design, is a
characteristic exploited and described in this thesis for a system based on
supramolecular analytical chemistry. It is desirable to identify particular affinities of
small molecules for proteins, so they can be used as ligands, inhibitors, or targeting
moieties in more complex systems.8 With that in mind, a methodology that screens
small molecules based on protein affinity would be useful to identify hits that are
synthetically more accessible, cheaper, and easier to modify than other known ligands.

2

Previously, the same protein-ligand binding capacity has been used to give
specificity to self-assembling nanostructures, including soft and hard nanoparticles,
towards a target protein.3,5 However, the importance of the ligand location on a
nanoassembly has been disregarded, and nothing is known about how it affects either
disassembly or the further release of encapsulated guest molecules.
Since this thesis is about the protein-ligand binding event and its influence on (i)
discrimination of small molecules affinity in a screening assay, (ii) disassembly of
dendrimeric aggregates and (iii) release efficiency, in this chapter, we will discuss some
relevant aspects about determination of binding affinity and dendron responsiveness to
diverse stimuli, what has been shown previously from our lab.

1.2 Protein-Ligand Binding Affinities, Importance and Discrimination
Protein-ligand interactions are known for their specificity and biological
relevance, which is due to the myriad of physiological functions triggered upon a
protein-ligand binding event.9 Mimicking the details and advantages of receptors’
binders has been an important task for pharmacological science; this problem has been
approached by designing ligand-like small molecules with the purpose of either
enhancing or reducing a physiological response after interaction with a specific
protein.10 Discriminating protein-affinity of a new molecule when comparing it to a
different molecule with already known binding affinity, i.e. how well the new molecule
inhibits the action of a target protein by blocking its binding site, is a matter of great
importance in the fields of drug discovery and bioresponsive materials.
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Discriminating methods for rapid screening of small molecules is a crucial
requirement in drug discovery and development. Even though there has been significant
advancement in diversity-oriented organic synthesis to obtain a large library of small
molecules, developing screening techniques with greater efficacy is still a challenging
task for the pharmaceutical industry.11 Most of the current methods require either
radio-labeling of the ligand molecule or labeling the receptor itself.12 Although there are
a number of non-labeling methods, they involve expensive instrumentation and
excessive time consumption. An efficient approach to address these issues would
involve the development of versatile screening methods, utilizing simple analytical tools,
thereby improving their broader applicability without compromising the speed of test.11
In the past several decades, great efforts in medicinal chemistry and the advent
of combinatorial chemistry have generated the possibility of synthesizing large libraries
of organic molecules to target a number of diseases. However, only limited efforts have
been made in finding new techniques for screening these huge numbers of molecular
compounds.13
For the screening of large numbers of molecules, the pharmaceutical industry
requires simple and robust methods that could be easily transferred to automated drug
screening. While high throughput screening (HTS) is currently available for such
endeavors, 14 these techniques require special instrumentation with highly complicated
methodologies and expertise. Thus, it is pertinent to develop novel and more
straightforward methods than the existing ones, using simple instrumentation
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techniques to make the screening process and the identification of “hits” economical
and time-saving.
The identification of “hit” molecules is important during the early stages of drug
discovery. The following stages involve the transformation of the hit into a “lead”
molecule, and then the optimization of those “lead” molecules. However, quantitatively
assessing the binding strength of molecule-receptor interactions at an early stage plays
a vital role in expediting the drug discovery process. Some of the most used methods for
this purpose are described in the following sections.

1.2.1 X-Ray Crystallography
An increase in the speed and power of protein crystallography has had a
significant impact on screening of small molecules through defining drug binding modes
more rapidly and with greater certainty, which has significant importance on lead
discovery.
In an X-ray approach to screening,15 protein crystals are exposed to either single
molecules or molecule cocktails in a solvated environment. Since protein crystals
contain extensive channels filled with solvent accounting for approximately 50% of the
three-dimensional structure volume of the protein, ligand small molecules will generally
diffuse rapidly into the crystals and interact as if they were in solution, as long as the
crystal packing does not occlude the binding site. Once the initial protein crystals have
been characterized, the small molecules can be visualized by collecting sets of X-ray data
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on each soaked crystal under identical conditions. The aid of automatic procedures
enables the rapid analysis of the protein–ligand complex solutions.16

Figure 1.1. Fragment based approach to lead discovery; a) schematic representation
of an active site with three pockets; b) two fragments binding two of the pockets; c) a
scaffold linking three fragments binding the pockets; e) the real binding site defined
by van der Waals surface; f) a fragment defined by X-ray crystallography.15

However, the protein fragments are used at much higher concentrations than in
conventional HTS approaches, assuming that the crystal is adequate for the study.
Figure 1.1 shows a known binding site in a soaked protein crystal and illustrates how
different small molecules are identified according to their fit within the protein.17
Although this method has several disadvantages including the required high
concentrations and proper crystallization, high-throughput crystallography is now a
viable screening method in the recognition of molecular fragments that bind protein
targets and precise definition of the protein binding sites. 18 It can subsequently be used
as a rapid technique to guide lead optimization.
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1.2.2 NMR Based Strategies
Several NMR based strategies have been developed with a particularly useful set
for drug discovery.19 These include traditional chemical-shift mapping, ligand-based
techniques that monitor changes in nuclear ligand spin relaxation properties upon
binding, and diffusion measurements. However, some of these approaches are better
suited to validate hits coming from HTS campaigns while others are better suited to
guide hit optimization to lead compounds, mostly due to the high concentration of
protein needed for the screening of large libraries of compounds.
One of the most often utilized for hit identification and validation by NMR is
called chemical-shift mapping.20 This approach exploits the differences in chemical shift
between free and bound target protein, in two-dimensional correlation spectra upon
titration with a ligand or a mixture of ligands. This is a ligand-binding assay that can
provide meaningful information on the binding site; it has advantages over other
screening techniques, as compounds bound to the target protein can be found and
characterized without need for an assay. When the structure of the target has been
determined by NMR, it could be possible to derive ligand-protein distances. However,
for target proteins over 30-40 kDa at least one amino acid needs to be labeled to reduce
the spectral complexity.
The ligand-based techniques use a smaller amount of protein than the previous
approach, and are based on the observation of perturbations induced by a
substoichiometric amount of target protein on the NMR spectra of the ligand. 21
Saturation transfer difference (STD) is one of these techniques in which a simple 1H
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NMR is recorded for a ligand in the presence of a small amount of target i.e.
ligand:protein 100:1, with and without selective irradiations of the protein resonances
in regions that are not occupied by resonances of the small molecule ligand. This
technique also exploits the relaxation differences between bound and free state of a
ligand nuclei, even if the binding is transient in the presence of a substoichiometric
amount of protein. This approach however, is less informative than chemical-shift
mapping and is typically used for screening and validation.
Another interesting strategy uses both X-ray crystallography and NMR based
methods for hit screening and validation along with in silico docking of compounds to
predict those that should bind to a target protein. This is a very important aid used in
the fragment-based drug design (FBDD) strategy, which combine the information
acquired from either X-ray crystallography or NMR with computational simulations that
help to save time and resources. FBDD is now an alternative to conventional HTS. 15,19

1.2.3 Mass Spectrometry
Mass spectrometry (MS) plays a role in nearly every step of the drug
development process. However, it was not until recently that MS has emerged as an
effective technique for identifying lead compounds based on the characterization of
ligand-protein target interactions. One of the main advantages of this strategy is the
small quantities of ligand and target protein required, and the capacity to study them
without labeling them.22

8

A MS approach stands apart in the identification of hits and lead compounds
when is combined with electrospray ionization (ESI). ESI-MS reduces considerable
constraints on the purity of both targets and ligands due to differentiations in molecular
mass, allowing for detection of non-covalent complexes, which makes it useful in
compound screening and structure-activity relationship (SAR) optimization.23
A different method that can measure binding of small molecules to protein
targets either directly or indirectly is affinity selection mass spectrometry (AS-MS). All
varieties of AS-MS include a step of affinity selection, where the protein is equilibrated
with at least one potential ligand; during this stage the protein forms a complex with
any compound capable of binding. In the next step the resulting receptor-ligand
complexes are separated from unbound components. In a final step, ligands are
identified by MS or MS-MS.24
AS-MS methods measure the binding event directly or indirectly. The direct
methods separate protein-ligand complexes from unbound components within the mass
spectrometer. Then, the mass of the non-covalent or covalent protein-ligand complex is
measured in the gas phase. Indirect methods use a separation technique, usually
chromatography, to isolate the protein-ligand complex formed from unbound
components before MS. Both direct and indirect methods have been applied in
screening of libraries of compounds, compound mixtures, and unpurified natural
products extracts.
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1.2.4 Microcalorimetry
Currently, isothermal scanning calorimetry, also known as isothermal titration
calorimetry (ITC), permits direct determination of enthalpy values and gives complete
thermodynamic profiles for binding events. The instruments for ITC most commonly use
a power compensation design in which the temperature difference between a sample
cell and a reference cell is monitored. While both cells are maintained at a constant
temperature, a titration system delivers a reactant to the sample cell where any heat of
reactant binding results in an imbalance between the reference and sample cells, which
is compensated for by modulating the power applied to cell heaters.25
Figure 1.2 shows an example of ITC data of a ligand binding to a protein. The top
panel shows the primary titration data, or raw data, in which power is displayed as a
function of time. The programmed titration delivery steps are evident by the series of
peaks that return to baseline. The area of each peak is the heat of reaction for each
reactant addition and the magnitude decreases as the receptor binding site becomes
saturated. The bottom panel shows the primary ITC data transformed into a binding
isotherm displaying the characteristic sigmoidal shape. This binding isotherm is fit into a
particular binding model to get the binding constant, binding enthalpy, and the
stoichiometry of the binding event.
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However, ITC is a laborious and time
consuming method. Even an experienced
investigator can usually complete only a few
experiments

per

day,

which

relegates

calorimetry to the pharmaceutical industry for
use as a secondary screening method for
validation of other assays. High throughput
calorimeters are still a work in progress with
less than promising early results. Perhaps the
most impressive results come from a hybrid
Figure 1.2. ITC data for a binding
event. The top panel shows the raw
titration data; the bottom panel
shows the binding isotherm
constructed from the raw data.

technology

between

calorimetry

and

fluorimetry. ThermoFluor measures the
fluorescence of dyes that sense protein

unfolding; it is used to conduct miniaturized thermal shift assays in drug discovery.26

1.2.5 Fluorescence Based techniques
Fluorescence techniques can be easily implemented as a HTS.14 There are a
number of methods involving fluorescence as screening techniques; although most of
these methods are robust, many require specialized and costly instrumentation as well
as the required knowledge to keep them working well.11,27 The most popular methods
involve fluorescence-based displacement assays. Among them, fluorescence correlation
spectroscopy (FCS) based assays are worth mention; these assays utilize the difference
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in the diffusion time of bound and unbound ligands, and yet they require special
instrumentation and expertise to correlate the data. Assays based on FRET partners are
also of importance; although these assays require simpler fluorescent instruments the
required labeling of the protein itself reduces their versatility.
Fluorescence-polarization

activity-based

protein

profiling

(fluopol-ABPP)

technology, an interesting technique that has recently been developed, is compatible
with HTS (Figure 1.3).28 Fluorescence polarization, a measure of the apparent size of a
fluorophore, is widely used to study molecular interactions. When excited with planepolarized light, a fluorophore emits light parallel to the plane of excitation, unless it
rotates in the excited state. The speed of molecular rotation and resulting extent of
depolarization are inversely proportional to molecular volume. Typically, small
fluorophores of less than 10 kDa rotate quickly and emit depolarized light that is
registered as a low fluorescence polarization signal when free in solution, but, when
they are bound to a protein, they rotate more slowly and emit highly polarized light that
is registered as a high fluorescence polarization signal.29 The reaction between an
activity-based probe and an enzyme results in a time-dependent increase in
fluorescence polarization signal, enabling real time monitoring of enzymatic activity in a
homogeneous assay format.
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Figure 1.3. Pictorial representation of a fluopol-ABPP assay. a) An inhibitor mixed with
a protein shows low fluorescence polarization, b) an inactive compound shows high
fluorescence polarization.27
As a pictoric representation of this technique’s concept, in Figure 1.3, a protein is
placed into a 384 well plate, followed by the addition of a different test compound into
each well. The figure represents an inhibitor (a) and an inactive compound (b). A
fluorescent ABPP probe is then introduced to each well and the plate incubated for
some time. The reaction of the probe with unbound protein (but not with bound
protein) will greatly increase the apparent mass of the probe, resulting in the
maintenance of a strong fluorescence polarization signal.

1.3 Dendrimers, Mono-Dispersed Polymers
It was mentioned before that amphiphilic molecules are primarily interesting
due to the self-assembling characteristics they exhibit, both in solution as micelles or
vesicles and in aggregates. The driving force for the formation of these amphiphile
assemblies is to maintain a favorable hydrophilic–lipophilic balance (HLB) between the
hydrophilic and the lipophilic components. In solution, these molecules self-assemble
only when they are above certain concentration, which is known as critical aggregation
13

concentration (CAC).30 Amphiphilic macromolecules exhibit CACs substantially lower
than smaller surfactants. While small surfactants have CACs in the millimolar range,
assemblies formed by macromolecules such as dendrimers, amphiphilic homopolymers,
amphiphilic random copolymes or amphiphilic block copolymers have CACs lingering in
the micro and nanomolar range.31,32,33 In a way, amphiphilic macromolecules could be
seen as macro-surfactants. Although polymers form more stable self-assembling
structures with lower CACs than the small molecule surfactants, the inherent
polydispersity associated with their synthesis makes a challenge of the synthetic
reproducibility, which could be a drawback for this kind of polymeric system in drug
delivery, sensing, and in general in the study of nanoassemblies’ surface properties.34 In
that sense, dendrimers have the advantage of synthetic reproducibility, monodispersity,
and controlled molecular weight.

1.3.1 Structural Characteristics of Dendrimers
Among amphiphilic macromolecules, dendrimers are interesting due to their
uniform structures, controlled functionalization, and defined molecular weight.
Multivalency is another important feature that is provided by the highly branched
dendrimer structures,35 which mean a high number of terminal functional groups are
available for functionalization.
In fact, branching is the primary characteristics of dendrimers. For this reason,
the macromolecules were initially called “arborols” by Newkome,36 and later on
“dendrimers” by Tomalia, which became the term accepted in the literature.37 The
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words dendrimer, and dendron, come from the Greek word δένδρον (read dendron),
which means “tree”, and refers to the branched structures of the molecules. Usually, a
dendrimer or a dendron contains a monomer or a single group called the core or the
focal point. Typically, a dendrimer is symmetric around the core but a dendron branches
out from the focal point in one hemisphere direction. The branches’ terminal groups are
called the periphery in either case, as it can be seen from the cartoon depicting the
backbone of dendrons in Figure 1.4.

Figure 1.4. Cartoon representation for the focal point, middle layer, and periphery of a dendron
generation 1 (G1), and a dendron generation 2 (G2).

Amphiphilic dendrimers are formed using hydrophilic and hydrophobic
components. As mentioned before, the non-covalent forces drive dendrimers to selfassemble above their CAC, when dispersed in aqueous media. Hydrophilic components,
that often incorporate structures of carboxylates, phosphates or quaternary ammonium
groups, render these dendrimers water soluble. However, the non-specific interactions
of these charged species with biomolecules i.e. non-specific binding, often limit their
use in biological applications. To address that issue, non-ionic and well known
biocompatible hydrophilic molecules, such as poly(ethylene glycols), have been used as
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the hydrophilic part.38 On the other hand, hydrophobic components dictate parameters
such as stability and loading capacity.
There are also amphiphilic dendrimers that do not form assemblies. Instead,
Fréchet-type dendrimers form unimolecular micelles in solution by displaying a
hydrophilic periphery and a hydrophobic polyether core.39 Newkome,40 and Meijer41
have reported on similar kinds of dendrimers.
Dendrimers, as a type of monodispersed macromolecules, are synthesized in a
controlled fashion. The appearance of dendrimers in specialized literature increased
considerably in the last two decades, as well as their applications on a variety of fields.
In our lab, a unique kind of biaryl amphiphilic self-assembling dendrons has been
developed incorporating a range of different functionalities, with the goal of imparting
the macromolecules with responsiveness towards different stimuli.

1.3.2 Divergent and Convergent Methods for Dendrimer Synthesis
Usually, a self-assembly is formed by amphiphilic macromolecules such as
synthetic polymers, which show broad molecular weight distributions after synthesis;
unlike natural amphiphilic polymers i.e. proteins, which are monodispersed despite their
complexity. Thus, polymers are polydispersed regardless of the advances in
polymerization techniques achieved during the last three decades. 42 One way to access
macromolecules with defined molecular weights is through iterative synthesis. Although
this method is more tedious, time consuming and less efficient than step-by-step and
radical polymerizations, it allows for successive and controlled attachment of
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Figure 1.5. Illustration representing divergent (top) and convergent (bottom) syntheses
of dendrons.
monomers. With this type of synthesis, it is possible to control the exact molecular
weight and location of ligands and various functionalities into the macromolecule.
Dendrimer synthesis involves either divergent43,44 or convergent covalent
attachment strategies,45 which generally require molecular scaffolds and synthetic
pathways as outlined in Figure 1.5. Simply stated, the divergent strategy involves the
controlled and iterative assembly of AB2 type monomers, where the co-reactive nature
of A and B allows for a controlled covalent attachment of the monomers. This might be
visualized as a molecular tree growing from the stem towards the branches, and ending
when it has reached the periphery of the branches or tree canopy. The convergent
strategy also involves the controlled, iterative assembly of AB2 type monomers, where
the B and A components are co-reactive; in this case protection and deprotection
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protocols are used to build the dendrons, generation by generation. In essence, the
molecular tree starts to grow from the periphery of the branches or tree canopy
towards the inner branches, until reaching the stem (focal point), to produce a
molecular tree, as shown in Figure 1.5. In general, dendrimers produced by the
divergent strategy suffer an increase of reactive functionalities as the generation
increases, which leads to a higher number of defects at higher generations. Dendrimers
synthesized by the convergent strategy are nearly free of defects due to a fewer number
of reactive functionalities that remain constant as the generation increases. However,
steric hindrance produced by the growing bulky groups leads to reaction problems at

Figure 1.6. G4 dendrimer and its monodispersed MS obtained from a convergent
approach.
higher generations.
An example of a single product generated using the convergent approach is
shown in Figure 1.6.46 Briefly, a polyphenylazomethine-based dendrimer, which consist
of a -conjugated backbone synthesized up to the 4th generation (G4) using the
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convergent method, led to a single macromolecular structure, as it was observed by
MALDI-TOF-MS. The product was monodispersed and showed a consistent molecular
weight (m/z 5451.26 [M + H]+). Figure 1.7 shows an example of how the divergent
approach affects the purity of the products by introducing defects that lead to
byproducts of diverse molecular weights.47 Briefly, a poly(propylene imine) dendrimer
synthesized via a divergent approach accumulated statistical defects as soon as the first
synthetic step, which led to imperfections in the G1, G2, G3, and final products (Figure
1.7. with m/z 740.6, 1622.0, 3384.0, 6909.7 for increasing generations of this

Figure 1.7. Main G4 dendrimer and polydispersed MS for its synthetic
divergent approach including G2, G3, and higher generations.
dendrimer).

1.3.3 Biomimetic Characteristics of Dendrimers
The synthesis of dendrons and dendrimers provides a precise and tunable
strategy for the controlled construction of macromolecules. Formed by reproducible
monomers, dendrimers are often compared to proteins due to their size and threedimensional structure, characteristics imparted by the forming monomers. Each
19

architectural component bears a specific function that will define specific properties in
the nanostructures, generation by generation. Dendrimers’ monodispersity and threedimensional architecture resemble the homogeneity of the naturally occurring proteins,
and closely mimic the globular shape and scale of the bio-macromolecules. These
characteristics grant dendrimers and dendrons the epithet of artificial proteins. 48,49
The groups that are primarily exposed to the solvent and nanoenvironment
surrounding them lie at the surface of the nanostructure. These functionalities might
consist of either reactive or unreactive terminal groups that impart important properties
to the macromolecule such as solubility, charge surface, accessibility to the interior from
the outside and to the outside from the interior, surface functionalization, and
specificity towards a target or stimulus. Within the interior of the nanostructure lie the
group functionalities that are less exposed to the solvent; these functionalities define
the type of interior based on the groups’ composition and branching, the hydrophobic
properties of the macromolecules, and also the host-guest properties. The spherical 3D
nanostructure generates a nanoenvironment at the inner layers of the dendrimer that
allows for encapsulation of small molecules kindred to that nanoenvironment. The core,
or focal point, provides information about the kind of monomer forming the dendrimer;
the size, shape, and directionality are expressed by the connectivity of the core towards
the outer layers.4
Such architectural components form the overall set of physicochemical
properties namely size, shape, flexibility, and reactivity of the dendrimers. In particular,
the encapsulation property of dendritic globular nanostructures and the possibility of
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altering that property, as a response to an external stimulus, resemble protein’s
characteristics, in which the active site is buried in hydrophobic pockets. Figure 1.8
shows a Fréchet type globular dendrimer which forms a unimolecular micelle, making it
a system free of CAC. Such structure bears a hydrophilic periphery that might be formed
by carboxylic acid functionalities (red beats in the figure) and a hydrophobic interior (red

Figure 1.8. Globular amphiphilic dendrimer with hydrophilic periphery and
hydrophobic inner layers.50
waving lines in the figure).50 Due to its globular shape and by means of the hydrophilic
periphery of the macromolecule, the whole structure is water soluble regardless of its
hydrophobic interior. Figure 1.8 clearly shows the voids in between hydrophobic
branches (green), which, though unrealistic, are a pictoric representation of where the
encapsulated hydrophobic molecules might remain trapped in a dendrimer
(hydrophobic interior).
Amphiphilic dendrimers, such as the one represented in Figure 1.8, should adopt
a globular shape in aqueous solution,4,48 displaying a hydrophobic core and hydrophobic
inner layers (green color) that could be used as pockets to encapsulate small
21

hydrophobic molecules in between the branches of the unimolecular micelle inner
layers. Encapsulation, one of the main characteristics of amphiphilic dendrons and
dendrimers, will be discussed in the next section.

1.3.4 Encapsulation of Molecules within the Dendritic Architecture
Due to the interstitial space between branches in the dendritic architecture, the
possibility of encapsulating hydrophobic small molecules has been explored thoroughly.
In amphiphilic dendrimers, water solubility is given by the hydrophilic groups at the
periphery, which wrap the hydrophobic inner layers screening them from the solvent. As
a result, the dendritic structure is water soluble regardless of its encapsulated
hydrophobicity. This phenomenon offers the possibility of using dendrimers and
dendrons to interact with poorly soluble or non-water soluble molecules, such as
drugs.51 The nature of guest non-covalent encapsulation could be simply physical
entrapment or, could involve interactions with the dendritic structure depending on the
branching functionalities.39
Encapsulation of hydrophobic small molecules in the hydrophobic interior of
dendrimers prevents them from precipitating out of an aqueous media. Given a
hydrophobic drug molecule, encapsulation would enhance its bioavailability and
circulation time in a biological system, improve its transit across biological barriers, and
slow drug metabolism. Given the right functionalization, a dendrimer could act as a
nanocarrier, taking the drug to specific types of cells i.e. active targeting rather than
passive targeting through enhanced permeation and retention effect (EPR). 34,51 Thus, a
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Figure 1.9. Unimolecular dendritic micelle for encapsulation of hydrophobic guests.
dendrimer with optimized characteristics would enhance drug bioavailability to diseased
cells, and would reduce the risk of the drug reaching healthy cells, preventing the side
effects of chemotherapies.52
One of the first dendritic systems forming a unimolecular micelle, able to
encapsulate guest molecules was described by Hawker and Fréchet. 39 The
macromolecule was a dendritic polyether synthesized by a convergent protocol and
based on the electron rich 3,5-dihydroxybenzyl alcohol unit as the primary building
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block. The final structure displayed carboxylate groups as terminal functionalities to
asses a hydrophilic periphery. Such a system had the capability of encapsulating
hydrophobic molecules like pyrene, anthracene, 1,4-diaminoanthraquinone, and
2,3,6,7-tetranitrofluorenone. The sequestration of these small molecules was tracked by
UV-VIS spectroscopy once they were solubilized by the dendrimer, which is shown in
Figure 1.9. For the encapsulated hydrophobic small molecules, the dendrimer showed a
high solubilizing power, which is also known as encapsulation efficiency. The reason for
this phenomenon was not only due to physical entrapment, but also to the formation of
stabilizing - interactions between the dendritic aromatic rings forming the
hydrophobic branches and the aromatic small molecules.
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However, hydrophobic components in dendrimers could potentially cause
precipitation of the entire system due to lack of solubility. Poly(ethylene glycol) (PEG)
has been conjugated to dendrimers and dendrons with the purpose of increasing the
hydrophilicity of the system and, in general, to translate the PEG properties to the
dendrimers. That is, PEG is usually conjugated to the surface of a dendrimer or a

Figure 1.10. G2 dendritic unimolecular micelle funtionalized with PEG.
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dendron to provide a biocompatible hydrophilic shell, diminish non-specific interactions
of the macromolecule in a biological media, and increase the circulation time of the
conjugated system.53
An example of a dendritic molecule capable of forming a unimolecular micelle
with a hydrophobic core surrounded by a hydrophilic shell is shown in Figure 1.10.
Briefly, the macromolecule was prepared by coupling a hydrophobic dendrimer with
PEG.

The

monomer

used

to

build

the

dendritic

core

was

4,4-bis(4’-

hydroxyphenyl)pentanol, which provided flexibility and, consequently, contributed to
the cavity size or container capacity of the dendritic architecture.53
The G2 micelle shown in Figure 1.10 contains a hydrophobic alkyl-aryl core
surrounded by a hydrophilic PEG shell. Such micelles were able to encapsulate
hydrophobic small molecules like pyrene and indomethacin. In general, it was found
that the encapsulation capacity for a unimolecular micelle depends on the generation
and the PEG chain length that is grafted to the dendritic hydrophobic core. 53
Encapsulation of small molecules within a dendrimer becomes interesting and
important from the pharmaceutical and sensing points of view, as long as there is a way
of triggering or controlling their release. For that, it is necessary to design dendritic
structures incorporating sensitive functionalities to render stimuli-responsive host-guest
systems. The next section refers to a particular class of stimuli-responsive dendrons that
self-assemble into aggregates able to encapsulate small hydrophobic molecules, rather
than forming unimolecular micelles.
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1.4 Stimuli-Responsive Supramolecular Aggregates formed by Biaryl Amphiphilic
Dendrons
Biaryl amphiphilic dendrons present a particular design in which hydrophilic and
hydrophobic moieties are displayed toward opposite directions in every layer of the
dendron. Unlike Fréchet type dendrimers, biaryl amphiphilic dendrons do not form
unimolecular micelles; instead these macromolecules self-assemble in water into
aggregates of sizes around 100 nanometers containing hydrophobic pockets. Such

Figure 1.11. Pictoric representation of biaryl amphiphilic dendrons forming a micellelike assembly in water (right) and an inverse micelle-like assembly in a non-polar
solvent (left).
pockets are product of the dendrons hydrophobic moieties collapsing towards the
interior of the aggregate, and the PEG chains being exposed towards the aqueous
solvent, shielding the nanoassembly from water. Surprisingly, when the same dendrons
are in a non-polar media, such as toluene, the self-assembly process evolves towards an
inverse micelle-like aggregate in which the hydrophobic moieties are exposed to the
solvent and the hydrophilic branches collapse towards the interior of the aggregate, as
shown in Figure 1.11.54,55
Although, by definition, this type of nanoassembly has a CAC, which could be
taken as a disadvantage when comparing them to dendritic unimolecular micelles; the
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capability of these dendrons to self-assemble presents an opportunity to control the
disassembly and, if no cleavage of covalent bonds is involved, to make the disassembly
event reversible.56 Furthermore, adding the non-covalent encapsulation of guest
molecules, disassembly is the key to produce release of a structurally unaffected guest
molecule, since the guest is not covalently conjugated to the dendron. It has been
observed that disassembly could be triggered by diverse stimuli, depending on which
responsive unit has been incorporated into the molecular structure of the dendron.

1.4.1 Temperature Sensitive Dendrimeric Supramolecular Aggregates
This section refers to amphiphilic dendrons that undergo temperaturedependent solubility changes once the lower critical solubility temperature (LCST), or
“cloud point”, is reached. There are many reports on temperature-sensitive hard and
soft nanoparticles.57,58,59,60 Such thermoresponsive materials could be utilized as drug
delivery vehicles for biomedical applications in thermotherapy (hyperthermia), which
involves exposure of the diseased cells or tissues to high temperature in order to
damage them. This therapy involves the use of clinically approved radiofrequency
ablation as a local heating system. LCST behavior has been observed and thoroughly
studied

in

poly(N-isopropylacrylamide)

polymers

(PNIPAM)

and

PEG

based

macromolecules. It has been determined that the LCST depends greatly on the balance
between hydrophilicity and hydrophobicity of the system.61
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a)

b)

Figure 1.12. Temperature sensitive dendrimers. a) G2 dendrimer incorporating
balanced hydrophilic and hydrophobic moieties in the backbone; b) G3 dendrimer
that forms micelle-like aggregates rather than unimolecular micelles.
Temperature-sensitive dendrimers could be prepared by conjugating them to
thermoresponsive polymers, either at the periphery or at the focal point. There are
amphiphilic dendrimers that showed the particularity of aggregating in micelle-like
assemblies with thermosensitive properties (Figure 1.12.b), i.e. LCST behavior.62 Such
dendrimers were formed using a hydrophobic oligo(p-phenylene vinylene) core and a
hydrophilic periphery consisting of oligoethylene glycol. The temperature sensitivity was
found to be dependent on the oligoethylene glycol moieties and on the dendrimer
generation. Dendrimers with a backbone that displays hydrophobicity and hydrophilicity
adequately balanced also act as temperature sensitive dendrimers. In fact, the first
report on a thermoresponsive dendrimer including temperature sensitive functionalities
as part of the backbone used oligoethylene glycol as a building block (Figure 1.12.a).63
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G1

G2

G3

Figure 1.13. Structure of temperature sensitive G1, G2, and G3 dendrons.
The concept of having hydrophilic and hydrophobic units in each building block is
applied in biaryl amphiphilic dendrons, in which oligoethylene glycol acts as a
hydrophilic moiety being present in every repeating unit of the molecular design along
with hydrophobic decyl fragments. This confers the dendrons, and their assemblies,
responsiveness toward changes in temperature in such a way that these systems exhibit
a macroscopic transition, or LCST, in which the assembly separates from the aqueous
phase at higher temperatures (42 oC for G1, 32 oC for G2, and 31 oC for G3). At these
temperatures the size of the supramolecular assemblies changes due to a decrease in
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the hydration of the oligoethylene glycol branches.64 Figure 1.13 shows the structure of
G1, G2, and G3 biaryl amphiphilic dendrons.
It was not until recently that a sub-LCST transition was found in the assemblies
formed by the biaryl G1 dendron; although this transition was not observed for the
assemblies formed by either G2 or G3 dendrons.64 Therefore this transition, which
occurs well below the LCST, was found to be dependent on the dendron generation. At
this sub-LCST, the size of the dendron supramolecular assembly changes significantly in
response to temperature variations due to an enhanced hydration of the oligoethylene
glycol branches. A larger energetic penalty for reorganization could be the reason for a
lack of sub-LCST transition in higher than G1 generation dendrons.

1.4.2 Photosensitive Dendrimeric Supramolecular Aggregates
Photoresponsive materials have found application in biomedical sciences, where
they have been developed for photodynamic therapy in the treatments of superficial
tumors and age related muscular degeneration. This technique involves the
photochemical generation of a reactive single oxygen species (1O2) directly on the
diseased site to cause oxidative damage of cells. Although dendritic nanoparticles
encapsulating or conjugated to photosensitizers have been developed, photodegradable
dendrimers constitute a more interesting class of light-sensitive systems.34,61 The latter
are called self-immolative dendrimers; after a photochemical reaction at the dendrimer
core, the entire molecule is broken down into low molecular weight fragments,
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ultimately resulting in the release of non-covalently encapsulated molecules or
covalently conjugated peripheral groups, as depicted in Figure 1.14.50,65

Figure 1.14. Self-immolative photoresponsive dendron.
In our lab, a class of photoresponsive biaryl amphiphilic dendrons was developed
by incorporating a photosensitive linker in the hydrophobic face of the design.66 While
PEG was used as the hydrophilic face, an o-nitrobenzylesther moiety was incorporated
as a linker in the hydrophobic chains in such a way that after photocleavage, a residual

Figure 1.15. Photosensitive biaryl amphiphilic dendron
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carboxylic acid functionality remains as part of the dendron backbone, terminating the
amphiphilicity of the system and causing disassembly, as depicted in Figure 1.15. If small
guest molecules are encapsulated in the hydrophobic core of the assembly, release can
be observed after photocleavage due to a change of the core’s hydrophobicity into
hydrophilicity, resulting in disassembly.
The same kind of previously mentioned micelle-like aggregates can be stabilized
through photochemical crosslinking, if the photosensitive moieties incorporated at the
hydrophobic face of the dendrons react with each other in a dimerization process after
photo-stimulus. Since photodimerization of coumarin is well known, a coumarin
derivative was used as terminal functional groups in the hydrophobic branches of the
dendron. As expected, after photo-stimulation at 365 nm the aggregate stage in solution
was locked.67 Since photodimerization of coumarin is reversible, the crosslinked micellelike nanoassembly can be decrosslinked simply by using a 250 nm wavelength light, as it
was inferred and it is shown in Figure 1.16.

Figure 1.16. Crosslink of dendrons in the aggregate stage
The crosslinking of dendritic aggregates increases the encapsulation stability of
the system, since the equilibrium between monomeric stage and micelle-like aggregate
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stage is shifted then towards the aggregate stage, preventing the inherent leakage due
to the equilibrium.

1.4.3 Protein-Sensitive Dendrimeric Supramolecular Aggregates
Bioresponsive materials are of great importance due to their potential to
respond to pathologically relevant stimuli.30,34,61,68 Among the known bio-stimuli, some
have greater relevance than others for they are directly related to diseases. Examples
are imbalances in protein concentrations or enzymatic activities,69,70,71 which are known
as primary imbalances of the human organism. Then, a system that disassembles and
releases cargo in presence of proteins presents advantages in comparison to either
thermoresponsive or photoresponsive systems.
The capability of a system to distinguish a target protein among a mixture by
molecular recognition is of great importance. Such specificity, capability of
encapsulation, nanometer size, and ability to prevent non-specific interactions are
characteristics that have been described for biaryl amphiphilic dendrons. Particularly,
the ability to respond to specific proteins can be embedded in these dendrons by
incorporating specific protein substrates.72 Using this concept, a dendritic aggregate was

Figure 1.17. Enzymatic cleavage of hydrophobic moieties of a dendron. Change in HLB
based on covalent modifications.
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made responsive to an esterase, as shown in Figure 1.17.
In Figure 1.17 an esterase cleaves the ester functionalities linking the

Figure 1.18. Protein-aggregate binding through non-covalent interactions change the
HLB of the dendron and the aggregate, triggering disassembly and release.
hydrophobic chains to the backbone of the dendron. As a result, the hydrophobic
terminal groups of the dendron are transformed into carboxylic acid functionalities.
Hence, by means of an enzymatic hydrolysis, the dendron loses its amphiphilicity and
HLB, which results in the aggregate disassembly.72 Although disturbing the dendron’s
HLB by breaking covalent bonds and increasing its hydrophilicity is a successful
approach, there are many non-enzymatic proteins that could be used as a target for
drug delivery. For such targets, non-covalent interactions remain as an option to disrupt
the HLB and trigger disassembly.
By tethering a ligand specific to the target protein, a dendron and its assembly
acquire specificity towards that protein. After the binding event, the enhanced
hydrophilicity of the protein disturbs the HLB of the dendritic aggregate, triggering
disassembly, and, as depicted in Figure 1.18, the release of guest molecules.73
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1.5 Summary
The importance of ligand-protein interactions has been reviewed along with
some of the most relevant methods for the screening of small molecules in the quest of
the pharmaceutical industry for hits and lead molecules. Among the different screening
methods, probably the most versatile and accessible are those based on fluorescence.
Most important, although tethering with at least one fluorophore is required in most
cases, fluorimetry based methods are rapidly adaptable as a HTS technique, which
presents advantages for screening high numbers of compounds in less time.
Some interesting characteristics of classical amphiphilic dendrimers, which form
unimolecular micelles, have been discussed in this chapter along with the recently
developed biaryl amphiphilic dendrons, which self-assemble to form nanometer size
aggregates able to non-covalently encapsulate hydrophobic small molecules. Unlike
unimolecular micelles, aggregates formed by biaryl amphiphilic dendrons are not rigid,
covalently bound nanostructures; on the contrary, when the biaryl dendrons are in
water, they form micelle-like aggregates but when they are in a non-polar solvent, they
form inverse micelle-like aggregates.
This chapter also explored the disassembly capability of the aggregates
depending on the responsive features installed in the dendrons and when stimuli are
applied. Once disassembly is triggered, the release of guest molecules is observed. We
discussed relevant stimuli, such as proteins, which could cause disruption in the
system’s HLB without breaking any covalent bond. For that method, the installation of a
ligand, specific to the target protein is necessary. In the upcoming chapters of this
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manuscript, we will discuss how the location of the ligand might affect disassembly of
the dendritic nanoaggregates and the release of encapsulated guest molecules. From
there, mechanisms to explain our results will be proposed.
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CHAPTER 2
SUPRAMOLECULAR DISPLACEMENT AND ACTIVATION OF A SILENT FLUORESCENCE
PROBE FOR LABEL FREE LIGAND SCREENING

2.1 Introduction
The ability of a small molecule to tightly bind to a target protein receptor is
arguably the most important criterion in drug development. For this purpose, the
development of reliable methods for rapidly screening small molecules against specific
proteins is essential. Current methods for small molecule screening include X-ray
crystallography,1 NMR,2 mass spectrometry,3,4,5 microcalorimetry,6 and fluorescence
based techniques,7,8,9 as mentioned in detail in the previous chapter. These techniques
are generally complementary to each other. While ITC gives the most valuable
thermodynamic information, such as precise binding affinities, the difficulty of adapting
it as a HTS technique makes it a more valuable method for validation those promising
molecule candidates found using other techniques more easily adaptable to HTS, such
as fluorescence and MS. On the other hand, techniques such as X-ray crystallography
give valuable information about the binding site and ligand interactions but again, it is
often only use as a validation method and less often for screening due to the amount of
target protein required and the need for adequate crystals for the measurements. 10
NMR is used as a validation method but also for screening, although the analysis of the
acquired data requires great expertise. An extra inconvenience of NMR screening
methods is the limitation in size for the target proteins, since samples larger than 30 kDa
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require labeling of at least one amino acid close to the binding site in order to facilitate
the interpretation of the data.
Among the different techniques, fluorescence stands apart as the premier tool
due to its simplicity and speed in analysis along with the easy adaptability of it as a HTS
method.11 However, most fluorescence-based approaches require labeling the target,
drug candidate, or analyte with dyes.12,13 Tagging adds another step of planning and
design to the screening process. To skip the labeling step, here we present a new labelfree, fluorescence-based supramolecular platform to rapidly discriminate binding
affinities of analytes against a target protein.

2.2 Approach and Molecular Design
The general scheme depicting the approach is shown in Figure 2.1. It is based on
the observation that when a small molecule binds to a protein, nearby proteins,

Figure 2.1. Label-free ligand screening. a) Probe characteristics; b) schematic illustration
of the strategy.
including enzymes, cannot bind to the small molecule, or at least not until it is dislodged
from the initial protein.
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In the strategy illustrated in Figure 2.1a, the probe is designed using a known
ligand that is complementary to the protein and is connected to a pro-fluorophore
through a linker.14 The key features of the molecular design are: (i) the linker is cleavable
by an enzyme; (ii) enzymatic cleavage of the linker converts the non-fluorescent
precursor to a water-soluble fluorophore; (iii) when the probe is bound to the target
protein, the linker is sterically inaccessible for the enzyme, as depicted in Figure 2.1b. By
designing a probe molecule that satisfies these requirements we envisaged the
possibility of using this system to screen small molecule binders for the target protein.
For this, the analyte small molecule with comparable or better binding affinity than the
probe molecule would be able to displace it from the protein, depending on its relative
concentration. This displacement would expose the enzyme-active linker,15 the cleavage

Figure 2.2. Probe structure. Benzenesulfonamide as the ligand, an ester group as the
cleavable linker, and umbelliferone as the reporter or fluorophore.
of which should result in the formation of the fluorophore. The concentrationdependence of the fluorescence generation can then be used to evaluate the ability of
the ligand candidates to bind the target protein.
To test this design hypothesis, we chose human carbonic anhydrase I (hCA1) as
the target protein, an interesting and well characterized protein that has been

46

implicated in a variety of pathophysiological processes.16,17 The molecular structure of
our probe is shown in Figure 2.2. Arylsulfonamide is a ligand for hCA1,18,19,20,21 while the
coumarin derivative, umbelliferone is an excellent fluorophore. The ligand and the
fluorophore are linked through an aliphatic chain bearing an ester bond. Coumarin is
attached to the ester through an acetal moiety, where the cleavage of the ester using
porcine liver esterase (PLE) would release the fluorophore, umbelliferone.
Since the binding pocket in hCA1 is a 15 Å deep cleft,21 the linker length of the
probe was designed to be modifiable in order to have two probes with different linker
lengths as this would impact the enzyme’s accessibility to the ester moiety. In this way,
we are making the linker length a critical component of our molecular design. As it will

Chart 2.1. Structure of the analyte molecules used in the assay and their literature-reported
binding affinities.9

Comp.
1
2
3
4
5
6
7
-9
-6
-6
-6
-6
KD(M) 9x10 1.15x10 1.67x10 3.4x10 90x10 N/A N/A
be shown in the synthesis of the probe, the attachment of the ligand is performed as a
final step to allow for the use of a variety of ligands, depending on the chosen protein to
target. This, along with the variations in the linker length renders the design modular.
The analytes to use, as represented in Figure 2.1b, must be a set of molecules with
diverse affinities for hCA1, ranging from excellent ligands with nanomolar affinity to
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ligands with middle and low affinity. These molecules are ethoxzolamide 1,
acetazolamide 2, p-toluenesulfonamide 3, 4-carboxybenzensulfonamide 4, and 4aminobenzenesulfonamide 5, which are shown in Chart 2.1. In this set, we have also
included analyte molecules that have not been reported as ligands for hCA1 and that
are unlikely to have any affinity for the protein, these molecules are p-iodoaniline 6 and
p-nitrophenol 7. The molecules used as ligands and their binding constants (KD) are
shown in Chart 2.1. Analyte 8 was synthesized as a probe analogue; lacking the esterase
substrate it will not be cleaved by PLE and, hence, will show no increase in fluorescence.
This analogue should have similar binding affinity as the probe.

2.3 Results and Discussion
2.3.1 Synthetic Strategy
In order to have a modular design and a working probe for the conditions of our
experiments, certain characteristics must be fulfilled. The most important of those
requirements is that the reporter must be silent, if we are to track the binding of the
analytes to the target protein; this means that the fluorescence of the fluorophore
should be very low when it is linked to the benzenesulfonamide moiety. Also, it should
be water soluble after enzymatic cleavage of the linker. For that purpose, 4methylumbelliferone, a coumarin modified with a methyl group in position 4 and with a
hydroxyl group in position 7 is an ideal molecule, for when it is O-alkylated at the
position 7 its fluorescence decreases considerably and when it is not alkylated its
solubility in water is better than an unmodified coumarin.
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It was observed that when an ester bond is directly formed at the position 7 of 4methylumbelliferone, it is rapidly hydrolyzed in a buffer solution at pH 7.4. However,

Scheme 2.1. Synthesis of the probes, (a) and ester group cleavage by an esterase or a
nucleophile (b).
when an acetal moiety is placed between the ester bond and the aromatic
umbelliferone the ester functionality remains stable during the timeframe of our
experiments. Also, by introducing a short spacer, as is the acetal, we prevent possible
hindrance from the 4-methylumbelliferone system on the PLE action over the ester
group.
The acetal and ester groups are formed in a two-step one-pot reaction between
4-methylumbelliferone 11, dibromomethane, and an alkyl carboxylic acid 9 in refluxing
acetone aided by the catalyst 18-crown-6, as shown in Scheme 2.1. The carboxylic acid is
the molecule that dictates the final length of the linker. As seen in Figure 2.2 for the two

49

probes with n = 4 and n = 8, the carboxylic acids used were 6-bromohexanoic acid 9a
and 10-bromodecanoic acid 9b, respectively. To prevent nucleophilic attacks on the
terminal carbon attached to the bromine, an planning on having a terminal primary
amine the halogen was substituted by an azide 10a,b before esterification by reacting
with sodium azide in N,N-dimethylformamide (DMF). Once the 4-methylumbelliferone
has been O-substituted in the 7 position 12a,b, the terminal azide is reduced to a
primary amine 13a,b through a Staudinger reduction in tetrahydrofuran (THF).
This reduction is a critical step when n = 4, since the newly formed amine can act
as a nucleophile and attack the carbonyl ester via an intramolecular cyclization to form a
7 membered -caprolactam, while recovering the 4-methylumbelliferone and releasing
the formaldehyde byproduct (Scheme 2.1b). The yield for this step was low. Finally, the
last step of the synthesis is the coupling of the ligand. Since the previously mentioned
scaffold 13a,b holds a primary amine, it is convenient that the ligand moiety has a
carboxylic acid functional group 14, in that way, the two fragments are tethered via
amide coupling in DMF using 1,1’-carbonyldiimidazole (CDI) as the coupling agent.

Scheme 2.2. Synthesis of analyte 8.
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The synthesis of the analyte 8 is faster and less troublesome to accomplish than
the synthesis of the probes, since 8 lacks the ester and acetal functionalities that are
prone to hydrolysis. So, as it is shown in Scheme 2.2, the analyte was synthesized
starting from the O-alkylation of 4-methylumbelliferone 11 with the commercially
available N-Boc protected 6-bromohexylamine 15, refluxing in acetone, using K2CO3 as
the base and 18-crown-6 as a catalyst to get 16. Then, the primary amine is deprotected
using trifluoroacetic acid in dichloromethane getting the molecule 17. Then, once again
the terminal amine can be attached to the ligand 14 through amide coupling using CDI
as the coupling agent to get the analyte 8.22

2.3.2 Supramolecular Displacement23
2.3.2.1 Hindering Enzymatic Action on the Probe
To first test our hypothesis, we chose the Probe A where the linker length is n=4
and exposed it to different concentrations of hCA1, as shown in Figure 2.3a. First, the
probe itself does not hydrolyze in the buffer without the enzyme (green line). Secondly,
while 5 µM concentration of Probe A with 50 nM PLE generated significant fluorescence
within a few seconds (red line), this combination did not generate meaningful
fluorescence in the presence of 20 µM hCA1 (blue line). At smaller concentrations of
hCA1, such as 15 µM, there was intermediate fluorescence (purple line) in presence of
PLE. Thirdly, we were surprised to find that the presence of hCA1 at a lower
concentration (10 µM), enhanced the enzymatic cleavage of the probe (black line). This
could be because the protein concentration is not enough to hinder enzymatic action on
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the ester moiety of Probe A during the binding equilibrium but helps in improving the
probe’s solubility, making it more available for the PLE.
When we tested 5 µM of Probe B, the probe itself also does not hydrolyze in the
buffer without the enzyme (green line) and is stable in the sole presence of 20 µM hCA1

Figure 2.3. Hindering enzymatic action on the probe. a) Probe A (5 µM) is exposed to
different concentrations of hCA1 and PLE 50 nM; b) Probe B (5 µM) is exposed to
hCA1 20 µM and PLE 50 nM.
(orange line). Exposing Probe B to 50 nM PLE generated significant fluorescence within a
few seconds (red line), similar to Probe A. However, under these conditions, a higher
fluorescence in the presence of 20 µM hCA1 (blue line) is generated, unlike Probe A.
This is due to the longer distance between the ligand moiety and the enzyme cleavable
bond in Probe B, which makes it more difficult for hCA1 to hinder the action of PLE.
Once again, the presence of hCA1 helped to improve the solubility of the probe and
enhance enzymatic cleavage of the probe, as seen in Figure 2.3b. This could be because
the protein does not sufficiently mask the ester moiety upon binding.
As shown in Scheme 2.1, both probes have a hydrophobic component that, to
some extent, could compromise their water solubility, especially for Probe B where n =
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8. Then, hCA1 acts as a solubilizing agent for the probes, when it is at lower
concentrations.

2.3.2.2 Pre-incubation Time
It is important for a HTS technique to be expedited in each of its steps. For this
label-free supramolecular displacement assay to fulfill that requirement, the time for
the binding event equilibration must be reasonable. Given the right concentration of
hCA1 needed to efficiently hinder enzymatic action on the substrate, 20 µM in our
experiments, the pre-incubation time with the probe was tested up to 18 hours.

Figure 2.4. Effective hCA1-Probe A pre-incubation time.
As seen in Figure 2.4, the pre-incubation timeframe for Probe A-hCA1 was
reduced to 15 minutes, after which PLE (50 nm) was added to the system. These
experiments were accomplished without losing the steric masking provided to the probe
by hCA1, since the difference in fluorescence intensity between just Probe A and PLE is
meaningful.
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2.3.2.3 Competitive Displacement
With the identification of a combination of Probe A and the optimal relative
Probe A:protein concentrations, along with their effective pre-incubation time, we were
interested in testing the possibility of competitive displacement of the probe from the
hCA1 binding pocket as an assay for the relative affinity of an analyte molecule. The
analyte molecules used for this purpose were mentioned previously and are shown in
Chart 2.1, along with their corresponding binding constants. Briefly, ligands 1-5 are
known to be good inhibitors for hCA1, while molecules 6 and 7 are randomly chosen
and are presumably not good ligands for hCA1. Analyte 8 should have a similar binding
affinity as the probe.

Figure 2.5. Displacement-mediated activity profiles generated by a) the analytes 1, 2,
4-7; and (b) 1, 3, 4, 8 with the slopes of the curve corresponding to the effective probe
displacement by the analytes
When different amounts of these molecules were introduced into a solution
containing a mixture of the Probe A:hCA1 (5:20 µM) and 50 nM PLE, the system showed
an increase in fluorescence as a response to increasing concentrations of molecules 1-5.
However, the response of the system to molecules 6 and 7 did not exhibit any
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appreciable change in fluorescence with concentration. The fluorescence profiles for the
set of molecules are shown in Figure 2.5a.
Three key features are evident from these plots: (i) analytes with strong to
moderate binding affinities can displace Probe A and the displacement profile can be
traced by the fluorescence evolution; (ii) since the relative concentration of Probe A vs.
hCA1 dictates that there are some free proteins in the system, the fluorescence
response remains flat in the initial part of the plot, which indicates that the ligands are
first binding to the excess free proteins;24 (iii) the slope of the fluorescence change
correlates with the analyte binding affinities, thus providing an opportunity to assess the

Figure 2.6. Control experiments. a) Probe A at 5 µM, hCA1 at 20 µM, PLE at 50 nM;
b) enzymatic activity of PLE (50 nM) on Probe A (5 µM) in presence of the analytes 18 (40 µM).
relative binding affinities of the analyte molecules tested (Figure 2.5b). When there are
no probe molecules remaining to be enzymatically hydrolyzed, the fluorescence stops
increasing and the displacement profile reaches a final plateau.
The experiment is complete once the concentration of analyte has reached 100
µM, which is achieved in less than 45 minutes. During that time, Probe A must remain
stable in the buffer media and PLE must be unable to hydrolyze the substrate. If so, the
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increase in intensity accounts for the analyte binding affinity to the target protein and
displacement of the probe. Figure 2.6a shows a control experiment with the highest
fluorescence intensity of the reporter reached by enzymatic cleavage of Probe A (blue
curve), and the probe in the buffer media (green line). The low fluorescence of the
combination of PLE exposed to the pre-incubated probe:hCA1 (red line), accounts for
the hCA1 esterase activity,25 which is much lower compared to the PLE activity on the
probe. The conditions of this control experiment and the displacement assays are
identical.
It is also important to note that the PLE activity is not inhibited by any of the
analytes to which the enzyme is exposed in solution. To confirm this, 5 µM of the probe
was exposed to 50 nM PLE in absence and presence of 40 µM of each analyte. As it is
shown in Figure 2.6b, PLE activity is not inhibited to any extent by any of the analytes 18.

2.3.3 Correlation between Binding Affinity and Displacement
The analyte molecules 1-5 were chosen for this approach mainly because they

Figure 2.7. Correlation between binding constants and fluorescence profiles. Fitting
equation: Log Slope = 0.2254 (-Log KD) + 5.5209; R2 = 0.9217
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have been reported as effective inhibitors for hCA1. It is clear that the trend in the
slopes obtained in our assays correlates well with the literature-reported KD values.
Since the displacement rate of the probe is directly related to the affinity of the analyte
for the binding pocket of the protein, which is reflected in the slopes of the fluorescence
profiles, in Figure 2.5 we provide an example of the type of qualitative comparison that
could be obtained with this method.
Molecules 3 and 4 have an identical functional group, benzene sulfonamide
(Chart 2.1); however, while 3 has a methyl group in para- position to the sulfonamide, 4
has a carboxylic acid functional group, which provides different hydrophilic properties.
This difference can be attributed to the higher affinity of 3, which is more hydrophobic
than 4. Molecule 8 has a carboxamide functional group at the para- position that could
be comparable to the carboxylic acid in 4, but this molecule is more hydrophobic than 3.
To test whether the hydrophobicity indeed influences the binding affinity, we tested the
relative binding affinity of 8 (Section 2.3.5). Our results suggest that 8 is indeed better
than 3, but as seen in Figure 2.5b, it is not as good of an inhibitor as 1.
From Figure 2.5, and based on the analysis above, the displacement assay
Table 2.1. Logarithmic correlation between binding constants and slopes from Figure
2.5a.
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described here is useful to qualitatively discriminate binding affinities of small molecules
for a target protein. Therefore, it is possible to evaluate the predictive capability of the
assay developed here. Figure 2.7 shows a correlation between the literature-reported KD
values and the slopes obtained from the linear regime of the plot in Figure 2.5a, where
there is significant fluorescence change. In Figure 2.7 we provide a numeric correlation
that could be used for predictive purposes as a calibration curve. In fact, using the
equation from the calibration curve (Log Slope = 0.2254 (-Log KD) + 5.5209), and the
slope displayed in Figure 2.5b (1.20 x 10-7), the numeric value obtained for the binding
constant of analyte 8 is 1.22 x 10-7 M, which represents a better binding constant than
analyte 3 but not as good as analyte 1, as was inferred qualitatively above. Table 2.1
shows the numeric values.
The reproducibility of the slopes obtained for the analytes and the experiment,
in general, is an advantage for the assay, if it is to be adapted as a HTS method.
It has been reported that the coumaryl moiety could contribute to the binding
affinity of a ligand.26 However, this could happen only if the sulfonamide ligand moiety is
connected to the coumaryl through a short linker (two or three carbons) in such a way
that when the ligand is completely bound to the binding pocket of the hCA1, the
coumaryl is buried into the binding site, since it can interact only with the amino acid
fragments buried deep in the binding cleft and not with the fragments close to the rim.
Although the coumaryl moiety could be contributing to the improved affinity of 8, and
consequently the affinity of the probe, this is not likely.
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Figure 2.8. Probe A displacement-mediated activity profiles generated by the analytes 1,
3, 4, 6, 7 with 96-well plate reader.

2.3.4 Adaptability as a HTS Method
The approach outlined here works well in providing an evaluation of relative
affinities, but does not provide direct quantitative binding affinity measurements.
However, the possibility of getting approximate binding constants through a calibration
curve has been introduced as an option. Therefore, for such an approach to be useful, it
is necessary that we can adapt this strategy for the rapid screening of analytes. For this
purpose, we further tested the versatility of our approach in a 96-wells plate reader setup. In such a setting, the volume of the components needed to generate a data point
would be low and the screening can be done in a highly parallel fashion. The data
generated from this experiment are shown in Figure 2.8 (compare with Figure 2.5a). The
results indeed are consistent and reliably reproducible. As it is observed from Table 2.1,
data for analyte 3 were incorporated from a similar experiment held at a different time
and yet, its binding constant value remains between the values of analytes 2 and 3. This
is an example of the methodology’s precision.
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2.3.5 Inhibitory Concentrations
As it was mentioned before, during the analysis of Figure 2.5, our results suggest
that analyte 8 is indeed better than analyte 3, but is not as good as 1. However, our
attempts to independently obtain KD values for 8 through isothermal titration
calorimetry (ITC) were unsuccessful due to precipitation issues in the concentration
regimes needed for the experiment. Although ITC is the best validation method
available, an alternative to compare the binding constants of Probe A, Probe B, and
analyte 8 is to evaluate affinities through a comparative binding assay e.g. inhibitory
concentration, or IC50.27 It is possible to get such values via an hCA1 inhibition assay
using 4-nitrophenyl acetate (NPA) as the substrate.28
In an hCA1 inhibitory assay, it is the esterase activity of the protein that is
evaluated. Since the active site is the same binding pocket targeted by the probes and
analytes, a molecule that binds at that site could be potentially used as an inhibitor for
hCA1. In the presence of hCA1, the ester bond in NPA is cleaved (Figure 2.9a); this event
can be tracked by UV-Vis spectroscopy through observing the maximum absorbance of
the p-nitrophenol (λabs = 348 nm), which is formed in situ. So, hCA1 must be preincubated with the inhibitors and then exposed to the substrate, NPA. Figure 2.9 shows
the inhibition profiles for Probe A, Probe B, and analyte 8.
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Figure 2.9. Inhibition of hCA1 (2 µM) activity on NPA (2 mM). a) Enzymatic cleavage of
NPA; b) analyte 8 as inhibitor; c) Probe A as inhibitor; d) Probe B as inhibitor.
The IC50 is found based on the normalized maximum absorbance of the pnitrophenol at a determined time of enzymatic action, in the presence of an inhibitor at
different concentrations. Indeed, we found the IC50 of 8 to be in the low micromolar
region (0.10 μM), close to the IC50 of Probe A (0.04 μM), although it was clearly a better
hCA1 inhibitor than Probe B (1.37 μM). Figure 2.10 illustrates the plots of concentration
of inhibitor against the percentage of hCA1 activity.
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Figure 2.10. IC50 of a) Probe A, b) analyte 8, c) Probe B.
The analogues with shorter linkers than Probe B show a better IC50. Although, for
the analogue 8 and the Probe A the coumaryl moiety might be contributing to improve
the affinity for hCA1, it could be that the less rigid nature of Probe B is diminishing its
affinity for the target. The IC50 values were measured in a Varian UV-Vis
spectrophotometer CARY 100, following the procedures described in literature.

2.4 Summary
In summary, we have introduced a new approach to screen the binding of small
molecules to proteins using a supramolecular displacement approach. Following are the
noteworthy features of our approach: (i) a protein-specific ligand is attached to a
fluorophore via an enzyme cleavable linker, which is chosen such that the cleavage
results in the generation of a water-soluble, high quantum yield fluorophore,
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umbelliferone; (ii) the linker length is chosen such that the enzyme-cleavable functional
group is sterically masked from the enzyme, when bound to the protein; (iii) molecules
with different binding affinities for the protein show different probe displacement
profiles to expose the enzyme cleavable functionality and thus exhibit affinitydependent fluorescence response; (iv) this approach can be rendered high throughput,
as this is easily translated to a multi-well plate reader based fluorescence measurement;
(v) a limitation of the approach is that one initial molecule with a reasonable binding
affinity for the target protein must be known to successfully design the fluorescent
probe and execute further ligand optimization. We envision that the design principles
outlined here have the potential to be broadly adapted for rapid screening of small
molecules against a protein target.

2.5 Experimental Section
2.5.1 Synthetic Procedures and Characterization of Compounds
All reagents and solvents were purchased from commercial sources and were
used as received. 1H-NMR spectra were recorded on a 400 MHz Bruker spectrometer
using residual proton resonance of the solvent as the internal standard.

13

C-NMR

spectra were recorded on a 100 MHz Bruker spectrometer. Fluorescence spectra were
recorded using a JASCO FP-6500 spectrofluorimeter. FAB-MS spectra were measured on
a JEOL JMS700. IR spectra were measured on a Bruker Alpha-P FT-IR.
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2.5.1.1 General Synthesis of Azidoalkanoic Acids 10a,b
To a solution of bromo alkanoic acid 9a,b (1 equivalent) in DMF (15 mL) was
added NaN3 (3.0 equivalents). This reaction mixture was heated at 80 oC for 18 hours,
stirring under argon atmosphere. After cooling to room temperature, most of the
solvent was evaporated under vacuum. The crude material was mixed with water (50
mL) and extracted with ethyl acetate (3 x 50 mL). The organic layers were collected on
Na2SO4. After filtration, the solvent was evaporated under vacuum to yield a yellowish
oil that was used for the next step without further purification.

2.5.1.2 General Synthesis of Azidoalkanoic-Coupled 4-Methylumbelliferone 12a,b
In a two-necked round bottom flask, 4-methylumbelliferone 11 (1.2 equivalents)
and dibromomethane (2.4 equivalents) were mixed and stirred in acetone (50 mL), with
K2CO3 (2.2 equivalents) and 18-crown-6 (0.2 equivalents) under argon atmosphere at
reflux for 1 hour. Then, the azidoalkanoic acid 10a,b was added (1 equivalent) with extra
dibromomethane (1.2 equivalents). The reaction mixture was refluxed for 18 hours.
Then, the reaction crude was filtered and washed with acetone. The filtrates were
collected and the solvent was evaporated. The crude was then poured into water and
extracted with ethyl acetate (5 x 100 mL). The organic layers were dried over anhydrous
Na2SO4, filtered, and concentrated in vacuo. The product was obtained after purification
using Combiflash chromatography.
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2.5.1.3 General Amide Coupling Reaction to get Probes a,b and Analyte 8
A

mixture

of

4-carboxybenzenesulfonamide

(1.5

equivalents)

and

carbonyldiimidazole (CDI) (1.8 equivalents) in anhydrous DMF was stirred for 20 minutes
under argon atmosphere. Then, the resultant solution was added to a solution of 4methylcoumarin-7-oxymethyl aminoalkanoate (1 equivalent) in anhydrous DMF stirring
under argon atmosphere at 50oC. After 12 hours, the reaction was cooled to room
temperature and the solvent was vacuum evaporated. Then, the crude was mixed with
aqueous solution of sodium bicarbonate to be extracted with ethyl acetate with 1%
methanol. The organic layers were dried over anhydrous Na2SO4, filtered and
concentrated. The remaining crude solid was washed with acetone to obtain the
product as the insoluble solid.

2.5.1.4 Synthesis of 4-Methylcoumarin-7-oxymethyl 6-Azidohexanoate 12a (DA-2-65)

According to the general procedure described above for coupling of
umbelliferone with azidoalkanoic acids, the reaction of 4-methylumbelliferone 11 (4.71
g, 27.0 mmol), dibromomethane (13.94 g, 80.0 mmol), 6-azidohexanoic acid 10a (3.50 g,
22.3 mmol), K2CO3 (6.77 g, 50.0 mmol), and 18-crown-6 (1.18 g, 4.5 mmol) in acetone,
yielded 1.98 g of a white solid 12a (35% yield). 1H NMR (400 MHz, CDCl3) δ 7.56 (d, J =
8.7 Hz, 1H, b), 7.03 (d, J = 2.1 Hz, 1H, d), 6.99 (dd, J = 8.7, 2.3 Hz, 1H, c), 6.22 (s, 1H, a),
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5.84 (s, 2H, e), 3.25 (t, J = 6.8 Hz, 2H, j), 2.44 (s, 3H, k), 2.42 (t, J = 7.5 Hz, 2H, f), 1.69 (tt, J
= 7.4 Hz, 2H, i), 1.65-1.52 (m, 2H, g), 1.47-1.36 (m, 2H, h). 13C NMR (100 MHz, CDCl3) δ
172.2, 161.1, 159.6, 155.2, 152.4, 125.9, 115.3, 113.3, 113.1, 103.5, 84.8, 51.3, 34.0,
28.6, 26.2, 24.3, 18.8. FAB-MS m/z calculated for C17H19N3O5 + H+: 346.3; found: 346.2.

2.5.1.5 Synthesis of 4-Methylcoumarin-7-oxymethyl 10-Azidodecanoate 12b

According to the general procedure described above for coupling of
umbelliferone with azidoalkanoic acids, the reaction of 4-methylumbelliferone 11 (2.97
g, 16.9 mmol), dibromomethane (8.76 g, 50.4 mmol), 10-azidodecanoic acid 10b (3 g,
14.1 mmol), K2CO3 (4.29 g, 31.0 mmol), and 18-crown-6 (0.74 g, 2.8 mmol) in acetone,
yielded 1.85 g of a white solid 12b (33% yield). 1H NMR (400 MHz, CDCl3) δ 7.52 (d, J =
8.6 Hz, 1H, b), 6.99 (d, J = 2.3 Hz, 1H, d), 6.95 (dd, J = 8.6, 2.4 Hz, 1H, c), 6.16 (s, 1H, a),
5.80 (s, 2H, e), 3.22 (t, J = 8.8 Hz, 2H, p), 2.39 (s, 3H, k), 2.38-2.32 (m, 2H, f), 1.65-1.54
(m, 4H, g-h), 1.45-1.15 (m, 10H, i-n). 13C NMR (100 MHz, CDCl3) δ 171.4, 160.4, 154.0,
153.1, 152.1, 125.4, 118.1, 114.3, 110.3, 51.3, 34.1, 28.7 (5C), 26.4, 24.5, 18.6. IR-FT (cm1

) 2917.2, 2849.1, 2085.0, 1707.6, 1262.1, 1128.1, 960.0, 842.5, 448.6.
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2.5.1.6 Synthesis of 4-Methylcoumarin-7-oxymethyl 6-Aminohexanoate 13a (DA-2121)

The 4-methylcoumarin-7-oxymethyl 6-azidohexanoate 12a (2.0 g, 5.8 mmol) was
dissolved in anhydrous THF and then, triphenyl phosphine (1.82 g, 7.0 mmol) was
added. The reaction was stirred under argon atmosphere for 5 hours at room
temperature. Afterwards, water (1 mL) was added to the reaction and the temperature
was increased to 50oC. After 5 hours, the reaction mixture was poured into water and
extracted three times with dichloromethane. The organic layers were dried over
anhydrous Na2SO4, filtered, and the solvent was evaporated. The product was purified
by silica flash column on Combiflash to obtain 240 mg (15% yield) of a white solid 13a.
1

H NMR (400 MHz, CDCl3) δ 7.53 (d, J = 8.7 Hz, 1H, b), 6.99 (d, J = 2.5 Hz, 1H, d), 6.96 (dd,

J = 8.5, 2.5 Hz, 1H, c), 6.18 (s, 1H, a), 5.99 (bs, 2H, q), 5.80 (s, 2H, e), 2.49-2.44 (m, 2H, j),
2.40 (s, 3H, k), 2.39-2.33 (m, 2H, f), 1.79-1.72 (m, 2H, g), 1.72-1.59 (m, 4H, h-i). 13C NMR
(100 MHz, CDCl3) δ 172.7, 162.1, 159.7, 155.0, 153.6, 126.0, 115.4, 113.1, 111.0, 103.5,
84.9, 43.2, 36.6, 34.1, 29.9, 23.4, 18.7. FAB-MS m/z calculated for C17H21NO5 + H+: 320.3;
found: 320.1.
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2.5.1.7 Synthesis of 4-Methylcoumarin-7-oxymethyl 10-Aminodecanoate 13b (DA-250)

The 4-methylcoumarin-7-oxymethyl 10-azidodecanoate 12b (0.70 g, 1.75 mmol)
was dissolved in ethanol (15 mL) and then, zinc (0.15 g, 2.27 mmol) was added to the
mixture.29 An aqueous solution (5 mL) of ammonium chloride (0.22 g, 4.01 mmol) was
added to the reaction mixture and then, it was refluxed for 30 minutes. The reaction
was stopped and the ethanol was evaporated in vacuo. More water was added to the
remaining mass and then extracted with ethyl acetate (3 x 20 mL). The organic layers
were dried over anhydrous Na2SO4, filtered, concentrated, and purified by column
chromatography. The product was recovered as 0.16 g of a white solid 13b (25% yield).
1

H NMR (400 MHz, MeOD) δ 7.75 (d, J = 8.8 Hz, 1H, b), 7.09 (dd, J = 8.8, 2.5 Hz, 1H, c),

7.05 (d, J = 2.4 Hz, 1H, d), 6.24 (s, 1H, a), 5.89 (s, 2H, e), 2.90 (t, J = 7.8 Hz, 2H, p), 2.47 (s,
3H, k), 2.39 (t, J = 7.2 Hz, 2H, f), 1.64-1.58 (m, 4H, g,n), 1.40-1.27 (m, 10H, i-m), 1.24 (s,
2H). 13C NMR (100 MHz, MeOD) δ 175.3, 160.5, 159.0, 156.0, 154.1, 131.2, 115.1, 114.4,
109.1, 101.1, 85.6, 42.3, 35.3, 34.4, 30.1, 30.0, 29.9, 27.0, 19.6. FT-IR (cm-1) 2917.2,
2849.1, 1724.1, 1614.8, 1262.1, 1128.1, 960.0, 842.5, 448.6. FAB-MS m/z calculated for
C21H29NO5 + H+: 375.5; found: 375.2.
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2.5.1.8 Synthesis of 4-Methylcoumarin-7-oxymethyl 6-(4Sulfamoylbenzamido)hexanoate, Probe A

According to the general procedure described above for the reaction of 4methylcoumarin-7-oxymethyl 6-aminohexanoate 13a (0.16 g, 0.50 mmol) with 4carboxybenzenesulfonamide 14 (0.15 g, 0.75 mmol) and CDI (0.15 g, 0.90 mmol) in DMF,
0.10 g of a white solid were obtained as the product Probe A (40%). 1H NMR (400 MHz,
DMSO-d6) δ 8.58 (t, J = 5.4 Hz, 1H, q), 7.96 (d, J = 8.5 Hz, 2H, x), 7.88 (d, J = 8.3 Hz, 2H,
y), 7.73 (d, J = 8.8 Hz, 1H, b), 7.47 (s, 2H, z), 7.12 (d, J = 2.4 Hz, 1H, d), 7.06 (dd, J = 8.7,
2.5 Hz, 1H, c), 6.27 (s, 1H, a) 5.89 (s, 2H, e), 3.19 (dd, J = 13.0, 6.6 Hz, 2H, j), 2.40 (s, 3H,
k), 2.39 (t, J = 8.0 Hz, 2H, f), 1.61-1.51 (m, 2H, g), 1.52-1.42 (m, 2H, i), 1.32-1.21 (m, 2H,
h).

13

C NMR (100 MHz, DMSO-d6) δ 172.5, 165.7, 160.4, 159.6, 154.9, 153.9, 146.6,

138.1, 128.2, 127.4, 126.2, 115.1, 113.5, 112.6, 103.6, 85.0, 33.7, 29.2, 26.3, 24.5, 18.7.
FAB-MS m/z calculated for C24H26N2O8S + H+: 503.5; found: 503.2.

2.5.1.9 Synthesis of 4-Methylcoumarin-7-oxymethyl 10-(4Sulfamoylbenzamido)decanoate, Probe B (DA-2-70)
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According to the general procedure described above for the reaction of 4methylcoumarin-7-oxymethyl 10-aminodecanoate 13b (0.16 g, 0.43 mmol) with 4carboxybenzenesulfonamide 14 (0.13 g, 0.65 mmol) and CDI (0.13 g, 0.78 mmol) in DMF,
0.09 g of a white solid were obtained as the product Probe B (38%). 1H NMR (400 MHz,
DMSO-d6) δ 8.60 (t, J = 5.0 Hz, 1H, q), 7.97 (d, J = 8.5 Hz, 2H, x), 7.88 (d, J = 8.2 Hz, 2H,
y), 7.74 (d, J = 8.7 Hz, 1H, b), 7.47 (s, 2H, z), 7.11 (d, J = 2.4 Hz, 1H, d), 7.07 (dd, J = 8.7,
2.5 Hz, 1H, c), 6.28 (d, J = 1.1 Hz, 1H, a), 5.89 (s, 2H, e), 3.23 (td, J = 8.0, 4.0 Hz, 2H, p),
2.40 (s, 3H, k), 2.36 (t, J = 7.1 Hz, 2H, f), 1.51-1.44 (m, 4H, g,n), 1.28-1.09 (m, 10H, h-m).
13

C NMR (100 MHz, DMSO-d6) δ 171.9, 165.0, 160.1, 158.9, 154.5, 153.4, 146.4, 137.5,

127.8, 126.81, 125.6, 114.8, 112.9, 112.2, 103.1, 84.3, 33.3, 28.6, 28.2, 26.6, 24.2, 18.1,
7.5. FAB-MS m/z calculated for C28H34N2O8S + H+: 559.6; found: 559.3.

2.5.1.10 Synthesis of tert-butyl (6-((4-Methylcoumarin-7-yl)oxy)hexyl)carbamate 16
(DA-2-52)

The compound 16 was obtained from the O-alkylation of 4-methylumbelliferone
11 with the commercially available N-Boc protected 6-bromohexylamine 15 using K2CO3
(2 equivalents) as the base, and 18-crown-6 (0.2 equivalents) as the catalyst, refluxing in
acetone for 13 hours (43% yield). C21H29NO5, 1H NMR (400 MHz, CDCl3) δ 7.48 (d, J = 8.8
Hz, 1H, b), 6.84 (dd, J = 8.8, 2.5 Hz, 1H, c), 6.79 (d, J = 2.4 Hz, 1H, d), 6.12 (sd, J = 1.1 Hz,
1H, a), 4.53 (bs, 1H, q), 4.00 (t, J = 6.4 Hz, 2H, e), 3.13 (dd, J = 12.2, 6.0 Hz, 2H, j), 2.39 (s,
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3H, k), 1.90-1.74 (m, 2H, f), 1.59-1.33 (m, 15H, g-i, w). FAB-MS m/z calculated for
C21H29NO5 + H+: 375.5; found: 375.2.

2.5.1.11 Synthesis of the Analyte 8 (DA-2-64)

After deprotection of the amine functionality in 16 with trifluoroacetic acid in
dichloromethane at room temperature, the mixture was concentrated in vacuo and the
remaining dry oil 17 was dissolved in anhydrous DMF and coupled with 4carboxybezenesulfonamide 14 in presence of CDI following the procedure for the
general synthesis of the probes (n=4, n=8). The product 8 was obtained as a white solid
(7%). 1H NMR (400 MHz, MeOD) δ 7.96 (d, J = 8.0 Hz, 2H, x), 7.95 (d, J = 8.0 Hz, 2H, y),
7.66 (d, J = 8.8 Hz, 1H, b), 6.93 (dd, J = 8.8, 2.4 Hz, 1H, c), 6.89 (d, J = 2.4 Hz, 1H, d), 6.16
(d, J = 1.1 Hz, 1H, a), 4.09 (t, J = 6.3 Hz, 2H, e), 3.42 (t, 2H, j), 2.45 (s, 3H, k), 1.92-1.79 (m,
2H, f), 1.74-1.64 (m, 2H, i), 1.64-1.54 (m, 2H, g), 1.54-1.44 (m, 2H, h). 13C NMR (100 MHz,
DMSO-d6) δ 165.1, 162.0, 160.4, 154.9, 153.5, 146.2, 137.7, 128.0, 126.5, 125.7, 113.1,
112.5, 111.1, 101.3, 68.4, 29.1, 28.5, 26.3, 25.3, 18.3. FAB-MS m/z calculated for
C23H26N2O6S + H+: 459.5; found: 459.2.
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2.5.2. Protocols for Screening Experiments
2.5.2.1 Protocol for Screening of Analytes
A stock solution of the Probe (1.0 x 10-2 M) was prepared in DMSO and then 5 µL
of this stock was dissolved in 10 mL of HEPES buffer (50 mM, pH 7.4). 1 mL of this
solution was transferred to a cuvette. A solution of hCA1 (5.0 x 10-4 M) was prepared
and 40 µL of it were mixed with the 1 mL Probe solution in the cuvette, leaving the final
solution to stir gently for the pre-incubation time (15 min - 5 h). The concentrations of
Probe and hCA1 in the cuvette are 5 and 20 µM respectively.
A solution of the esterase (PLE, 5.0 x 10-5 M) was prepared and 1 µL of this
solution was transferred to the cuvette with the pre-incubated Probe and hCA1. A
fluorescence spectrum at this time showed no increase in the intensity before and after
exposure to the esterase. The concentration of PLE in the cuvette was 50 nM.
Stock solutions of the analytes (1 x 10-2 M) were prepared in DMSO. For a given
analyte, 100 µL of its stock were diluted to 1 mL with the buffer and mixed well. Then, 5
µL of this analyte solution were transferred to the cuvette with the solution of Probe,
hCA1, and PLE. After two minutes, 5 µL more of the analyte solution are added. The
same volume of the analyte solution is added every two minutes until the end of the
experiment. The evolution of the experiment was tracked by fluorimetry during 35 to 50
minutes, depending on the affinity of the analyte for the target protein. The increasing
concentration of the analyte in the cuvette generates a fluorescence profile with time
(sigmoidal shape), depending on the affinity of the analyte for the target protein.
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2.5.2.2 Protocol for Screening of Analytes in a 96 Well Plate Reader
The protocol for the plate reader experiments follows the same principles
applied in the cuvette based assay. From a stock solution of the Probe (1.0 x 10 -2 M) in
DMSO 5.0 µL were dissolved in 10 mL of HEPES buffer (50 mM, pH 7.4). To a different
vial 6.0 mL of the Probe solution 5.0 µM were transferred and hCA1 was added until
reaching the concentration of 20 µM. This solution was left stirring gently to preincubate (15 min to 1 h).
Solutions of 2.0 x 10-3 M of the analytes were prepared. 400 µL of the previous
analyte solutions were diluted to 2.0 mL with buffer solution. A PLE solution (10 mL, 5
µM) was also prepared.
The wells in the plate are set with 200 µL of the pre-incubating solution. 2 µL of
the PLE solution were added to the wells plate and their fluorescence were recorded.
Then, 1 µL of the analyte solutions were added every two minutes and the evolution of
the experiment was followed by fluorimetry.

2.5.2.3 Criteria Used for Calculating the Slope
Once the displacement-mediated activity profiles were generated, the data
involved in the linear increment in fluorescence were selected to analyze the difference
in binding affinity. Out of this selected data, only the data points with a higher value
than the inflection point were selected to calculate the slope of the curve, trying to
avoid any incidence of the excess hCA1 binding.
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2.5.2.4 Finding Optimal Pre-incubation Time
A solution of Probe A (5 µM) in buffer (HEPES 50 mM, pH 7.4) was pre-incubated
with hCA1 (20 µM) for different times (15 min, 1 h, and 5 h). Then, the solutions were
exposed to PLE (50 nM) and the fluorescence spectra were registered. The evolution of
the emission intensities with time were plotted in order to find the minimal time that is
required for the pre-incubation of probe with hCA1 (Figure 2.4).

2.5.2.5 Enzymatic activity of PLE in Presence of the Analytes 1-8
To a cuvette, with 1 mL solution of Probe (5 µM) and analyte (1-8) (40 µM) were
added 1 µL of PLE (50 µM) and the evolution of fluorescence (λ exc: 365 nm, λem: 445 nm)
was measured every minute for 7 minutes and after 20 to 50 minutes. The enzymatic
activity of the PLE was not affected by any of the analytes as is shown in Figure 2.6b. A
curve from a control experiment just exposing Probe A to PLE in the same
concentrations as before is also shown.
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CHAPTER 3
PROTEIN-TRIGGERED SUPRAMOLECULAR DISASSEMBLY OF DENDRITIC AGGREGATES
BASED ON LIGAND LOCATION

3.1 Introduction
Host systems that can spontaneously self-assemble and stably encapsulate guest
molecules under one set of conditions, but disassemble and release the guest molecules
when external conditions change, have been of great interest in supramolecular
chemistry due to implications in a variety of biomedical applications.1,2,3,4 While earlier
studies have primarily focused on properties observed initially, i.e. self-assembly and
binding, there has been a recent surge in interest in the latter features i.e. disassembly
and release in response to an environmental change.
The responsiveness of the assemblies has primarily focused on physical or
chemical changes. For example, there has been a significant interest in systems that
disassemble in response to chemical stimuli such as pH5,6 or redox7,8 variations, as well
as physical stimuli such as light,9,10 temperature,11,12,13 or a magnetic field.14,15 While
systems incorporating features sensitive to light and magnetic field have been designed
to respond to external triggers for biological applications, pH- and redox- responsive
systems have been designed to respond to the inherent imbalances observed in certain
diseased tissues. The anomalous pH or redox conditions in disease locations can be
considered to be secondary imbalances, as the primary imbalances in biology are the
result of aberrant protein concentrations or enzymatic activity.16,17,18 Therefore, there is
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a growing interest in rendering supramolecular systems that respond to these primary
factors in biology.19,20,21,22,23,24,25,26
Protein-responsive systems can be broadly classified into two categories, viz.
covalent modification of the hosts to disable their capacity to hold the guest molecules
and non-covalent modification of the host assemblies to produce the same effect. 27,28,29
The former is often achieved by an enzyme-driven chemical reaction that modulates the
host characteristics of the molecule; in the latter case, this is achieved due to a noncovalent binding interaction. While there have been several systems designed to be
degradable or covalently modified by enzymes,30 supramolecular assemblies that lose
their host capacities due to non-covalent binding with proteins have been limited.
Among the systems that undergo binding induced disassembly, polyelectrolyte
assemblies that can non-covalently bind a complementarily charged surface to cause a
disassembly have attracted some attention.31,32,33,34 Although non-specific in its
interaction, the simplicity of these systems has proven useful in applications such as
specific separations of peptides.35,36 It has also been clear that for a binding induced
approach to be useful in applications such as delivery and sensing, where specificity is
critical, strategies that use specific ligand-protein interactions are needed.37,38,39 Since
dendritic macromolecules can be produced in high molecular weights, but with a great
degree of control, these scaffolds have certain unique advantages for this strategy.40,41
For example, the critical aggregate concentrations of the dendrimer-based amphiphilic
assemblies are low, an advantage that polymeric systems have over small moleculebased amphiphilic assemblies. Similarly, the control over functional group placements in
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dendritic architectures captures the advantage that small molecules have over their
polymeric counterparts.42
The features mentioned above allow for structure-property relationship studies
that unravel the factors that underlie the binding induced supramolecular disassembly
process. In this chapter, we take advantage of this unique feature by incorporating
specific locations within facially amphiphilic dendrons and interrogating the efficiency of
supramolecular disassembly and molecular release in response to a specific protein
binding event. We use both experiments and some of the molecular dynamics (MD)
simulations developed by our collaborators to gain insights into the ligand-protein
recognition based disassembly event.43

3.2 Approach and Molecular Design
Facially amphiphilic dendrons, containing a biaryl-based internal repeat unit and
an aryl peripheral unit, both consist of hydrophilic and hydrophobic functional groups as
side chains in each of these repeat units.44,45 The amphiphilic functional groups are
placed at opposite faces of the biaryl backbone of the dendron such that these
molecules are endowed with the capability to form micelle-like assemblies in aqueous
phase and form inverse micelle-like assemblies in apolar solvents.46,47 In preliminary
findings from our lab, it has been shown that placing a ligand moiety at the hydrophilic
face of the dendron can provide binding-induced disassembly of the micelle-like
structure in the aqueous phase.37 In that work, the ligand moiety was placed at the focal
point of the dendron, as this structure is synthetically most easily accessible. However,
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Figure 3.1. G2 and G1 dendrons molecular design. Schematic of self-assembly
sequestering hydrophobic small molecules, and releasing them upon protein binding.
Nomenclature of the design in the bottom right part.
the release efficiency of guests following to protein binding was relatively low reaching
43% for G1 and G2. In order to fully realize the potential of this process, it is critical that
we understand the effect of the functional group placement, hence taking advantage of
one of the most critical advantages of dendritic architectures in this supramolecular
process. Thus, in this chapter, we investigate the effect of the placement of a proteinspecific ligand moiety at specific positions of a dendron upon the accessibility of the
complementary protein to the supramolecular assembly, and hence the effects on the
concomitant guest release response as it has been represented in Figure 3.1.
The CAC of even the first generation of this kind of dendrons is substantially
lower than the corresponding amphiphilic small molecule (µM compared to mM).
Within each generation of dendrons however, the CAC gain has been relatively small, if
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Figure 3.2. Possibilities to target a single position in each layer of a dendron.
any, especially when one accounts for the difference in molecular weights. Therefore,
here we focus on the G1 and G2 dendrons, which provide sufficient variations in the
functional group placement. We targeted five different dendrons within these two
generations, where the ligand placement is the key difference as it can be appreciated
from the structures in Figure 3.1. Pentaethyleneglycol monomethylether (PEG) was
chosen as the hydrophilic moiety not only for its ability to provide the macromolecules
and the nanoassembly with the requisite solubility in the aqueous phase, but also for its
propensity to present a charge neutral surface on the assembly that exhibits minimal
non-specific interactions.48 Decyl moieties were incorporated as the hydrophobic
components of the amphiphile. Biotin was chosen as the ligand, because of its wellestablished high affinity towards avidin.49,50
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As it is shown in Figure 3.2, a ligand can be incorporated on a G1 dendron either
at the focal point or at the periphery. On a G2 dendron, a ligand can be incorporated on
three different layers: (i) the focal point; (ii) the middle layer; and (iii) the periphery. To
install a single ligand at a specific place, one of the PEG units was replaced by the ligand,
attaching it to the dendron backbone via a hydrophilic linker. This placement allows the
ligand to be exposed to the aqueous solution on the hydrophilic face of the assembly.
Note from Figure 3.2 that the focal point is synthetically the easiest place to
attach a single functional group, since the focal point is a single and unique position in a
dendron. However, to install a single functional group at the periphery, it is necessary to
distinguish one of the peripheral monomers from otherwise identical positions within
the dendron.
The G1 dendron has two such identical positions in the periphery, while the G2
dendron has four such locations. Similarly, the middle layer of the G2 dendron contains
two similar positions that need to be distinguished for specifically placing a ligand
moiety. Accordingly, the degree of difficulty in placing a unique functional group in the
dendron increases as we move from the focal point to the periphery and as we increase
the generation. To achieve these selective functionalization, we and others have
developed a variety of synthetic strategies that afford multi-functionalized dendrons
and dendrimers.42,51,52,53
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3.3 Results and Discussion
3.3.1 Synthetic Strategy
In all our syntheses, we initially targeted dendrons containing an acetylene
moiety, which will be used as the handle to “click” the biotin moiety in the last steps of
the syntheses. Overall, we made the syntheses of the dendrons modular in order to
assemble the targeted dendrons in a small number of steps. Accordingly, we first
synthesized the biaryl protected AB2 monomer 7 (Scheme 3.1), the propargylfunctionalized periphery unit 12, and the non-functionalized amphiphilic periphery unit

Scheme 3.1. Synthesis of protected AB2 monomer 7.

13 (Scheme 3.2) following the previously reported procedures.
Scheme 3.1 shows the synthesis of the protected AB2 monomer 7. First, from
commercially available 3,5-dimethoxybromobenzene 1 involving (i) deprotection of the
phenolic hydroxyl groups from the methyl substituents, (ii) treatment of the phenolic
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hydroxyls with MOM-Cl to introduce a protecting group easier to handle in 3 and, (iii)
conversion of the bromo functionality to a stannane 5. The bottom aryl ring 6 was
obtained from 4-bromo-3,5-dihydroxybromobenzoic acid 2. This involves, first,
esterification of the acid followed by mono-O-alkylation of a phenolic hydroxyl by
means of treatment with n-bromodecane in the presence of potassium carbonate and
18-crown-6 to get 4. Secondly, protection of the remaining hydroxyl by means of an Oacetylation to get 6. The stille coupling between the aryl stannane 5 and the
arylbromide 6, followed by deprotection of the acetyl-protected hydroxyl and the
reduction of the ester moiety, was accomplished in one step to generate the benzyl
alcohol and biaryl AB2 monomer 7.
Scheme 3.2 shows the synthesis of periphery containing an alkyne moiety 10.
First, mono O-alkylating 3,5-dihydroxybenzyl alcohol 8 using n-bromodecane in the
presence of potassium carbonate and 18-crown-6 to get 9. The mono alkylated
compound 9 could be further treated with propargyl bromide using the same conditions
of O-alkylation than before to yield the propargyl bearing periphery 10. Compound 9
could also be treated with PEG-Ts in the same conditions to get amphiphilic periphery
11. The resultant hydroxymethyl compounds 10 and 11 were converted to the
corresponding bromides 12 and 13 respectively, using phosphorus tribromide.
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Scheme 3.2. Synthesis of periphery bearing either propargyl or PEG.

Scheme 3.3. Synthesis of biotin azide 18.

Scheme 3.4. AB2 monomer.
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In order to attach the biotin ligand to the dendrons through click chemistry, not
only the installation of a propargyl unit on the dendrons structure is imperative, but also
the functionalization of the ligand with a pendant azide. Scheme 3.3 shows such biotinazide preparation. Briefly, it involves the amine-protection of 2-(2-aminoethoxy)ethanol
14 to get 15, which is followed by mesylation of the alcohol moiety and then, treatment
with sodium azide to obtain the azide-compound 16. Next, the amine functionality of 16
was de-protected upon acidic treatment to get the amino-azide 17, which is coupled
with biotin as a final step to the biotin azide 18.
To achieve the targeted dendrons G1 and G2 (see Figure 3.1 for structures), it is
imperative to deprotect and further functionalize the AB2 molecule 7. In Scheme 3.4 the
functionalization of 7 is accomplished in two different ways, (i) using propargyl bromide
and (ii) using PEG-Ts in the conditions for alkylation described above.

3.3.1.1 Synthesis of Final G1 Dendrons
To achieve G1-P, the biaryl monomer 20 was first mono-alkylated with a
periphery unit 12 to get the propargyl-functionalized scaffold 21 (Scheme 3.5) in 25%
yield. The low isolated yield was because of the statistical distribution mono- and disubstituted products obtained in this reaction. It is worth to mention that although the
di-substituted product has no further use in our synthetic design, the initially attempted
mono-substitution of monomer 20 with periphery 13 generated also a di-substituted
byproduct, which could have been used for the synthesis of G2 dendrons. However, the
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isolation of such mono-alkylated product from the di-alkylated byproduct could not be
accomplished due to their similar polarities and close retardation factors (Rf).
Molecule 21 was then treated with the amphiphilic peripheral monomer 13
under similar alkylation conditions to achieve the G1 dendron 22 containing the reactive
propargyl moiety at its periphery. The G1 dendron 22 was then treated with the azide
modified biotin 18 under click chemistry conditions54,55,56,57 in presence of copper(II)
sulfate and sodium ascorbate to obtain the final G1 dendron with a single biotin moiety
installed at the periphery G1-P in 70% yield.

Scheme 3.5. Synthesis of G1-P and installment of the ligand at the periphery.
Similarly, as shown in Scheme 3.6, the molecule G1-F was synthesized starting
from the monomer 19, which was dialkylated with periphery units 13 to get the
dendron 23 in a single step. Notice the difference in yields with the two steps required
to get dendron 22. Then, by clicking the biotin azide 18 to the propargyl moiety present
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in the biaryl repeat unit of 23, we got the G1 dendron with a single biotin moiety
installed at the focal point G1-F.

Scheme 3.6. Syntesis of G1-F.
3.3.1.2 Synthesis of Final G2 Dendrons
Before the next steps towards the targeted G2 dendrons, the hydroxymethyl
moieties of G1 dendrons 22 and 23 were transformed into the corresponding
bromomethyl fragments 24 and 25 respectively, which are shown in Figure 3.3. These
substitutions were accomplished using phosphorus tribromide in the same conditions
that rendered the periphery amphiphiles 12 and 13 (Scheme 3.2). In the same way, the
dendron obtained from dialkylation of the monomer 20 with two periphery units 13 is
rendered into its bromomethyl derivative 26.
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Figure 3.3. Brominated G1 dendrons.
The syntheses of the targeted G2 dendrons were achieved using a similar set of
synthetic strategies than for G1-P and G1-F, as shown in Scheme 3.7. To achieve the
syntheses of these dendrons, the previously described amphiphilic G1 dendron 26 was
treated with the biaryl monomer 20, where the mono-alkylated product 27 was
separated from a statistical mixture in 24% yield. In this case, although the isolation of
the mono-substituted product from the di-substituted byproduct was the bottle neck of
the entire synthesis, the byproduct can be used as a control dendron for the
disassembly and release experiments. Also using a brominated dendron 24, which is
more difficult to obtain than 26, to mono-substitute 20 produces a di-substituted
byproduct that does not have any further use in our designed synthesis. Monosubstituting 20 with brominated dendron 25, which takes the same number of synthetic
steps than 26, also generates a byproduct that has no further use in our synthetic
design.
Molecule 27 was then treated with the bromomethyl dendron 25 or 24 to obtain
the G2 dendrons 28 or 29, containing the propargyl moiety at the middle layer or the
periphery of the dendron respectively. Copper-catalyzed Huisgen reaction of 28 and 29
with the azide-functionalized ligand 18 afforded the dendrons with a single biotin
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Scheme 3.7. Synthesis of G2-M and G2-P.
moiety installed at the middle layer G2-M, and a single biotin moiety installed at the
periphery G2-P, respectively (Scheme 3.7).
In a similar fashion than with dendron G1-F, to get a single biotin unit installed at
the focal point of a G2 dendron, G2-F, we started from the monomer 19, which was dialkylated with the brominated G1 dendron 26 to get the G2 dendron 30, bearing a
propargyl fragment at the focal point in a single step. Then, by clicking the biotin azide
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18 to the propargyl moiety present in 26, we got the G2 dendron with a single biotin
moiety installed at the focal point G2-F. This synthesis is shown in Scheme 3.8.

Scheme 3.8. Synthesis of G2-F.
3.3.2 Self-Assembly and Determination of CACs of Dendrons
The self-assembly properties of the target dendrons G1-F, G1-P, G2-F, G2-M, and
G2-P in water were studied before trying to understand their disassembly. For this
purpose, Nile red was used as the hydrophobic spectroscopic probe. After
encapsulation, the CACs of the dendrons were determined using the fluorescence
intensity of Nile red (λem= 615 nm), as shown in Figure 3.4. Since Nile red is a
hydrophobic small molecule it is not water soluble and precipitates if it is exposed
directly to an aqueous environment, and hence its emission spectrum cannot be
detected (λex= 550 nm). However, once the dye is encapsulated its emission spectrum
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can be easily acquired. Then, Nile red is dispersed in the aqueous solution once it is
encapsulated in the hydrophobic pockets of the dendritic containers.

Figure 3.4. CAC plots based on nile red fluorescence for dendron assemblies a) G1-F,
b) G1-P, c) G2-F, d) G2-M, e) G2-P.
Initially, when the dendron concentration is high, the intensity of the emission
spectrum of the dye is high. However, when the concentration of the dendron in
solution decreases the intensity of the emission of Nile red also decreases. Given the
same amount of dye, when the dendron concentration goes down drastically, less
dendron hold less dye molecules, and the non-encapsulated small molecules precipitate
out of the solution. Finally, when the dendron reaches the CAC the emission intensity of
Nile red decreases to a value that remains more or less stable, indicating that most of
the hydrophobic pockets in the aggregate have been lost and only those hydrophobic
moieties in the disassembled dendrons can hold a few molecules of dye. Such
fluorescence intensity is close to cero, since the container properties of the assembly
have been lost.
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Then, for each dendron encapsulating Nile red, the fluorescence intensities at
615 nm were recorded every time that the dendron concentration was reduced. The
intensity values were plotted against the concentration of dendron to get a CAC curve,
which should be sigmoidal ideally. From the curve, the point where the best fitted
horizontal and vertical lines merge was taken as the CAC. Table 3.1 shows the CACs and

Dendron

Table 3.1. Critical aggregation concentrations
G1-F
G1-P
G2-F
G2-M

G2-P

CAC (µM)

11.65

7.01

8.02

7.25

7.08

the corresponding dendrons.
From Figure 3.4 is evident that the dendrons have CACs with close values, since
the CAC curves look very similar, and as it is reflected in Table 3.1. As anticipated, the
CACs of final G1 and G2 dendrons were determined to be in the low micromolar range.

3.3.3 Disassembly of the Dendritic Aggregates
With the installment of a single ligand at different layers of a dendron, and after
knowing the lowest concentration at which they assemble into nanostructures, we
investigated the response of the different dendritic aggregates in presence of the
complementary protein extravidin and in presence of non-complementary proteins with
diverse pI values and molecular weights, viz. α-chymotrypsin (Chy, pI = 8.1-8.6), pepsin
(Pep, pI = 2.9), and myoglobin (Myo, pI = 7.2).
Prior to analyzing the interaction between the dendritic assemblies and the
proteins, we analyzed the size of the assemblies in aqueous phase using dynamic light
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scattering (DLS), with G1 dendron concentrations of 12.5 µM and G2 dendron
concentrations of 10 µM; both concentrations are above the respective CACs. The sizes
of the assemblies were found to be in a few tens of nanometers, ranging from ~30 nm
to ~200 nm, 44 nm for G1-F, 220 nm for G1-P, 29 nm for G2-F, 92 nm for G2-M, and 51
nm for G2-P. These initial aggregate sizes are represented as red lines in Figure 3.5. The
reason for the variations in size with the subtle change in the position of the ligand is
not clear. However, note that the replacement of a hydrophilic PEG chain in a G1 or G2

Figure 3.5. DLS-size change of dendritic assemblies in aqueous phase upon interaction
with different proteins. a) G1-F, b) G1-P, c) G2-F, d) G2-M, e) G2-P.
dendron by a less hydrophilic pendant biotin decreases the PEG density on the assembly
surface, decreasing hydrophilicity and increasing the chance of non-specific interactions
with non-complementary proteins. Such decrease in PEG density seemed to be more
relevant in G1, where substituting one of the three PEG chains in a dendron molecule
could mean a reduction of up to 33% in hydrophilicity, while in a G2 it could mean a
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reduction of up to 14%. It is possible that these differences confer changes in the way
the assemblies pack together in solution, which results in size variations among the
biotin functionalized dendrimeric assemblies.
It is interesting however that the size of all these assemblies reduced to about
~13 nm in presence of extravidin at 2 µM. A particular difference in disassembly among
the biotin-functionalized dendrons was observed in the case of the G2-P that
disassembled into smaller aggregates of around ~7-8 nm in presence of extravidin, as
seen in Figure 3.5e. G1-P also presented some deviations, showing larger aggregates
around ~28 nm. However, these larger aggregates could also be formed by further

Figure 3.6. DLS-size unchanged of control dendritic assemblies in aqueous phase upon
interaction with different proteins. a) G1 dendron, b) G2 dendron, c) proteins.
aggregation of smaller assemblies.
The decrease in the size of the assemblies was observed only in presence of the
complementary protein, extravidin. In the presence of the non-complementary
proteins, no disassembly was observed, although a tendency of the biotin functionalized
dendrimeric assemblies to increase size, forming larger aggregates was noticed for G1-F
and G1-P, as shown in Figure 3.5a,b. This aggregate enlargement did not occur when
control dendrons G1 at a concentration of 12.5 µM, and G2 at a concentration of 10 µM,
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both with PEG replacing the ligand moiety, were exposed to the same proteins. Figure
3.6a,b shows such control dendrons. This suggested that biotin functionalization of
dendrons was the reason for such aggregate enlargement. Figure 3.6c shows what could
be the size of the proteins at a concentration of 20 µM, since the same proteins at 2 µM
were undetected by DLS.
Although DLS, in volume percentage, shows disassembly for the biotin-

Figure 3.7. DLS distributions by volume, intensity, and number of the disassembly
experiments
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functionalized dendritic aggregates when they are exposed to extravidin, the same data
also shows that not all the aggregates suffer disassembly. This is shown in Figure 3.5 as a
small and broad peak around 100 nm for all the dendritic aggregates when they are
exposed to extravidin (red lines). To have a better appreciation of what particles with
different size remain in solution after exposure to extravidin, we must refer to the
percentage of intensity curves in DLS as shown in Figure 3.7.
Briefly, DLS measures Brownian motion and relates this to the size of the
particles. It gives information about the size of the particles in three different
distributions: (i) the number distribution or number percentage, depending on the
number of particles of each size. (ii) The volume distribution, which shows the volume
occupied by the detected particles according to the volume of a sphere ((4/3)  r3),
which means that by volume distribution a particle of 50 nm (area of the peak) is 1000
times larger than a particle of 5 nm (1:1000 ratio). (iii) The intensity distribution, which
makes the area of the peak at 50 nm 1000000 times larger than the area for the 5 nm
particle (1:1000000), which is due to large particles scattering much more light than
small particles according to Rayleigh’s approximation (I ~ d6; where I is the intensity of
light scattered and d is the diameter of the particle).
Then, from Figure 3.7 it is certain that non-specific proteins do not trigger
disassembly of our dendritic aggregates since the size of the assemblies is not reduced;
on the contrary, aggregation that helps increasing the size of the particles could be
happening. On the other hand, when the dendritic aggregates were exposed to
extravidin, it is clear how the distribution by number shows the formation of particles of
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size around 10 nm in every case, similar to the distribution by volume. However, from
the intensity distribution it is clear that after exposure to extravidin, there are still some
large particles that either did not suffer disassembly or aggregated from smaller
particulates.

3.3.4 Release of Encapsulated Guest Molecules
Next, we investigated the host capabilities of the dendrons in the presence and
absence of complementary and non-complementary proteins. Specifically, we were
interested in assessing the effect of incorporating the ligand moieties at different
locations within the dendrons upon the disassembly-induced guest release from the
dendron host. To investigate these differences, Nile red was encapsulated in the
micelle-like nanoassemblies and its release was triggered as a consequence of binding
induced disassembly upon exposure to extravidin. Nile red is a hydrophobic molecule
that exhibits reduced fluorescence in water, unless it is sequestered in a hydrophobic
pocket. Therefore, the reduction in fluorescence is a good indicator of the binding
induced disassembly event.
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Figure 3.8. Fluorescence based percentage of release upon interaction of dendrons
with a) increasing concentration of extravidin, b) 14 µM of extravidin, c) buffer
solution, d) (control dendrons exposed to) extravidin.
As shown in Figures 3.8a and 3.8b, small differences in placement of the ligand in
the dendron produced rather different responses. First, percentage of dye released was
assessed after exposing 25 µM solutions of the dendrons to increasing concentrations of
extravidin. We noticed that G1-P and G2-P responded to increasing concentrations of
extravidin more than other dendrons studied. To further evaluate this behavior, we
monitored the release profiles over time for all the dendritic assemblies upon exposing
these assemblies to 14 µM of extravidin as shown in Figure 3.8b. During the first hour,
the release in the G2-P assembly was as high as 65%, while the release of the G1-P
assembly was around 22% increasing to 40% after 3 hours. Interestingly, the release
from the G1-P assembly ultimately reached about 77%, which is comparable with the
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81% observed for G2-P. In comparison, similar exposures to extravidin resulted in 35%,
25%, and 13% for G1-F, G2-F, and G2-M respectively. Interestingly, the release in G2-M
is comparable to the release percentages observed due to non-specific interactions.
As a control experiment, the release of the Nile red from the dendritic
assemblies was also monitored in the absence of any protein, as shown in Figure 3.8c.
No discernible release (<10%) was seen in these dendritic assemblies. Similarly, Figure
3.8d shows that control dendrons lacking the biotin ligand also did not exhibit
appreciable dye release in the presence of extravidin. These results show that the
release profiles observed in Figure 3.8a and 3.8b are indeed due to the ligand-protein
binding. Moreover, it is clear that among the second generation dendrons, G2-P
assembly is the only one releasing efficiently the hydrophobic guests following to
extravidin binding.
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To test the selectivity in the systems towards the target protein further, the
biotin-functionalized dendrons were exposed to increasing concentrations of noncomplementary proteins, Chy, Pep, and Myo monitoring the change in Nile red
fluorescence (Figure 3.9a-c). No significant change in the emission intensity was

Figure 3.9. Exposure of dendritic assemblies to increasing concentrations of a) Chy, b)
Pep, c) Myo, and d) absorption based percentage of release upon interaction of
dendrons with 14 µM of Myo.

observed for any of the dendrons in the presence of Chy and Pep. However, while Myo
did not exhibit any change in the fluorescence intensity in the G1-P, G2-M and G2-P
based assemblies, there was a significant change in fluorescence in the G1-F and G2-F
based assemblies, as it was further tested exposing the assemblies to constant
concentrations of non-complementary proteins and it is shown in section 3.5.2.
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Interestingly, these latter dendrons also exhibited much smaller release in response to
extravidin, as it was previously shown in Figure 3.9b. It is noteworthy that Myo is a
metalloprotein and therefore the co-factors in metalloproteins could be simply
quenching the fluorescence of the dye molecule without the need for releasing the
contents from the amphiphilic assembly. In fact, such a phenomenon has been
previously observed with polymer-surfactant co-assemblies.33
To test this possibility, we investigated the change in absorption spectrum for
Nile red in the presence of Myo. If it is simply a quenching phenomenon, no change
should be present in the absorption spectrum since all dye molecules are still confined
in the amphiphilic assembly without being released. Indeed, we noted that there was no
change in the absorption spectrum over time, suggesting that the observed
phenomenon is due to excited state quenching of the fluorescent dye molecules, as
shown in Figure 3.9d.

3.3.4.1 A Particular Case of Quenching of the Cargo
In this part, we were interested in gaining insights into the observed
fluorescence reduction in the presence of Myo, especially for G1-F and G2-F. There are
two limiting mechanisms by which such quenching could occur: (i) inherently different
encapsulation stabilities among the dendritic assemblies, causing the dye to leak out of
G1-F and G2-F and bind to the hydrophobic pockets in the protein, where the proximity
between the metalloprotein cofactor and the dye molecule causes fluorescence
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quenching; or (ii) the possible non-specific interactions between assemblies formed by
G1-F, and G2-F with Myo favour quenching of the cargo.
To test the possibility (i), we used a recently reported polymeric nanogel that has
been well-established to have crosslink-density dependent encapsulation stabilities.58,59
Nile red-encapsulated nanogels with 0%, 20%, and 50% crosslink densities were exposed
to Myo. If this mechanism was operative, there should be a crosslink density dependent
emission dependent quenching. In all cases, we found that the extent of quenching was
quite independent of the crosslink density (Figure 3.10). The quenching however was
found to increase with increasing concentration of the Myo, as observed with G1-F and
G2-F assemblies. These results are taken to suggest that Myo itself is not capable of
binding the Nile red molecule, because the 0% crosslinked nanogel assembly has been
found to be quite leaky. This rules out mechanism (i) and makes mechanism (ii) the most

Figure 3.10. Encapsulation stability and quenching. a) Quenching of Nile red (NR)
fluorescence encapsulated in nanogels (NG, 1 mg/mL) at different crosslink densities
and concentrations of Myo, b) quenching after a single exposure to Myo (5.5 mg/mL).
likely possibility.
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Within the realm of quenching, it is also important to know whether the
quenching is due to dynamic collisions or non-specific binding (a static quenching
event). Since dynamic and static quenching differ in their temperature dependence, we
exposed the assemblies G1-F and G2-F encapsulating Nile red, to increasing
concentrations of Myo at two different temperatures. The number of collisions between
the dendritic assemblies and the protein was expected to increase at a higher
temperature in the case of dynamic quenching, leading to an increase in quenching. 60
On the other hand, in the case of static quenching, the weak dendritic assembly–protein
complex would dissociate at a higher temperature, leading to a decrease in quenching. 61
Figure 3.11 shows the Stern–Volmer plots for G1-F and G2-F respectively at 25 °C and 38
°C. The fact that the quenching increases with temperature supports the weakly bound
complex hypothesis. Thus, it is interesting to note that G1-F and G2-F exhibit higher
non-specific interaction and at the same time do not exhibit significant release of the
guest molecules in response to the target extravidin. On the other hand, the dendrons
G1-P and G2-P that exhibited the highest release in response to extravidin did not
exhibit any non-specific quenching with Myo.
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Figure 3.11. Quenching of cargo. a) Stern-Volmer plot for G1-F + NR at 25 oC and 38 oC
vs increasing concentration of Myo, d) Stern-Volmer plot for G2-F + NR at 25 oC and 38
o
C vs increasing concentration of Myo.

This evidence of a weakly bound complex between G1-F or G2-F and Myo,
supports the idea that, eventhough PEG is coating these nanoassemblies, thetering of
biotin to the focal point of the dendrons is generating assemblies where the PEG shell is
not efficiently preventing non-specific interactions.
Additionally, the release of nile red observed by absorption from G1-F assembly,
shown in Figure 3.9d, reached up to 20% which is high for mere non-specific
interactions. Thus, it could be explained as due to the formation of a weak complex
assembly-quencher, since formation of a ground-state complex that generates static
quenching can result in different extintion coefficients for those fluorophores
encapsulated but distant from the quencher metalloprotein, and for those closer to the
metalloprotein. This results in perturbation of the fluorophore absorption spectrum and
hence, in a false release profile that supports the static quenching in the system.
The idea of having two populations of fluorophores encapsulated in the same
assembly, one of them not accesible to the quencher, is in turn supported by the
downward curvature towards the x-axis displayed in the Stern–Volmer plots in Figure
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3.11, a phenomenon seen in proteins having some triptophan residues on the surface
and some buried.61

3.3.5 Making Sense of Disassembly and Release
These latter data and those from the previous sections indicate that if the
release of hydrophobic guests is triggered by the specific extravidin-biotin interaction,
the selective binding with the complementary protein can occur more easily when a
biotin ligand is grafted at the periphery than when it is grafted at the middle layer or at
the focal point of the dendron, and that somehow this makes the release of
hydrophobic guests faster for G2-P than for the other constructs, as observed in Figure
3.8a,b. If disassembly is controlled by the same interaction, since the biotin-extravidin
binding is considered irreversible, when extravidin binds to a dendron in the assembly a
reduction in the size of assembly will occur after some time, while the system
reorganizes and equilibrates in smaller size assemblies as it was observed by DLS (Figure
3.5). Thus, although all systems reorganized into smaller size assemblies, the release
was higher for the dendron systems with a ligand located at the periphery. The reason
for this disparity was not entirely clear to us.
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Based on the release kinetics, which was also faster for the dendritic systems
with ligand at the periphery, we hypothesized that in these cases the assembly
reorganization was drastic enough to produce a higher release. On the other hand, in
the cases with a ligand at the middle layer and focal point the assemblies rearranged
slower into smaller size structures, allowing for the encapsulated hydrophobic small
molecules to still be accommodated in hydrophobic pockets. In fact, Figure 3.8b shows
that even after 6 hours of G2-M (25 µM) exposure to a constant concentration of
extravidin (14 µM), the release was as low as 13%. At this point, the interesting question

Figure 3.12. Pictoric representation of protein approaching a G2 dendron with biotin
grafted at a) the periphery, b) the middle layer, and c) the focal point.
of why is the release from G2-P so high compared to the release from G2-M and G2-F
remain still open.
Nevertheless, based on our data and analysis at a molecular level, we propose a
hypothesis involving the approach of a tetrameric extravidin to the biotin ligand
surrounded by a different PEG nano-environment in the different locations, as
represented in Figure 3.12. When biotin is grafted at the middle layer (Figure 3.12b) or
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at the focal point (Figure 3.12c) it is surrounded by an environment rich in PEG. This
makes the specific binding with extravidin, which implies deep penetration of the ligand
inside one of the four binding pockets of tetrameric extravidin, very difficult compared
to G2-P (Figure 3.12a). We have employed molecular dynamics (MD) simulations,
carried out by our collaborators,43 to gain additional insights in the understanding of
why the different positioning of a biotin ligand within the dendron scaffold has such a
strong effect on the final properties.
First, it was important to understand how these molecules fold in solution. In
fact, it is known that similar dendritic structures can undergo strong folding in
solution,62,63 so that if the biotin ligand is backfolded and surrounded by PEG in the
experimental conditions the specific binding with extravidin will be unlikely.
The entire simulation work was carried out with the AMBER 12 suite of
programs.64 Molecular models were created with three different functionalization points
for biotin, to understand how the individual dendrons arrange in solution. G2-P, G2-M
and G2-F dendron models were created and parameterized according to similar studies
on dendrons interacting with proteins.65,66,67 Starting configurations of the dendrons
were then immerged in a simulation box (Figure 3.13a) containing explicit water
molecules. All systems underwent 200 ns of MD in periodic boundary conditions at 25 °C
(298 K) of temperature and 1 atm of pressure. During this time, all dendrons reached
the equilibrium with good stability. The root mean square displacement (RMSD) and the
radius of gyration (Rg) data extracted from the MD simulations were used to assess the
system’s equilibration.
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Figure 3.13. MD simulation of G2 dendrons in water. a) Dendron folded in solution
assuming a globular shape; b) RDF plots for the biotin in the G2 dendrons.
The size of G2 in water predicted by MD simulation does not change substantially
depending on the tethering position of biotin, i.e. the radius of gyration (Rg) in the three
cases is 9.4-10 Å (Figure 3.13a). In general, the dendrons tend to compact the
hydrophobic decyl chains at the core, and to surround them with hydrophilic PEG. On
the other hand, in terms of distribution of the biotin ligand the situation is different. The
plots in Figure 3.13b report the radial distribution function(RDF) g(r) of the biotin ligand
calculated with respect to the dendrons center and expressed as a function of the
dendron radius (Rg) for the cases where biotin is grafted at the periphery (G2-P: red),
the middle layer (G2-M: blue), or at the focal point (G2-F: black). In general, the g(r)
values give indication on the relative probability to find the biotin ligand at a certain
distance from the dendron center, being the position of the g(r) maximum peak the
most probable one.
The biotin density, going from the center to the surface, is calculated at each
simulation step, and the reported g(r) data are averaged in time over the equilibrated
phase MD trajectories (the last 100 ns). Thus, high and sharp peaks in g(r) identify high
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biotin density regions, but they also indicate high localization, confinement and
backfolding (namely, atoms that cannot move are counted at each step in the same
region of space).
On the contrary, flexible and fluctuating groups will have low and broad g(r)
peaks. Figure 3.13b shows that at the equilibrium biotin distribution is very different for
G2-P, G2-M and G2-F. In particular, the biotin g(r) maximum peak for G2-P (red curve)
corresponds well with its Rg indicating that, on average, the ligand availability on the
surface is very good. On the contrary, the maximum peaks of black and blue g(r) curves
at a distance r~0.5 Rg suggest that biotin is considerably more backfolded in the case of
G2-F and G2-M. These data give indication on how much the biotin ligand is available at
the surface of the dendron, and thus also on the probability to have a specific binding
with extravidin.
The experimental biotin-avidin energy of binding is known to be -20.4 kcal mol1 68,69,70

,

however the dendron-extravidin affinity will be worse for G2-F and G2-M

dendrons since biotin is backfolded for them, unlike in G2-P. From the experimental
biotin-avidin affinity and the biotin availability at the dendrons surface, it was possible to
calculate the relative probability for the dendron-avidin specific binding (statistical
weight). So, if we set the probability of having extravidin specifically bound to the biotin
moiety in G2-P to 1, then the probability of having extravidin bound to the biotin moiety
in G2-F and G2-M is reduced to ~0.1 due to reduced ligand availability. This means that
the probability of extravidin specific binding to biotin ligands at the surface of G2-P
aggregates is ten times higher than in the case of G2-F and G2-M.
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3.3.5.1 Multivalent Binding of Extravidin
Given the differences of ligand availability for the dendrons, our results suggest
that when extravidin gets in contact with a biotin at the surface of a G2-P aggregate, the
formation of a specific binding will be an energetically favored event. In addition, it is
worth noting that extravidin is a protein tetramer possessing four binding sites for
biotin. Thus, after a first specific binding occurs between extravidin and one biotin at the
G2-P aggregate surface, the protein can find also other biotin ligands available in the
neighborhood to establish more specific bindings in a cooperative way. This will be an
energetically favored thus highly probable event,71,72 according to the so-called
multivalent effect, and to the fact that extravidin is energetically favored to bind four
biotins at the same time.
The consequences of this behavior can be important. In fact, this tendency of
extravidin to bind more biotin ligands at the same time, when available, can in principle
speed up the disassembly process. Conceptually, since extravidin will tend to preserve its
structure much more than the dendron aggregate, in case of cooperative binding to
multiple ligands, it is reasonable to think that the dendrons from the aggregate will
adapt over extravidin, rather than the unlikely opposite option: protein collapsing over
the G2-P surface. This is consistent with a picture where G2-P aggregates are
progressively degraded.
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Figure 3.14. Proposed mechanism for disassembly and release from biaryl amphiphilic
dendrons. a) In G2-P biotin is highly available for extravidin - exfoliation-like
disassembly; b) in G2-M and G2-F biotin is less available for extravidin.

3.3.5.2. Proposed Mechanisms for Disassembly and Release
One key factor allowing for multivalent binding is biotin availability. Namely,
biotin ligands must be accessible at the aggregate surface and free to complete specific
interactions with extravidin. In fact, as we already discussed on Figure 3.13, the chance
of having multivalent specific binding between the dendrons and extravidin will be
extremely sensitive to biotin availability at the surface of the aggregates. As our results
suggested, biotin availability is high for G2-P and low for G2-M and G2-F (Figure 3.13).
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Thus, at the G2-P aggregates surface extravidin will find many accessible binding spots
for completing specific interactions. Moreover, after a first specific binding is
established, the same extravidin protein will be then energetically favored to bind more
biotins from other G2-P dendrons. On the other hand, since the probability to have
specific binding for G2-M and G2-F is reduced, even if a first specific interaction occurs
between extravidin and one biotin ligand, it is reasonable to hypothesize that the chance
of having multivalent extravidin binding at the surface of G2-M and G2-F aggregates will
be lower.
In light of our overall results, we propose two different possible mechanisms for
self-assembly schematized in Figure 3.14. (i) For the G2-P case, multivalent binding of
extravidin leads to the rapid disassembly of the dendron aggregates in solution, in an
exfoliation-like manner as in Figure 3.14a. (ii) For G2-M and G2-F, the aggregates would
disassemble more slowly due to the destabilization induced by extravidin binding, as in
Figure 3.14b. In principle, the first proposed mechanism would result in the rapid
production of smaller aggregates limited by extravidin size, and in a higher level of
hydrophobic guest release. Here, the velocity of the process and the small size of the
aggregates would not allow for the structural rearrangement necessary to retain the
guest molecules. The second proposed mechanism would most likely produce larger size
aggregates and thus, lower levels of release.
To summarize this section, the high level of biotin availability of G2-P is
compatible with its fast disassembly and hydrophobic guests in presence of extravidin,
as shown by our DLS and fluorescence experiments. At the same time our data
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demonstrates that G2-M and G2-F aggregates also disassemble in presence of extravidin
(Figure 3.5), but more slowly. In addition, the final size of the disassembled aggregates is
larger than that of G2-P (~14 vs ~7 nm), and no appreciable guest release is present
during the disassembly of the G2-M and G2-F aggregates (Figure 3.8a,b).

3.4 Summary
Our research reveals that ligand placement on a supramolecular scaffold for
binding induced disassembly greatly impacts disassembly and release of encapsulated
guest molecules, as we have shown from the high release difference observed, for
example, between G2-P and G2-M. The best place to attach a ligand, looking for a
protein triggered release from a dendritic micelle-like nanostructure, is the periphery.
MD simulations show backfolding of the ligand when attached to middle layer and focal
point and a better availability for protein binding when the ligand is attached at the
periphery. Incorporation of the biotin ligand in the dendrons gives the dendritic
assemblies selectivity towards the target protein extravidin, regardless of the ligand
position. Nonetheless, ligand positioning in the dendrons gives the assemblies sensitivity
towards release upon binding of a target protein. In addition, multivalent binding of the
same extravidin protein to other G2-P dendrons via specific biotin-extravidin interaction
is an energetically favored event. These evidences allowed us to hypothesize two
different mechanisms of disassembly induced by extravidin binding that depend on the
ligand location in the scaffold. A fast one for G2-P based on high biotin availability at the
aggregate surface, multivalent interactions and aggregates exfoliation. This mechanism
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leads to fast formation of small disassembled aggregates and to a high release of
hydrophobic guests. A second mechanism for G2-M and G2-P portraits a slower
disassembly, based on extravidin binding induced aggregate destabilization, and the
formation of larger and more ordered aggregates in solution that are still capable of
retaining the guest molecules in their interior.
Substitution of a PEG unit in the dendron for a pendant biotin increased nonspecific interactions of the assemblies with proteins, which was seen as the formation of
larger aggregates in solution. This became more evident when the density of PEG chains
on the hydrophilic face was low, as it is in a G1 dendron compared to a G2. This, in turn,
facilitates the formation of a weak complex assembly-protein that was evidenced when
a metalloprotein acted as a quencher, generating static quenching of the encapsulated
fluorophore molecules. The research reported here gives a picture of how
supramolecular disassembly and release might be largely affected by choosing a specific
location for a trigger, rather than a random placement based on molecular architecture.
Also, we have shown how controlled variations in PEG density could affect interactions
of nanoparticles with proteins.

3.5 Experimental Section
3.5.1 Synthetic Procedures and Characterization of Compounds
All chemicals and solvents were purchased from commercial sources and were
used as such, unless otherwise mentioned. 1H NMR spectra were recorded on a 400
MHz Bruker NMR spectrometer using the residual proton resonance of the solvent as
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the internal standard. Chemical shifts are reported in parts per million (ppm). When
peak multiplicities are given, the following abbreviations are used: s, singlet; bs, broad
singlet; d, doublet; t, triplet; m, multiplet. 13C NMR spectra were proton decoupled and
recorded on a 100 MHz Bruker spectrometer using the carbon signal of the deuterated
solvent as the internal standard. Fluorescence spectra were recorded using a JASCO FP6500 spectrofluorimeter. FAB-MS spectra were measured on a JEOL JMS700. MALDITOF spectra were measured on a Bruker OmnifleX. IR spectra were measured on a
Bruker Alpha-P FT-IR.

3.5.1.1 General Procedure for the Synthesis of Dendritic Compounds
To a solution of the biaryl monomer AB2 (1.0 equiv.) and the appropriate
bromobenzyl compound (1.0-3.0 equiv.) in anhydrous acetone, was added K2CO3 (3
equiv.) and 18-crown-6 (0.1 equiv.). The reaction mixture was refluxed under argon
atmosphere for 12-24 h (12 h for G1 and 24 h for G2). The progress of the reaction was
monitored by TLC. After completion of the reaction, acetone was evaporated and the
crude reaction mixture was partitioned between ethyl acetate and water. The aqueous
layer was extracted three times with ethyl acetate and the combined organic layer was
dried over Na2SO4. Afterwards, the solution was filtered and evaporated to dryness. The
crude product was purified by silica gel column chromatography, CombiFlash.
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3.5.1.2 General Procedures for Incorporation of Biotin-azide to the Dendron using
“Click” Chemistry
Procedure A: To a solution of dendritic acetylene compound (1.0 equiv.), and
biotin-azide 18 (2 equiv.) in THF, was added the same volume of aqueous CuSO 4.5H2O
(0.2 equiv.) and sodium ascorbate (0.2 equiv.) in such a way that the final solution
THF/H2O was in a ratio 1:1. The reaction was heated at 50 oC for 24 h to 60 h, depending
on dendron generation. After completion of the reaction, NH 4Cl solution was added to
the reaction mass and then, extracted with ethyl acetate three times. The organic layers
were collected and dried over anhydrous Na2SO4, filtered, concentrated, and the
product purified by silica gel column chromatography, CombiFlash.
Procedure B: A mixture of the dendritic acetylene compound (1.0 equiv.), biotin
azide 18 (3.0 equiv.), CuSO4.5H2O (1.0 equiv.) and sodium ascorbate (1.0 equiv.) in
DMSO solvent was heated at 50 oC for 24-32 h (24h for G1 and 32h for G2). The progress
of the reaction was monitored by TLC. After completion of the reaction, the reaction
mixture was portioned between dichloromethane and saturated aqueous NH4Cl
solution. The aqueous layer was extracted twice with dichloromethane and the
combined organic layer was dried over anhydrous Na2SO4 and evaporated to dryness.
The crude product was isolated by silica gel column chromatography, CombiFlash.

3.5.1.3 Synthesis of compound 3 (DA-1-7)
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To a solution of 3,5-dihydroxybromobenzene (23 g, 121.6 mmol) in anhydrous
THF (500 mL) in an ice bath was added Hunig’s base (74.2 mL, 425.8 mmol); the mixture
was stirred at room temperature and under argon atmosphere for 15 min. At ice-bath
temperature, methoxymethyl chloride (MOM-Cl) (32.3 mL, 425.8 mmol) was added
slowly. The reaction mixture was allowed to stir overnight at room temperature. Then, it
was poured into water to quench the remaining chloride and then, most of the THF was
evaporated. The remaining aqueous solution was extracted three times with ethyl
acetate. The combined organic layers were evaporated and subjected to silica gel
column chromatography to yield 33 g (98%) of compound 3. For the characterization
details of this compound please see reference 37.

3.5.1.4 Synthesis of compound 4 (DA-1-19)

The ethyl ester of 3,5-dihydroxy-5-bromobenzoic acid (30 g, 114.9 mmol) was
mixed with 1-bromodecane (24.0 mL, 114 mmol), K2CO3 (47.6 g, 344.7 mmol) and 18crown-6 (3.0 g, 11.5 mmol) in anhydrous acetone (500 mL) in Ar environment and
refluxed overnight. Upon evaporation of the solvent, the mixture was dissolved in water
and extracted three times with ethyl acetate. The combined extracts were dried over
anhydrous Na2SO4. The crude product obtained upon evaporation of solvent was
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purified by silica gel column chromatography to yield 15.2 g (33%) of compound 4. For
the characterization details of this compound please see reference 73.73

3.5.1.5 Synthesis of compound 5 (DA-1-30)

To a solution of compound 3 (10 g, 36.1 mmol) in anhydrous THF (100 mL) was
added n-BuLi (43.3 mL of a 2.5 M in hexane solution, 108.3 mmol) under argon
atmosphere at -78 oC and stirred for 30 min. At the same temperature, SnBu 3Cl (29.4
mL, 108.3 mmol) was added and stirred from -78 to 25 oC, and then for 12 h. The
reaction mixture was quenched with saturated aqueous NH4Cl solution, the acetone was
evaporated, and the remaining aqueous solution extracted three times with ethyl
acetate. The organic layers were collected on anhydrous Na2SO4. The solvent was
evaporated to afford the crude reaction mixture, which was purified by silica gel column
chromatography to yield 14 g (75%) of product 5 as viscous oil. For the characterization
details of this compound please see reference 37.

3.5.1.6 Synthesis of compound 6 (DA-1-24)
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To a solution of mono-alkylated 4 (12 g, 30.0 mmol) in anhydrous
dichloromethane (150 mL) was added triethylamine (12.0 mL 90.0 mmol) and cooled to
0 oC. Then, acetylchloride (6.4 mL, 90.0 mmol) was added dropwise and stirred at room
temperature for 12 h. The reaction mixture was quenched with water and extracted
three times with dichloromethane. The organic layers were collected on anhydrous
Na2SO4. The solvent was evaporated to afford the crude reaction mixture, which was
purified by silica gel column chromatography to afford 12.5 g (91%) of product 6 as
viscous oil. For the characterization details of this compound please see reference 37.

3.5.1.7 Synthesis of compound 7 (DA-1-46)

The aryl stannane 5 (7 g, 14.3 mmol) and the bromo-ester 6 (6.35 g, 14.3 mmol)
were dissolved in deoxygenated DMF (20 mL) under argon atmosphere. To this solution,
2.5 mol% of Pd(PPh3)2Cl2 (0.25 g, 0.35 mmol) was added and the reaction mixture
heated at 120-130 oC for 24 h. After cooling the reaction mixture to room temperature,
the mixture was passed through a celite pad and washed with ethyl acetate. Finally the
filtrate was washed with water and the organic layer was evaporated to dryness. The
crude product was purified by silica gel chromatography to afford 4.4 g of biaryl coupled
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compound (55% yield). For the characterization details of this compound please see
reference 37.
Then, to a solution of the previous biaryl coupled compound (5 g, 8.9 mmol) in
anhydrous THF (25 mL), was added LiAlH4 (0.85 g, 22.3 mmol) in portions at 0 oC under
argon atmosphere, stirring at room temperature for 12 h. The reaction mixture was
quenched with ethyl acetate and then acidified using dilute HCl (1 N) solution. The
resultant mixture was extracted three times with ethyl acetate and the combined
organic extracts were dried over anhydrous Na2SO4. Upon evaporation of solvent, the
crude was purified by silica gel chromatography to afford 3.3 g of compound 7 (85%
yield). For the characterization details of this compound please see reference 37.

3.5.1.8 Synthesis of compound 9 (DA-1-10)

The mixture of 3,5-dihydroxybenzyl alcohol (10 g, 71.4 mmol), 1-bromodecane
(13.4 mL, 64.2 mmol), K2CO3 (19.6 g, 142.8 mmol), sodium iodide (10.6 g, 71.4 mmol)
and 18-crown-6 (1.8 g, 7.14 mmol) in anhydrous acetone (50 mL) was refluxed for 12 h.
Upon evaporation of the solvent, the mixture was dissolved in water and extracted
three times with ethyl acetate. The combined extracts were dried over anhydrous
Na2SO4. The crude product obtained upon evaporation of solvent was purified by silica
gel column chromatography to yield 8.2 g (41%) of compound 9. For the
characterization details of this compound please see reference 73.
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3.5.1.9 Synthesis of compound 10 (DA-1-16)

The mixture of compound 9 (2.8 g, 9.9 mmol), propargyl bromide (3.32 g mL
from a 80% sln. in toluene, 29.8 mmol), K2CO3 (4.1 g, 29.8 mmol), and 18-crown-6 (0.26
g, 1.0 mmol) in anhydrous acetone (20 mL) was refluxed for 12 h. Upon evaporation of
the solvent, the mixture was dissolved in water and extracted three times with ethyl
acetate. The combined extracts were dried over anhydrous Na 2SO4. The crude product
obtained upon evaporation of solvent was purified by silica gel column chromatography
to yield 3.0 g (95%) of compound 10. For the characterization details of this compound
please see reference 37.

3.5.1.10 Synthesis of compound 11 (DA-1-12)

The mixture of compound 9 (5.1 g, 18.3 mmol), PEG-Ts (6.7 g, 16.5 mmol), K2CO3
(6.8 g, 49.4 mmol), and 18-crown-6 (0.4 g, 1.6 mmol) in anhydrous acetone (20 mL) was
refluxed for 12 h. Upon evaporation of the solvent, the mixture was dissolved in water
and extracted three times with ethyl acetate. The combined extracts were dried over
anhydrous Na2SO4. The crude product obtained upon evaporation of solvent was

123

purified by silica gel column chromatography to yield 6.8 g (80%) of compound 11. For
the characterization details of this compound please see reference 73.

3.5.1.11 Synthesis of compound 12 (DA-1-104)

To a stirring solution of 10 (1.8 g, 5.65 mmol) in dichloromethane (20 mL) was
added PBr3 (1 mL, 11.31 mmol) under argon atmosphere at room temperature. The
reaction was monitored using TLC. After complete disappearance of the starting
material the remaining PBr3 was quenched by slow addition of a saturated NaHCO3
solution. The resulting mixture was extracted with dichloromethane (3x50 mL). The
combined organic layer was dried over anhydrous Na2SO4 and concentrated using
vacuum. The crude compound was purified on silicagel column chromatography
CombiFlash (1:4 Ethyl acetate, Hexanes) to afford 12 (1.65 g, 76%). 1H NMR (CDCl3400MHz)  6.57 (t, J = 1.9 Hz, 2H, a,b), 6.49 (t, J = 2.2 Hz, 1H, c), 4.67 (d, J = 2.3, 2H, d),
4.41 (s, 2H, f), 3.92 (t, J = 6.5 Hz, 2H, e), 2.53 (t, J = 2.3 Hz, 1H, g), 1.79-1.72 (m, 2H, h),
1.48-1.21 (m, 14 H, i), 0.87 (t, J = 6.8 Hz, 3H, j). 13C NMR (CDCl3-100MHz)  162.4, 160.5,
158.8, 139.8, 108.6, 107.7, 101.9, 78.4, 75.9, 68.32, 56.0, 33.7, 32.0, 29.7, 29.5, 29.5,
29.3, 26.1, 22.8, 14.3.
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3.5.1.12 Synthesis of compound 13 (DA-1-35)

To a stirring solution of 11 (6.4 g, 12.4 mmol) in dichloromethane (20 mL) was
added PBr3 (16.1 mL from a 1M sln, 16.1 mmol) under argon atmosphere at room
temperature. The reaction was monitored using TLC. After complete disappearance of
the starting material the remaining PBr3 was quenched by slow addition of a saturated
NaHCO3 solution. The resulting mixture was extracted with dichloromethane (3x50 mL).
The combined organic layer was dried over anhydrous Na2SO4 and concentrated using
vacuum. The crude compound was purified on silicagel column chromatography
CombiFlash (1:4 Ethyl acetate, Hexanes) to afford 32 (5.0 g, 70%). For the
characterization details of this compound please see reference 73.

3.5.1.13 Synthesis of compound 15 (DA-1-111)

To a solution of 2-(2-amino-ethoxy)-ethanol (10.0 mL, 100.0 mmol) in
dichloromethane (50 mL) and an Ar atmosphere was added di-tert-butyl dicarbonate
(32.8 g, 151.0 mmol) at ice bath temperature and stirred overnight. Water was added to
the reaction mixture and extracted three times with dichloromethane. The combined
organic extracts were dried over anhydrous Na2SO4. Afterwards, the solvent was
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evaporated to dryness. The crude product 15 was taken for the next step without
further purification.

3.5.1.14 Synthesis of compound 16 (DA-1-112)

To the solution of crude compound 15 (31.6 g, 100 mmol) in anhydrous toluene
(100 mL) was added triethyl amine (13.3 mL, 100.0 mmol) and cooled to ice bath
temperature. Then, methane sulfonyl chloride (7.7 mL, 100.0 mmol) was added
dropwise at the same temperature. After 20 minutes stirring at room temperature (RT),
tetrabutylammonium iodide (37 g, 100.2 mmol). An aqueous solution of sodium azide
(40 g, 615.4 mmol) was added. Then, the reaction mass was heated at 70 oC for 6h. After
cooling the reaction mixture to RT, water was added and extracted twice with ethyl
acetate and then dried over anhydrous Na2SO4. After the evaporation of solvent, the
crude product was purified by silica gel column chromatography to yield 18.0 g (78%) of
compound 16. For the characterization details of this compound please see reference
37.

3.5.1.15 Synthesis of compound 17 (DA-1-128)

To a solution of compound 16 (2 g, 8.2 mmol) in dichloromethane (40 mL) was
added trifluoroacetic acid (0.80 mL, 10.4 mmol) at 0 oC. After stirring at RT for 8 hours,
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the solvent was evaporated and dried under vacuum to obtain the Boc-deprotected
compound 17 that was used as such for the next step.

3.5.1.16 Synthesis of compound 18 (DA-1-129)

Biotin (1.0 g, 4.1 mmol) was dissolved in DMF (25 mL) and heated to 50-60 oC for
45 minutes, and then allowed to cool to RT. To this solution was added
carbonyldiimidazole (0.97 g, 6.0 mmol) previously dissolved in DMF (10 mL) and stirred
at RT for 3 h. Then, the previous solution was added to a solution of compound 17 (1.1
g, 8.7 mmol) previously dissolved in DMF (5 mL) and stirred overnight at in Ar
atmosphere. The solvent was removed under vacuum. The remaining solid was washed
with water and then, with cold acetone under negative pressure in a fritted funnel. After
a long drying the product was recover in 0.7 g (46%) of the product 18 as a white solid.
For the characterization details of this compound please see reference 37.

3.5.1.17 Synthesis of compound 19 (DA-1-66)
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To the propargylated product of the biaryl compound 7 (0.7 g, 1.3 mmol)
dissolved in a mixture of methanol (20 mL), 1,4-dioxane (2 mL), and water (1 mL), 1.4 g
of Dowex resin was added stirring under Ar atmosphere. The reaction mass was refluxed
for 4 h. Then, it was filtered and the remaining solid was dissolved in water and
extracted with ethyl acetate. The organic fractions were dried over Na2SO4. The solvent
was evaporated and the product purified by silica gel chromatography getting 0.3 g of
product 19 (58%). For the characterization details of this compound please see
reference [1].
Compound 20 was obtained in exactly the same way as compound 19. The
characterization details of this compound are in reference 37.

3.5.1.18 Synthesis of compound 21 (DA-1-107)

A mixture of compound 20 (0.25 g, 0.04 mmol), compound 12 (0.14 g, 0.04
mmol), K2CO3 (0.08 g, 0.06 mmol) and 18-crown-6 (0.01 g, 0.004 mmol) in acetone (15
mL) was refluxed for 12 h. Upon evaporation of the solvent, the mixture was dissolved
in water and extracted three times with ethyl acetate. The combined extracts were
dried over anhydrous Na2SO4. The crude product obtained upon evaporation of solvent
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was purified by silica gel column chromatography to afford of compound 21 (0.079 g,
25%). 1H NMR (Acetone d6-400MHz)  6.78-6.69 (m, 4 H, a,b), 6.51-6.50 (m, 3 H, c,d,e),
6.40 (d, J = 2.36, 1H, f), 5.01 (s, 2H, g), 4.78 (d, J = 2.40 Hz, 2 H, h), 4.63 (m, 2 H, i), 4.04
(t, J = 4.68 Hz, 2 H, j), 3.99 (t, J = 6.48 Hz, 2H, k), 3.91 (t, J = 6.28 Hz, 2 H, m), 3.65 (t, J =
4.56 Hz, 2 H, n) 5.53-3.52 (m, 11 H, o), 3.44-3.42 (m, 2H, p), 3.26 (s, 3H, q), 3.05 (t, J =
2.36, 1H, r), 2.84 (d, J = 12.8, 3H, u), 1.80-1.73 (m, 2H, v), 1.64-1.57 (m, 2H, w), 1.51-1.45
(m, 2H, x), 1.42-1.19 (m, 26H, y), 0.92-0.83 (m, 6H, z); 13C NMR (Acetone d6-100MHz) 
161.4, 159.9, 159.9, 158.2, 158.1, 157.9, 157.8, 144.3, 141.2, 137.3, 119.6, 112.4, 112.3,
109.9, 107.2, 106.8, 104.8, 104.6, 101.4, 79.7, 77.0, 72.6, 71.4, 71.4, 71.1, 71.1, 71.0,
70.2, 70.1, 69.5, 69.2, 68.6, 64.8, 64.7, 58.7, 56.3, 32.6, 32.6, 30.3, 30.3, 30.3, 30.1, 30.1,
26.8, 23.3, 23.3, 14.4, 14.3.

3.5.1.19 Synthesis of compound 22 (DA-1-127)

According to the general procedure for synthesis of dendritic compounds, the
biaryl mono-G1-propargyl monomer 21 (0.13 g, 0.116 mmol) was reacted with the
bromomethyl compound 13 (0.06 g, 0.127 mmol) to give compound 22 (0.12 g, 72%). 1H
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NMR (Methanol d4-400MHz)  6.69-6.67 (m, 2H, a), 6.65-6.51 (m, 7H, b), 6.46 (t, J = 2.2
Hz, 1H, f), 6.42 (t, J = 2.2 Hz, 1 H, f’), 4.99-4.97 (m, 4 H, g, g’), 4.69 (d, J = 2.36 Hz, 2 H, h),
4.60 (s, 2H, i), 4.10-4.08 (m, 2H, j), 4.02-4.0 (m, 2H, j’), 3.94-3.79 (m, 10H, w, w’), 3.613.39 (m, 38H, q), 2.91 (t, J = 2.40 Hz, 1H, r), 1.78-1.70 (m, 4H, v, v’), 1.59-1.12 (m, 44H,
y), 0.92-0.82 (m, 9H, z);
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C NMR (Acetone d6-100MHz)  168.5, 167.4, 165.3, 159.4,

159.1, 156.6, 154.8, 150.7, 144.2, 140.8, 136.1, 133.6, 125.5, 124.4, 110.9, 110.4, 107.3,
106.3, 102.5, 100.5, 83.4, 83.0, 78.7, 77.1, 74.1, 71.6, 70.3, 70.2, 69.9, 67.7, 65.8, 58.0,
55.5, 34.7, 31.7, 31.5, 30.1, 25.9, 23.0, 22.4, 20.8, 13.4, 12.3. MALDI-ToF m/z expected
for C82H130O19: 1420.9; found 1442.6 for C82H130O19+Na+.

3.5.1.20 Synthesis of dendron G1-P (DA-1-164)

According to the general procedure for click chemistry, the compound 22 (0.04 g,
0.0028 mmol) was reacted with biotin azide 18 (0.02 g, 0.0056) to give G1-P dendron
(0.03 g, 70%). 1H NMR (Methanol d4-400MHz) ; 8.22 (s, 1H, c), 6.81-6.72 (m, 3H, b), 6.706.63 (m, 5H, a), 6.62-6.53 (m, 2H, d) 6.47-6.43 (m, 1H, e), 5.25-5.15 (m, 2H, g) 5.10-4.95
(m, 4H, f, f’), 4.64 (s, 2H, i), 4.57 (t, J = 4.8 Hz, 2H, r), 4.52-4.40 (m, 1H, p), 4.29-4.22 (m,
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1H, q), 4.13-4.11 (m, 3H, x), 4.04-4.03 (m, 2H, j’), 4.0-3.96 (4H, j), 3.93-3.87 (m, 3H, v’),
3.86-3.82 (m, 2H, w’), 3.81-3.78 (m, 3H, w), 3.69-3.41 (m, 41H, t), 3.35-3.29 (m, 2H),
3.27-3.26 (m, 6H), 3.13-3.08 (m, 1H), 2.98-2.82 (m, 2H), 2.72-2.62 (d, J = 12.4 Hz, 1H, m),
2.17-2.14 (t, J = 7.2 Hz, 2H, k), 1.82-1.71 (m, 4H, v, v’), 1.67-1.52 (m, 6H, h), 1.51-1.18 (m,
44H, y), 0.2-0.82 (m, 9H, z);

13

C NMR (CDCl3-100MHz)  160.4, 160.0, 158.9, 157.4,

157.2, 157.0, 142.0, 139.4, 135.9, 119.3, 112.1, 111.0, 106.1, 105.6, 104.4, 104.2, 102.1,
100.8, 94.6, 77.2, 71.9, 70.8, 70.6, 70.5, 69.9, 69.7, 69.6, 68.8, 68.0, 67.4, 65.4, 59.0,
55.9, 31.9, 30.9, 29.5, 29.4, 29.3, 29.1, 26.0, 25.9, 22.6, 14.1. MALDI-ToF m/z expected
for C96H154N6O22S: 1777.34; found 1799.15 for C96H154N6O22S + Na+, 1777.14 for
C96H154N6O22S + H+.

3.5.1.21 Synthesis of compound 23 (DA-1-187)

According to the general procedure for synthesis of dendritic compounds, the
biaryl monomer 19 (0.088 g, 0.2 mmol) was reacted with the bromomethyl compound
13 (0.30 g, 0.52 mmol) to give 0.20 g (yield: 70%) of compound 23. The characterization
details of this compound are in reference 37.
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3.5.1.22 Synthesis of dendron G1-F (DA-1-91)

According to the general procedure for click chemistry, the compound 23 (0.07 g,
0.05 mmol) was reacted with biotin azide 18 (0.02 g, 0.006 mmol) to give 0.04 g (83%) of
G1-F dendron. The characterization details of this compound are in reference 37.

3.5.1.23 Synthesis of compound 24 (DA-2-78)

To a stirring solution of 22 (0.324 g, 0.228 mmol) in dichloromethane (10 mL)
was added PBr3 (0.22 mL, 2.28 mmol) under argon atmosphere at room temperature.
The reaction was monitored using TLC. After complete disappearance of the starting
material, the remaining PBr3 was quenched by slow addition of saturated NaHCO3
solution. The resulting mixture was extracted with dichloromethane (3x50 mL). The
combined organic layer was dried over anhydrous Na2SO4 and concentrated using
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vacuum. The crude compound was purified by column chromatography, CombiFlash
(1:4 Ethyl acetate, Hexanes) to afford 24 (0.076 g, 22%). 1H NMR (Methanol d4-400MHz)
 6.73-6.41 (m, 11 H, a), 4.95 (s, 4H, b), 4.67 (d, J = 2.4 Hz, 2H, c), 4.54 (s, 2H, d), 4.124.06 (m, 2H, e), 4.05-3.97 (m, 2H, f), 3.96-3.40 (m, 32H, g), 2.91 (t, J = 2.3 Hz, 1H, h),
1.81-1.70 (m, 4H, i), 1.62-1.11 (m, 42H, j), 0.95-0.82 (m, 9H, k); 13C NMR (Methanol d4100MHz)  160.4, 160.1, 158.9, 157.5, 157.0, 156.7, 139.8, 130.0, 106.0,105.6, 100.6,
100.4, 75.5, 71.5, 70.4, 70.3, 70.2, 70.1, 70.0, 69.9, 69.4, 69.2, 67.7, 67.2, 57.7, 55.3,
38.9, 31.7, 29.4, 29.3, 29.3, 29.1, 29.1, 25.9, 25.8, 22.4, 22.3, 18.7, 13.1, 13.1. MALDI-ToF
m/z expected 1483.79 for C82H129BrO18; found 1483.51 for C82H129BrO18 + H+.

3.5.1.24 Synthesis of compound 25 (DA-2-2)

To a stirring solution of a G1 23 (0.53 g, 0.373 mmol) in dichloromethane (20 mL)
was added PBr3 (0.3 g, 1.12 mmol) under argon at room temperature. The reaction was
monitored using TLC. After complete disappearance of the starting material the
remaining PBr3 was quenched by slow addition of saturated NaHCO3 solution. The
resulting mixture was extracted with dichloromethane (3x50 mL). The combined organic
layer was dried over anhydrous Na2SO4, filtered and concentrated using vacuum. The
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crude compound was purified by column chromatography using CombiFlash (1:4 Ethyl
acetate, Hexanes) to afford 25 (0.432 g, 78%). 1H NMR (Methanol d4 – 400 MHz);  6.89
(s, 1H, a), 6.76 (s, 1H, b), 6.58-6.53 (m, 7H, c), 6.42-6.40 (m, 2H, d), 4.96 (s, 4H, e), 4.574.55 (m, 4H, f, g), 4.47 (s, 1H, i), 4.08-4.06 (m, 4H, h), 3.94-3.78 (m, 11 H, i, j), 3.74-3.54
(m, 31 H, k), 3.53-3.46 (m, 5H, m), 2.91 (t, J = 2.3 Hz, 1H, n), 1.80-1.69 (m, 5H, p), 1.611.16 (m, 53H, q), 0.95-0.84 (m, 9H, z). MALDI-ToF m/z expected 1483.79 for
C82H129BrO18; found 1483.51 for C82H129BrO18 + H+.
Compound 26 was synthesized in the same fashion.

3.5.1.25 Synthesis of compound 27

According to the general procedure for synthesis of dendritic compounds, the
biaryl monomer 20 (0.072 g, 0.115 mmol) was reacted with the bromomethyl dendritic
compound 26 (0.192 g, 0.115 mmol) to give the mono alkylated product 27 (0.061 g,
19%).1H NMR (CDCl3 – 400 MHz);  6.79-6.62 (m, 6H, a), 6.60-6.51 (m, 9H, b), 6.44-6.42
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(m, 2H, c), 5.02 (s, 2H, d), 4.92 (s, 4H, e), 4.69 (s, 2H, f), 4.14-4.06 (m, 8H, g), 3.94-3.87
(m, 12H, k, n), 3.78-3.44 (m, 70H, p), 3.35 (s, 6H, h), 3.33 (s, 3H, i), 3.31 (s, 3H, j), 1.791.72 (m, 8H q), 1.69-1.58 (m, 4H, r), 1.46-1.38 (m, 4H, r), 1.37-1.15 (m, 48H, r), 0.91-0.79
(m, 12H, w); 13C NMR (CDCl3-100MHz)  160.5, 160.1, 159.3, 159.1, 157.3, 157.2, 157.0,
141.9, 139.5, 138.4, 135.6, 119.8, 119.2, 110.3, 109.3, 106.3, 105.8, 105.2, 104.4, 103.6,
100.9, 72.0, 70.9, 70.7, 70.7, 70.6, 70.5, 69.8, 68.9, 68.2, 67.5, 65.9, 65.6, 59.1, 32.0,
31.7, 29.7, 29.7, 29.5, 29.4, 29.3, 26.2, 26.1, 22.8, 15.4, 14.2. MALDI-ToF m/z expected
for C124H202O33: 2221.91; found 2259.66 for C124H202O33 + K+, 2243.69 for C124H202O33: +
Na+, 2221.73 for C124H202O33 + H+.

3.5.1.26 Synthesis of compound 28 (DA-2-12)

According to the general procedure for the synthesis of dendritic compounds,
the dendron-mono-alkylated scaffold 27 (0.07 g, 0.031 mmol) was reacted with the
bromo-dendron compound 25 (0.087, 0.059 mmol) to give compound 28 (0.091 g, 80%).
1

H NMR (Acetone d6 – 400 MHz);  6.92-6.86 (m, 2H, a), 6.78-6.59 (m, 21 H, a), 6.47-6.43
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(m, 4H, a), 5.17-5.10 (m, 4H, b), 5.07-5.01 (m, 8H, c), 4.69 (d, J = 2.2 Hz, 2H, e), 4.67-4.63
(m, 2H, f), 4.22-4.20 (m, 1 H), 4.15-4.04 (m, 13H, g), 4.02-3.91 (m, 14H, h), 3.84-3.77 (m,
9H, i), 3.71-3.40 (m, 97H, g, i), 3.29-3.23 (m, 18H, j), 2.96(t, J = 2.2 Hz, 1H, k), 1.82-1.71
(m, 8H, h), 1.65-1.57 (m, 6H, h), 1.52-1.42 (10H, h), 1.42-1.17 (m, 88H, h), 0.92-0.82 (m,
21H, z); 13C NMR (Acetone d6-100MHz)  161.4, 161.2, 160.0, 159.9, 157.9, 157.7, 154.6,
140.9, 140.8, 139.6, 119.3, 111.5, 111.3, 111.2, 106.8, 106.5, 105.8, 104.7, 101.4, 101.1,
80.0, 77.1, 72.6, 71.4, 71.3, 71.2, 71.2, 71.0, 70.3, 70.1, 69.4, 69.3, 69.2,68.6, 68.4, 58.8,
56.9, 32.7, 32.6, 26.9, 26.8, 23.3, 23.3, 14.4, 14.3. MALDI-ToF m/z expected for
C206H330O51: 3623.79; found 3645.49 for C206H330O51 + Na+.

3.5.1.27 Synthesis of compound 29

According to the general procedure for synthesis of dendritic compounds, the
dendron-mono-alkylated scaffold 27 (0.103 g, 0.046 mmol) was reacted with the bromodendron compound 24 (0.076 g, 0.051 mmol) to give compound 29 (0.12 g, 71%). 1H
NMR (CDCl3 – 400 MHz);  6.73-6.41 (m, 27H, a), 5.11-4.9 (m, 12 H, b, f), 4.73-4.65 (m,
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4H, c), 4.16-4.02 (m, 10H, d, e), 3.97-3.81 (m, 20H, g, h), 3.77-3.44 (m, 104H, g), 3.383.32 (m, 18H, i), 2.52 (t, J = 2.2 Hz, 1H, k), 1.85-1.11 (m, 112H, g), 0.93-0.81 (m, 21H, j);
13

C NMR (CDCl3-100MHz)  160.5, 160.1, 159.2, 159.2, 159.1, 158.9, 157.4, 157.3, 157.1,

157.1, 139.7, 139.4, 138.0, 136.3, 136.1, 119.9, 119.6, 110.3, 106.9, 106.3, 105.8, 105.3,
105.2, 104.9, 104.9, 104.5, 101.2, 100.9, 72.0, 72.0, 70.9, 70.7, 70.7, 70.7, 70.6, 70.6,
70.5, 70.5, 69.8, 68.9, 68.2, 67.5, 65.4, 59.1, 59.1, 56.0, 32.0, 29.8, 29.7, 29.7, 29.5, 29.4,
29.4, 29.2, 26.2, 26.1, 22.8, 14.2.

3.5.1.28 Synthesis of dendron G2-M (DA-2-90)

According to general procedure for click chemistry, compound 28 (0.017 g, 0.005
mmol) was treated with biotin-azide 18 (0.005 g, 0.014 mmol) to give G2-M dendron
(0.0074 g, 40%). 1H NMR (Methanol d4 – 400 MHz);  7.71 (s, 1H, z), 6.82-6.41 (m, 27H,
a), 5.65-5.58 (m, 4H, b, c), 4.68-4.51 (m, 4H, x, y, d), 4.40-4.32 (m, 5H, k), 4.31-4.23 (m,
5H, f), 4.18-3.97 (m, 9H, e), 3.89-3.72 (m, 15H, n, r), 3.69-3.63 (m, 12 H, k), 3.62-3.56 (m,
48 H, g, k, m, u, ), 3.55-3.48 (m, 35H, g, m, v), 3.32-3.25 (m, 3H, n, w), 2.86-2.72 (m, 4H,),
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2.41-2.30 (m, 8H, q), 2.12-1.95 (m, 16H, i, m), 1.85-1.62 (m, 33H, i, r), 1.60-1.48 (m, 17H,
i, h), 1.45-1.20 (m, 80H, i, p), 1.01-0.85 (m, 21H, j).

13

C NMR (Acetone d6-100 MHz) 

160.6, 160.3, 159.1, 157.2, 157.1, 157.0, 156.5, 144.0, 143.5, 140.0, 138.7, 136.5, 136.3,
119.4, 110.5, 106.0, 105.7, 105.1, 104.5, 104.0, 100.8, 100.7, 100.3, 70.3, 70.3, 70.2,
70.0, 69.6, 69.5, 69.3, 68.8, 68.7, 68.5, 68.4, 67.7, 67.5, 57.9, 35.2, 31.8, 31.8, 29.6, 29.4,
29.2, 29.2, 28.7, 28.5, 28.4, 26.1, 26.0, 25.4, 22.5, 22.5, 13.6, 13.6, 13.5. MALDI-ToF m/z
expected for C220H354N6O54S: 3980.24; found 4023.08 for C220H354N6O54S + 2Na+.

3.5.1.29 Synthesis of dendron G2-P (DA-2-89)

According to the general procedure for click chemistry, compound 29 (0.022 g,
0.006 mmol) was treated with biotin-azide 18 (0.006 g, 0.018 mmol) to give (0.013 g,
17%) G2-P dendron. 1H NMR (CDCl3 – 400 MHz);  7.78 (s, 1H, z), 6.82-6.40 (m, 27H, a),
6.24-6.22 (m, 1H, x), 5.57-5.56 (m, 1H, y), 5.32-5.17 (m, 2H, w), 5.11-4.89 (m, 12H, c),
4.75-4.66 (m, 2H, d), 4.60-4.37 (m, 4H, u, v), 4.36-4.21 (m, 2H, t), 4.19-3.32 (m, 155H, e,
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f, i), 3.26-3.02 (m, 4H, r, s, q), 2.89-2.51 (m, 4H, r, q, k), 2.25-2.15 (m, 2H, h, k), 2.10-1.95
(m, 2H, g), 1.87-1.57 (m, 26H, j, l), 1.55-1.11 (m, 88H, i), 0.95-0.77 (m, 21H, ). 13C NMR
(Acetone d6-100 MHz)  160.9, 160.6, 159.8, 157.9, 157.6, 157.7, 156.5, 144.0, 143.5,
140.2, 138.8, 136.5, 136.3, 119.5, 110.6, 106.2, 105.9, 105.3, 104.7, 104.3, 100.9, 100.8,
100.4, 70.3, 70.2, 70.0, 69.6, 69.5, 69.3, 68.8, 68.7, 68.5, 68.4, 67.7, 67.5, 57.9, 35.3,
31.9, 31.8, 29.7, 29.5, 29.3, 29.2, 28.7, 28.5, 28.4, 26.1, 26.0, 25.4, 22.6, 22.5, 13.7, 13.6.
MALDI-ToF m/z expected for C220H354N6O54S: 3980.24; found 4025.46 for C220H354N6O54S
+ 2Na+.

3.5.1.30 Synthesis of compound 30

According to the general procedure for synthesis of dendritic compounds, the
monomer 19 (0.03 g, 0.07 mmol) was reacted with the bromo-dendron compound 26
(0.30 g, 0.18 mmol) to give compound 30 (0.20 g, 70%). The characterization details of
this compound are in reference 37.
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3.5.1.31 Synthesis of dendron G2-F

According to the general procedure for click chemistry, compound 30 (0.050 g,
0.014 mmol) was treated with biotin-azide 18 (0.007 g, 0.020 mmol) to give (0.025 g,
46%) G2-F dendron. The characterization details of this compound are in reference 37.

3.5.2 Encapsulation, Disassembly, and Release Protocols
3.5.2.1 Encapsulation of Nile red
To encapsulate nile red in a dendron aggregate 2 mL 50 µM solutions of each
dendron were prepared and stirred at 5 oC for 12 hours. Small amounts of Nile red were
mixed with the dendron solutions and these heterogeneous mixtures sonicated for 4
hours. The solutions were stirred at room temperature until temperature equilibration
and then stirred at 5 oC for 16 hours. Then, the samples were diluted to 25 μM and
stirred at 5 oC for 12 hours more. After that, each sample was filtered through a syringe
filter (0.22 μm). The 25 μM dendron solutions were thus ready for CAC measurement
and dye release.
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3.5.2.2 Determination of CACs
The CACs of the dendrons in aqueous solutions were determined using the
fluorescence intensity of nile red (λem= 615 nm), as shown in Figure 3.4. 1 mL of 25 μM
dendron solution as prepared above was transferred to a cuvette where its
concentration was varied by replacing a measured volume of this solution with the same
volume of water. An emission spectrum (λex= 550 nm) was recorded for each
concentration of the dendron and a decreasing fluorescence intensity was obtained
from each spectrum. When the concentration of the dendron was below the CAC the
change in fluorescence intensity became smaller each time. The intensity values were
plotted against the concentration of dendron to get a curve (ideally sigmoidal). From the
curve, the point where the best fitted horizontal and vertical lines merge was taken as
the CAC.

3.5.2.3 Dye release upon exposure to an increasing concentration of protein
500 µL solution of dendron 25 µM encapsulating Nile red was exposed to protein
2 µM (extravidin, α-chymotrypsin, pepsin, myoglobin) by adding 2 µL of protein solution
from a stock 500 µM. After mixing well, the emission spectrum of Nile red was recorded
(λem= 615 nm, λex= 550 nm). Consecutive additions of 2 µL of protein 500 µM were made
every two minutes, recording fluorescence after each time until completing 14 µM of
protein in the 500 µL of dendron solution. Temperature was maintained at 25 oC. A
control experiment to test stability of encapsulation over time was made by exposing
the assemblies only to the buffer solution (HEPES 25 mM, pH 7.4) as shown in Figure
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3.8c. A control experiment exposing 25 µM solutions of analog dendrimers G1 and G2,
with PEG instead of ligand, to increasing concentration of extravidin was made to test
the non-specificity of the assemblies lacking biotin towards the protein, as shown in
Figure 3.8d.

3.5.2.4 DLS Measurements to monitor disassembly
The size of the dendrimeric assemblies and their change in size, when exposed to
proteins, was measured by dynamic light scattering. For that, 12 µM solutions of the
dendrons were prepared in water. Initial size of the assemblies was measured in 1 mL
solution. Then, the assemblies were exposed to 2 µM protein and after mixing well, DLS
was measured. The results for disassembly in presence of extravidin, interactions with
α-chymotrypsin, pepsin, myoglobin, and control dendrons (PEG instead of ligand) are
shown in Figure 3.5 and Figure 3.7. The proteins’ sizes are shown in Figure 3.6. All
measurements were made in a Malvern Zeta-sizer.

3.5.2.5 Dye release upon a single exposure to 14 µM of protein
500 µL of dendron solution encapsulating Nile red was exposed to protein 14 µM
(extravidin, α-chymotrypsin, pepsin, myoglobin) by adding 14 µL of protein solution
from a stock 500 µM. After mixing well, the emission spectrum of Nile red was recorded
(λem= 615 nm, λex= 550 nm) every 15 minutes during the first hour, and then every hour
during six hours. Release profiles over time for α-chymotrypsin, pepsin, and myoglobin
are shown in Figure 3.15. Temperature was maintained at 25 oC.
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Figure 3.15. Release profile of 25 µM dendron assemblies when exposed to 14 µM
solution of a) α-chymotrypsin, b) pepsin, and c) myoglobin.

3.5.2.6 Encapsulation stability test based on crosslink density:
Three different solutions of nanogels with 0%, 20%, and 50% crosslink densities
encapsulating Nile red were prepared in a concentration of 1 mg/mL. The initial
fluorescence was measured. Then, 1 mL of these solutions was exposed to 0.5 mg/mL
myoglobin and the fluorescence recorded for 50 min. The concentration of myoglobin
was increased to 1.0 mg/mL, 1.5 mg/mL, and 2.0 mg/mL measuring fluorescence for
each change in myoglobin concentration for a few minutes. The final plots of time vs
quenching percentage are shown in Figure S4a. When the nanogels were exposed to a
high concentration of myoglobin, the change in quenching percentage was also high,
Figure 3.10.

3.5.2.7 Stern-Volmer Plots for G1-F and G2-F
Two samples of dendron solution 25 µM in 500 µL encapsulating Nile red, at
temperatures of 25 and 38 oC, were exposed to increasing concentrations of myoglobin.
The value of the initial fluorescence of the dendrons (F 0) divided by the fluorescence of

143

the same dendrons in presence of the myoglobin (F), in increasing concentration Vs the
metalloprotein concentration was plotted in Figure 3.11.
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CHAPTER 4
SYNTHESIS OF A CROSSLINKABLE DENDRON FOR INTRACELLULAR TARGETING OF
PROTEINS

4.1 Introduction
As discussed in Chapter 1, dendrimers possess high stability and the ability to
form unimolecular micelles in aqueous solutions. On the other hand, as stated in
Chapter 3, self-assembling dendrons can only form nanoassemblies in concentrations
above their CAC, which inherently is a disadvantage if a self-assembling system is to be
used as a drug delivery vehicle.1
In the previous Chapter, we discussed the synthesis and structural advantages of
dendrons, their characteristics, and their potential as scaffolds in drug delivery and
sensing. As a matter of fact, we used biaryl amphiphilic self-assembling dendrons to
study the stimulus-responsive disassembling properties of a supramolecular
nanoassembly in the presence of a complementary protein, taking advantage of the CAC
of the dendrons. The architecture of these dendrons was also used to discriminate the
ligand location on the molecular structure that better led to a release of guest
molecules upon protein binding.
A molecular system that requires being above a CAC to form nanoassemblies
with some degree of stability, inevitably involves equilibrium between the
nanoassembly stage and the molecular stage, as shown in Figure 4.1. During such
equilibrium, the non-covalently encapsulated guest molecules are prone to leak out of
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the assembly and into the media. In a biological system, this leakage can result in the
carrier unloading the drug before it reaches the target site. Then, the leaked cargo could
diffuse into normal tissue causing unwanted side effects.2 Also, a dendritic selfassembling system would have to overcome the dilution factor that implies translating
from in vitro to in vivo conditions without going too close to or below its CAC.

Figure 4.1. Inherent equilibrium of self-assembling dendrons.

A solution to overcome this stability problem involves the incorporation of
crosslinkers into the system, which can be adjusted to make the dendritic system
responsive to environmental changes, such as a reducing environment.3,4 Crosslinking is
a feature usually found in nanogels, although in a dendron, the crosslinkable units can
be incorporated exactly in the desired locations due to the possibility of controlled
functionalization during synthesis. Once the stability issue is corrected, a system could
go through biological barriers, such as cell membranes, without losing cargo. Then, if the
system is decorated with the right targeting moieties such as a ligand,5 it could reach the
complementary protein in the cell.
Decoration of nanoparticles with ligands has tremendous implications in drug
delivery and sensing due to the specificity that ligands confer to a system.6 In the
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particular case of dendrons, as shown in the previous Chapter, protein binding through
a ligand is the stimulus that triggers disassembly and release.5,7,8 Targeting mechanisms
for a delivery vehicle in cancer chemotherapy could be classified in two categories,
passive and active targeting. Passive targeting is based on the propensity of
nanoparticles of 10-200 nm in size to accumulate selectively in the tumor tissue. This is
possible due to the increased permeability of the tumor vasculature and ineffective
lymphatic drainage, also known as the enhanced permeation and retention (EPR)
effect.9 Active targeting is accomplished by decorating the nanoparticle with ligands that
exhibit high affinity for receptors, which are usually overexpressed on the surface of
cancer cells or as binding sites in overexpressed proteins inside the cell.10
Here, we present a dendritic system designed to overcome encapsulation and
stability problems resulting from an inherent CAC dependent equilibrium, with the
potential capability to respond to different stimuli, as shown in Figure 4.2.

Figure 4.2. Schematic of crosslinked dendritic aggregates.
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4.2 Approach and Molecular Design
Biaryl dendrons are facially amphiphilic in each layer of the design, the focal
point and the periphery. This is accomplished by incorporating hydrophilic and
hydrophobic side chains at opposite sides of the aryl moieties, which are oriented at
opposite faces when the dendrons are in aqueous solution, due to the inherent twist of
the biaryl.11 It has been shown in a recent work from our lab that dendrons can be
crosslinked at the core of the assembly by using UV light, if the proper crosslinking
moieties are incorporated in the hydrophobic face of the dendron, i.e. photodimerizable
coumarin.12 In the same work, it was shown how the system could encapsulate
hydrophobic guest molecules prior to crosslinking and preserve the crosslinking
capacity. However, the responsiveness of the crosslink in that design was not applicable
towards a biologically relevant stimulus, since light can only penetrate a few millimeters
in organic tissue. To fully exploit the capability of dendrons to be adapted as crosslink
nanoassemblies and stable nanocarriers, it is important to make the supramolecular
aggregate responsive to biologically relevant stimuli by introducing, in this case, a redox
responsive crosslinkable moiety and a ligand for protein targeting.
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We targeted a single dendritic design, initially with the potential to be
conjugated to any ligand able to perform a nucleophilic attack. The structure of the
targeted dendron is shown in Figure 4.3. Pentaethyleneglycol monomethylether (PEG)
was chosen as the hydrophilic moiety for the reasons mentioned in the previous
chapter. Briefly, PEG confers water solubility and biocompatibility when it is installed as
the outer shell in a nanoparticle.
Crosslinking in nanoparticles
could be performed either at the
surface or at the core.3 Our dendron
has the crosslinking units as the
hydrophobic
molecule,

moieties
which

of

the

means

the

hydrophobic chains will collapse
towards the core of the selfassembly where they will crosslink

Figure 4.3. Targeted G1 dendron.

upon a redox stimulus. For that, an
alkyl chain with a pyridyl disulfide as a terminal group functions as both the crosslinking
unit and the hydrophobic moiety. However, due to the reactivity of the pyridyl disulfide
functionality, the hydrophobic fragments must be attached to the dendron in the last
step of the synthesis via an orthogonal reaction. For this, the pyridyl disulfide bearing
alkyl chain has an azide as the other terminal group. If the dendron backbone is
functionalized with terminal alkyne functionalities, azide-alkyne click chemistry can be
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performed to attach the crosslinkable hydrophobic moieties to the dendron in the last
step of the synthesis.
It has been found that for this type of dendrons the gain in CAC from a G1 to a
G2 is already small,13 while the gain from G0 to G1 is significant (mM to µM) this is a
reason to limit the synthetic efforts to the synthesis of only a G1 type of crosslinkable
dendrons. Also, the simplest crosslinkable dendron will have 3 of such functionalities,
which corresponds to a G1 dendron with the redox responsive units at the hydrophobic
face. A G2 dendron would have 7 of these functional groups, although after crosslinking,
the formation of new covalent bonds between G1 dendrons in the assembly will render
a crosslinked aggregate, not different from the crosslinked aggregate formed by a G2
dendron. Then, it is worthwhile to synthesize only a G1 dendron, which, in the end, after
crosslink, does not present a meaningful difference with a G2.
A system that responds to a reducing environment is attractive from the drug
delivery perspective, due to the high reducing environment in the cells. 3 Although
glutathione, the most abundant reducing agent in most cells, has an intracellular
concentration of approximately 3 mM, its concentration in the blood is around 10 µM.14
Such difference in concentration is more than two orders of magnitude higher for the
intracellular environment, which makes glutathione a highly desirable stimulus to
target.
Given the possibility the aggregate remains preserved after it has been
internalized by the cell and de-crosslinked by glutathione, it would be interesting to
explore the possibility of triggering intracellular disassembly of the dendron self-
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assembly. For that, once more, we take advantage of the control over the
functionalization in the synthesis of a dendron to introduce a ligand as a second
responsive functionality to target an overexpressed protein, which is to be found within
a cancer cell.
Such

target

could

be

dihydrofolate reductase (DHFR), which is
an enzyme that has a critical role in
regulating

the

amount

of

tetrahydrofolate by reducing dihydrofolic
Figure 4.4. Targeted ligand.
acid to tetrahydrofolic acid in the cell.15
Tetrahydrofolate,

as

well

as

its

derivatives, is essential in the synthesis of purine and thymidylate, which in turn, are
important for cell proliferation and cell growth.16,17 DHFR plays a central role in the
synthesis of nucleic acid precursors, which makes it a target for anticancer drugs, along
with the fact that folate is needed in rapidly dividing cells to make thymine.18 The
deficiency of this enzyme causes deficiency in folate, which has been linked to health
problems such as anemia. The overexpression of DHFR is a requirement for the rapid
cell division shown by cancer cells. The highest concentrations of DHFR have been found
in brain cancer cells.19
Methotrexate (MTX), a folic acid derivative, is a ligand that has been found to
bind efficiently to DHFR (nanomolar range).20,21,22 However, its poor solubility makes it
difficult to functionalize, a requirement for its synthetic transformation. 23 For that, we
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functionalized this ligand with two hydrophilic fragments of amino-diethylene glycol in
an attempt to increase the ligand solubility in different solvents. The targeted ligand is
shown in Figure 4.4.
The functionalization of the dendron with the ligand can be accomplished at the
benzylic position by simply transforming the benzylic hydroxyl into an excellent leaving
group, trifluoromethanesulfonate (triflate, -OTf). Then, a hydroxyl from the ligand will
attack the benzylic position displacing the triflate and forming the ligand-functionalized
dendron. The reason to attach the ligand at the benzylic position of the focal point is
related to the HLB of the dendron. Since the pyridildisulfide components are highly
hydrophobic, a dendron in which a PEG chain has been replaced by a linker and ligand
that are not as hydrophilic could simply precipitate out of solution. A way to overcome
this problem, since we don’t want the ligand buried in the hydrophobic core, is to
endow the ligand with a hydrophilic linker and then attach it to a position that does not
involve substituting PEG in the molecule, i.e. the benzylic hydroxyl.

158

Scheme 4.1. Synthesis of the target G1 dendron.

159

4.3 Results and Discussion
4.3.1. Synthetic Strategy
In this synthesis, we target a dendron initially incorporating PEG chains as the
hydrophilic components and propargyl functionalities in the positions, where we want
the hydrophobic chains to be attached by click chemistry at a later step. Accordingly,
and as shown in Scheme 4.1, we started with the synthesis by mono-protecting one
phenolic hydroxyl in the ester of 4-bromo-3,5-dihydroxybromobenzoic acid 1 with tertbutyldimethylsilyl chloride (TBS-Cl), in presence of the base imidazole, to get the aryl
scaffold 2. The remaining phenolic hydroxyl was then acetylated by reacting it with
acetyl chloride using triethylamine as the base. From this reaction we obtained the
bottom aromatic ring 3, which is protected by two different protective groups in such a
way that it is possible to selectively deprotect the phenolic hydroxyls to make them
react individually.
Once we got the bromoaryl 3, its reaction with the arylstannane 4 (compound 5
in Chapter 3) under Stille coupling conditions, generated the biaryl protected AB 2
monomer 5. Then, the acetyl group protecting one phenolic hydroxyl was hydrolyzed
with lithium aluminum hydride (LiAlH4) to deprotect the hydroxyl; simultaneously, the
ester functionality was reduced to a methyl alcohol getting the mono-deprotected biaryl
6. The now available phenolic hydroxyl was O-monoalkylated using propargyl bromide in
the presence of potassium carbonate and 18-crown-6 to get the alkyne bearing biaryl 7.
The selective deprotection of the remaining phenolic hydroxyl in the bottom aromatic
ring, using tetrabutylammonium fluoride (TBAF), led to the biaryl 8, which was O-
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alkylated with PEG by reacting with PEG-Ts in the O-monoalkylation conditions already
described. From the previous step, we got the MOM diprotected AB2 compound 9.
Compound 9, which bears a PEG chain and a propargyl unit as well as the
benzylic alcohol, was reacted with Dowex resin to deprotect the phenolic hydroxyls in
the top ring to yield the AB2 monomer 10. Utilizing a bromomethyl periphery unit 11

Scheme 4.2. Test reaction for 13 under click chemistry conditions.

(compound 12 in Chapter 3) to O-alkylate the remaining phenolic hydroxyls, we got the
G1 dendron 12 with the required three alkyne functionalities for click chemistry. Finally,
the alkyne-azide click chemistry was possible between 12 and the hydrophobic molecule
13, which is functionalized with an azide on one end and with a pyridyldisulfide group
(PDS) on the other end, to get the targeted crosslinkable G1 dendron 14 (Scheme 4.1).
However, before performing this previous reaction, the pyridyldisulfide moiety in
13 had not been reported to be stable under the click chemistry conditions used in the
reaction with the dendron 12, as seen in Scheme 4.1, requiring certain synthetic efforts
to achieve. For that reason, we run a test reaction to observe the behavior of the
pyridyldisulfide moiety under the conditions of alkyne-azide click chemistry, as shown in
Scheme 4.2. Briefly, 3-hydroxybenzyl alcohol 15 was O-alkylated with a propargyl
substituent to get the product 16, which was set up to react with 13 in the click
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chemistry conditions overnight. The desired product triazol-pyridyldisulfide 17 was
obtained in acceptable yield and purified without major inconvenience.

Scheme 4.3. Synthesis of the hydrophobic crosslinkable moiety.

The synthesis of the azide 13 is shown in Scheme 4.3 and was started from the
commercially available 6-mercaptohexanol 18, which was functionalized and at the
same time protected with 2,2’-dipyridyl disulfide 19, in acidic conditions,24 to get 6-(2dithiopyridyl)hexanol 20. The terminal hydroxyl in 20 was functionalized into the
mesylate 21 by reaction with mesyl chloride (MsCl). The mesyl group is a good leaving
group and was substituted by an azide group to give the hydrophobic azide

Scheme 4.4. Modification of the ligand MTX.

incorporating a crosslinkable moiety 13.
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The modifications made to the ligand MTX are shown in Scheme 4.4. After
attempting to solubilize MTX in solvents such as N,N-dimethylformamide (DMF),
dimethylsulfoxyde (DMSO), methanol (MeOH) and mixtures of the solvents,
MeOH/DMF, NMP/DMF, only N-methyl-2-pyrrolidone (NMP) was suitable to accomplish
the reaction.23 For that, the carboxylic acid groups of MTX 22 were reacted in an amide
coupling with the amino group of 2-(2-aminoethoxy)ethanol aided by the coupling agent
HATU and Hünig’s base (N,N-diisopropylethylamine, DIPEA)25 to get the more soluble

Scheme 4.5. Attaching the ligand to a G1 dendron at the benzylic position.

modified ligand 23.
As mentioned before, to try to incorporate the ligand 23 to the structure of the
dendron with the least possible variation in the HLB of the dendron, we decided to
conjugate the ligand to the benzylic position of the dendron. For that, dendron 12 was
reacted with triflyl chloride (TfCl) to afford 24,26 as shown in Scheme 4.5. Then, the
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ligand 23 substituted the benzylic position of the dendron aided by DBU, yielding
dendron 25, which was clicked with the hydrophobic moieties 13 to afford the final
target 26.

4.3.2 Self-Assembly and Crosslink
The self-assembly properties of dendron 14 in water were studied using DLS,
with a dendron concentration of 25 µM, which is above the typical CAC found for these
dendrons (2-11 µM). The size of the assemblies formed by this dendron is around 142
nm. The size of the initial aggregate is represented in Figure 4.5 as the curves in red
color. The size discrimination by number of particles is consistent with the
discriminations in volume and intensity, showing that the distribution of the
nanoparticulates oscillates around a single size of dendritic assembly.

Figure 4.5. Size of the dendritic aggregates, before and after crosslink. a) distribution by
number shows only one size of assembly, b) distribution by volume is consistent with
the number %, c) distribution by intensity is also in the distribution range of number %.
To crosslink the assembly, we used a known reducing agent, dithiothreitol (DTT).
In this experiment, DTT plays the same role that glutathione (GSH) would play in the
intracellular

environment,

reducing

the

disulfide

bonds

and

cleaving

the

pyridothione,27,28 which is a good leaving group (Scheme 4.6). The remaining
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functionality, a thiol group, is attached to the backbone of the dendron by means of a
triazol ring. The reactivity of the thiol groups to form disulfide bonds is the basis for the
crosslinking reaction here.
The size of the crosslinked dendritic self-assembly distributes around 143 nm,
which is 9 nm smaller than the size of the aggregate before crosslinking. The shrinking
size of the nanoparticles is evidence that crosslink of the assembly indeed happened.
More evidence that the nanoparticle could have crosslinked is the formation of the
product from the reaction between DTT and the PDS moieties of the dendron,

Scheme 4.6. Crosslinking reaction of the dendron.
pyridothione. Pyridothione is a water soluble molecule that absorbs at 343 nm, making
it possible to quantify its presence in the dendron solution upon reaction with DTT.
Using UV-Vis spectroscopy, to monitor pyridothione absorbance, it was possible to
quantify the degree of reaction of the PDS functionalities of the dendron as up to 63%,
relative to the percentage of cleavage achieved when the dendron is exposed to a great
excess of DTT during 48 hours, as shown in Figure 4.6.
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Figure 4.6. Cleavage of pyridothione tracked by UV-Vis spectroscopy.

To be able to quantify the PDS groups cleavage when the dendron and DTT were
in solution in a molar ratio 1:3, which is equivalent to a ratio PDS:DTT 1:1 for the three
PDS units per G1 dendron, the sample was exposed to an excess of DTT in such a way
that the ratio PDS:DTT was increased to 1:20. After 48 hours of this reaction, the
absorbance detected was taken as a relative 100% of the PDS reacted. Since the
pyridothione molar absorptivity is known ( = 8.08 x 103 M-1cm-1 at 343 nm),27 we can
use it to calculate, theoretically, the 100% of 75 µM PDS that reacted (dendron at 25 µM
x 3 PDS groups per dendron) simply by using the Beer-Lambert law. From that, it was
found that only 74% of the PDS units were cleaved when the DTT excess was 20:1
respect the PDS groups. Based on this calculation, the percentage of crosslinking shown
in Figure 4.6 is close to 50% for the ratio PDS to DTT 1:1.
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Next, to test if the equilibrium dendron-aggregate has been shifted towards the
aggregate stage, the dendron self-assembly was exposed to a solution of
water:methanol 50% and the change in size was observed through DLS. In general,
methanol is a solvent in which these dendrons are solubilized, hence any aggregate
would be expected to promptly dissociate in presence of this solvent. As shown in
Figure 4.7, the size of the self-assembly increased from 142 to 332 nm for the non-

Figure 4.7. DLS measurements of the stability of the assemblies in 50% methanol. a)
distribution by number, b) distribution by volume, c) distribution by intensity.

crosslinked self-assembly, an increase in more than twice the initial size of the assembly
that indicates swelling of the aggregate and a disruption in the non-covalent forces that
held the assembly together. However, when the crosslinked dendritic assembly was
exposed to the same conditions, water:methanol 1:1, the size increased only from 142
to 182 nm. The large difference in size between crosslinked dendritic assembly and G1
dendron in 50% methanol is also evidence of the crosslinking taken place and being
effective in holding together the self-assembly.
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Figure 4.8. TEM images of non-crosslinked dendritic aggregates. Panels (a) and (b);
and crosslinked aggregates, panels (c) and (d).The panels come from different
samples.
The dendritic aggregates were also studied by transmission electron microscopy
(TEM) before and after exposure to DTT. The TEM images of G1 and G1 crosslinked are
shown in Figure 4.8. Before crosslinking, the images show more spherical shapes for the
aggregates; after crosslinking, the shapes of the nanoparticulates became more oval in
general. However, the size does not seem to change when going from non-crosslinked
to crosslinked, as it was observed by DLS although the size does seem to be slightly
larger in the images than what was observed by DLS.
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4.4 Summary
In summary, the functionalization of a dendron structure with hydrophobic
moieties containing PDS can be easily performed at a later step of the synthesis through
a reaction such as alkyne-azide click chemistry, which is orthogonal to the reactive
functional groups in both the dendron and hydrophobic moiety.
We found that assemblies of PEG-PDS dendrons can be formed in aqueous
solution. However, due to a higher inherent hydrophobicity, these dendrons cannot be
deprived of any PEG chain for the attachment of a ligand on the hydrophilic face of the
dendron. For that matter, the attachment of a ligand at the benzylic position of the
backbone of the dendron was successfully achieved via a triflate leaving group. On the
other hand, the solubility and hydrophilicity of the ligand MTX was accomplished by
functionalization with a short aminodiethylene glycol chain.
Crosslinking of the PDS functionalities in the dendritic aggregates, compared to
the non-crosslinked samples, gave the nanoparticulates more stability when they were
exposed to a mixture 1:1 of water and methanol. Although only half of the PDS
functionalities reacted, that was enough to confer the nanostructures more stability,
potentially locking the inherent equilibrium of these amphiphilic dendrons in the selfassembly stage and preventing the leakage of encapsulated guest molecules.
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4.5 Experimental Section
4.5.1 Synthetic Procedures and Characterization of Compounds
All chemicals and solvents were purchased from commercial sources and were
used as such, unless otherwise mentioned. 1H NMR spectra were recorded on a 400
MHz Bruker NMR spectrometer using the residual proton resonance of the solvent as
the internal standard. Chemical shifts are reported in parts per million (ppm). When
peak multiplicities are given, the following abbreviations are used: s, singlet; bs, broad
singlet; d, doublet; t, triplet; m, multiplet. 13C NMR spectra were proton decoupled and
recorded on a 100 MHz Bruker spectrometer using the carbon signal of the deuterated
solvent as the internal standard. Fluorescence spectra were recorded using a JASCO FP6500 spectrofluorimeter. FAB-MS spectra were measured on a JEOL JMS700. MALDITOF spectra were measured on a Bruker OmnifleX. IR spectra were measured on a
Bruker Alpha-P FT-IR.

4.5.1.1 General Procedure for the Alkylation of Phenolic Hydroxyls
The phenolic hydroxyl group (1.0 equiv.) was solubilized in anhydrous acetone
along with the benzyl bromide (1.0 equiv. for mono-alkylation and 2.20 equiv. for
dialkylation). The base K2CO3 (2.0-3.0 equiv.), and 18-crown-6 (0.05-0.1 equiv.) were
added. The reaction mixture was refluxed under argon atmosphere for 12-48 hours. The
progress of the reaction was monitored by TLC. After completion of the reaction, the
solvent was evaporated and the crude reaction mixture mixed with water and extracted
with dichloromethane or ethyl acetate three times. The combined organic layer was
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dried over anhydrous Na2SO4 and evaporated to dryness. The crude product was
purified by column chromatography using silica gel as stationary phase.

4.5.1.2 General Procedures for “Click” Chemistry
To a solution of dendritic triacetylene compound (1.0 equiv.), and PDS-azide 13
(4 equiv.) in THF, was added the same volume of aqueous CuSO4.5H2O (1.0 equiv.) and
sodium ascorbate (2.0 equiv.) in such a way that the final solution THF/H2O was in a
ratio 1:1. The reaction stirred at room temperature. After completion of the reaction,
NH4Cl solution was added to the reaction mass and then, extracted with ethyl acetate
three times. The organic layers were collected and dried over anhydrous Na 2SO4,
filtered, concentrated, and the product purified by silica gel column chromatography.

4.5.1.3 Synthesis of compound 2 (DA-2-171)

The aromatic ester 1 (21 g, 80 mmol) was dissolved in 450 mL of
dichloromethanealong with the imidazole (5.50 g, 80 mmol). The temperature of the
solution was reduced with an ice bath. The acetyl chloride was dissolved separately in
60 mL of dichloromethane and then added dropwise to the ester and base solution,
stirring and under Ar atmosphere in the ice bath for 1 hour. After 12 hours stirring the
reaction mass was washed two times with saturated NaHCO3 solution. The organic layer
was dried on Na2SO4, filtered, concentrated and purified by silica gel column
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chromatography to get the product 2 (13.21 g, 44%). 1H NMR (CDCl3-400MHz)  7.31 (s,
1H, a), 7.12 (s, 1H, b), 5.67 (bs, 1H, c), 4.35 (q, J = 7.1 Hz, 2H, d), 1.38 (t, J = 7.1 Hz, 3H, e),
1.05 (s, 9H, f), 0.28 (s, 6H, g).

4.5.1.4 Synthesis of compound 3 (DA-2-189)

The monoprotected ester 2 (11.4 g, 30.37 mmol) was dissolved in 125 mL of
dichoromethane, after adding triethylamine (6.14 g, 60.75 mmol) the temperature of
dropped by means of an ice bath and the acetyl chloride (4.8 g, 60.75 mmol) was added.
The reaction was left stirring under Ar atmosphere for 18 h. Then, it washed two times
with saturated NaHCO3 solution. The aqueous layers were collected and extracted with
125 mL of dichloromethane, once. The organic layers were dried on Na2SO4, filtered,
concentrated and purified by silica gel column chromatography to get the product 3
(10.95 g, 87%). 1H NMR (CDCl3-400MHz)  7.42 (d, J = 1.8 Hz, 1H, a), 7.40 (d, J = 1.9 Hz,
1H, b), 4.35 (q, J = 7.1 Hz, 2H, d), 2.36 (s, 1H, c), 1.38 (t, J = 7.1 Hz, 3H, e), 1.05 (s, 9H, f),
0.29 (s, 6H, g).

13

C NMR (CDCl3-100MHz)  168.3, 165.1, 154.1, 149.5, 130.5, 117.8,

117.0, 61.4, 25.6, 20.8, 18.3, 14.2, 4.3. FAB-MS for C17H25BrO5Si: m/z (r.i.) 417 (M+, 39),
375 (40), 361 (83), 359 (80), 331 (28), 319 (25).
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4.5.1.5 Synthesis of compound 5 (DA-3-43)

The solvent was degasified by bubbling Ar through it for 1 hour. The reagents 3
(6.91 g, 16.56 mmol) and 4 (7.32 g, 15.02 mmol) were placed in a 100 mL round-bottomflask (RBF) that was also purged with Ar for 15 min. 50 mL of DMF were transferred with
a syringe to the RBF with the reagents. The solution was heat to 110 oC. Then, the
catalyst, bis(triphenylphosphine)palladium(II) dichloride (0.43 g, 0.61 mmol), was quickly
added. The reaction was heat at 110-120 oC and stirred with Ar atmosphere for 24
hours. Then, the DMF was evaporated and the remaining mass was washed with 150 mL
of ethyl acetate and filtered. The organic solution was washed with water (2 x 100 mL)
and brine. The organic layer was dried on Na2SO4, filtered, concentrated and purified by
silica gel column chromatography in CombiFlash to get the stille coupling product 5
(52.15 g, 27%). 1H NMR (CDCl3-400MHz)  7.45 (d, J = 1.6 Hz, 1H, a), 7.42 (d, J = 1.5 Hz,
1H, b), 6.70 (t, J = 2.3 Hz, 1H, c), 6.61 (d, J = 2.3 Hz, 2H, h), 5.13 (s, 4H, i), 4.37 (q, J = 7.1
Hz, 2H, d), 3.46 (s, 6H, j), 2.04 (s, 3H, k), 1.39 (t, J = 7.1 Hz, 3H, e), 0.75 (s, 9H, f), 0.04 (s,
6H, g). FAB-MS for C27H38O9Si: m/z (r.i.) 535 (M+, 50), 503 (35), 477 (100), 447 (50), 373
(40), 345 (18).
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4.5.1.6 Synthesis of compound 6 (DA-3-13)

Compound 5 (2.12 g, 3.97 mmol) was solubilized in 35mL of anhydrous. Stirring,
under Ar atmosphere, and with an ice bath, the reducing agent LiAlH 4 (0.75 g, 19.85
mmol) was added in portions. After complete addition, the reaction was allowed to
reach room temperature. After 24 hours stirring the reaction mass was quenched by
adding 50 mL of ethyl acetate at 0 oC and stirring for a 10 min. The solvent was
evaporated to again, add ethyl acetate and water, extracting the aqueous solution three
times with ethyl acetate. The organic layers were collected and dried over Na 2SO4. The
solvent was evaporated and the product purified through column chromatography to
get 6 (0.86 g, 48%). 1H NMR (CDCl3-400MHz)  6.74 (t, J = 2.3 Hz, 1H, c), 6.67 (d, J = 2.3
Hz, 2H, h), 6.63 (m, 1H, a), 6.49 (m, 1H, b), 5.16 (s, 4H, i), 4.61 (s, 2H, d), 3.46 (s, 6H, j),
0.74 (s, 9H, f), 0.07 (s, 1H, e), -0.01 (s, 6H, g). FAB-MS for C23H34O7Si: m/z (r.i.) 451 (M+,
44), 433 (42), 393 (52), 331 (23).

4.5.1.7 Synthesis of compound 7 (DA-3-32)
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Compound 6 (0.73 g, 1.62 mmol), propargyl bromide (0.39 g, 3.23 mmol), K2CO3
(0.45 g, 3.23 mmol), and 18-crown-6 (0.09 g, 0.32 mmol) were refluxed in 15 mL of
acetone, as described in the general procedure for alkylations getting the product 7
after purification by chromatography (0.20 g, 25%). 1H NMR (CDCl3-400MHz)  6.77 (d, J
= 1.2 Hz, 1H, a), 6.68 (m, 1H, c), 6,67 (d, J = 2.0 Hz, 2H, h), 6.58 (m, 1H, b), 5.15 (s, 4H, i),
4.67 (d, J = 5.4 Hz, 2H, d), 4.61 (d, J = 2.4 Hz, 2H, n), 3.46 (s, 6H, j), 2.45 (t, J = 2.4 Hz, 1H,
k), 1.67 (t, J = 5.87 Hz, 1H, e), 0.75 (s, 9H, f), 0.02 (s, 6H, g).

4.5.1.8 Synthesis of compound 8 (DA-3-35)

Compound 7 (0.2 g, 0.41 mmol) was dissolved in anhydrous THF, to which TBAF
(0.43 g, 1.63 mmol) was added. The reaction was left stirring and in Ar environment at
room temperature for 12 hours. THF was evaporated with air flow at room
temperature. Then, 20 mL of NH4Cl solution were added. The aqueous solution was
extracted with ethyl acetate. The organic layers were collected and dried over Na2SO4.
The solvent was evaporated and the product 8 was purified through column
chromatography (0.15 g, 94%). 1H NMR (CDCl3-400MHz)  6.78 (t, J = 2.3 Hz, 1H, c), 6.71
(d, J = 1.2 Hz, 1H, b), 6.70 (d, J = 2.3 Hz, 2H, h), 6.68 (m, 1H, a), 5.17 (s, 4H, i), 4.68 (s, 2H,
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d), 4.64 (d, J = 2.4 Hz, 2H, n), 3.48 (s, 6H, j), 2.46 (t, J = 2.4 Hz, 1H, k), 1.71 (bs, 1H, e).
FAB-MS for C20H22O7: m/z (r.i) 374(M+, 100), 329(53), 297(72), 267(50), 69(85).

4.5.1.9 Synthesis of compound 9 (DA-3-37)

According to the procedure for alkylation of phenolic hydroxyls, the biaryl 8 (0.14
g, 0.38 mmol) was mixed with the tosylate of pentaethylene glycol monomethyl ether
PEG-Ts (0.16 g, 0.38 mmol), K2CO3 (0.16 g, 1.15 mmol), and 18-crown-6 (0.02 g, 0.08
mmol) in anhydrous acetone and refluxed, stirring and under Ar atmosphere. After
purification, 9 was obtained (0.16 g, 68%). 1H NMR (CDCl3-400MHz)  6.78 (s, 1H, b),
6.74 (s, 1H, a), 6.73 (d, J = 2.3 Hz, 2H, h), 6.68 (t, J = 2.3 Hz, 1H, c), 5.16 (s, 4H, i), 4.70 (s,
2H, d), 4.62 (d, J = 2.4 Hz, 2H, n), 4.08 (m, 2H, f), 3.71 (m, 2H, g), 3.61 (m, 11H, r), 3.53
(m, 5H, r), 3.48 (s, 6H, j), 3.37 (s, 3H, p), 0.07 (s, 1H, e). 13C NMR (CDCl3-100MHz)  157.5,
157.1, 155.6, 154.0, 142.1, 141.0, 135.5, 130.0, 119.6, 112.8, 111.7, 105.3, 104.9, 104.5,
103.7, 94.7, 78.8, 75.4, 71.9, 70.8, 70.7, 70.6, 70.5, 70.5, 69.6, 68.9, 68.8, 65.3, 59.0,
56.4, 56.0.
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4.5.1.10 Synthesis of compound 10 (DA-3-39)

Compound 9 (0.16 g, 2.61 mmol) was dissolved in 10 mL of methanol, 1 mL of
1,4-dioxane, and 0.5 mL of water. Dowex resin was added (0.48 g) and the reaction was
set to reflux, stirring and under Ar atmosphere. The mixture reacted for 4 hours. Upon
completion of the reaction the solvents were evaporated and the remaining mass
washed with acetone and filtered. The acetone was evaporated and 10 mL of water
added to remaining mass, to extract with ethyl acetate (3 x 10 mL). The organic layers
were dried over Na2SO4. The organic solution was filtrated and concentrated. After
purification, product 10 was got (0.12 g, 90%). ESI-MS m/z calculated for C27H36O10 + H+:
520.57; found: 1061.0 for (2(C27H36O10) + Na)+, 543.2 for (C27H36O10 + Na)+. Additional
characterization details for compound 10 are found in reference 29.29

4.5.1.11 Synthesis of compound 12 (DA-3-40)
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According to the procedure for the alkylation of phenolic hydroxyls, compound
10 (0.12 g, 0.24 mmol), compound 11 (0.25 g, 0.52 mmol), K2CO3 (0.16 g, 1.18 mmol),
and 18-crown-6 (0.03 g, 0.12 mmol) were mixed in anhydrous acetone and refluxed,
stirring under Ar atmosphere. After purification, compound 12 was obtained (0.19 g,
62%). 1H NMR (CDCl3-400MHz)  6.78 (s, 1H, b), 6.76 (s, 1H, a), 6.64 (d, J = 2.1 Hz, 2H, c),
6.63 (d, J = 2.0 Hz, 2H, d), 6.60 (d, J = 2.3 Hz, 2H, i), 6.55 (d, J = 2.3 Hz, 1H, z), 6.49 (t, J =
2.2 Hz, 2H, x), 4.97 (s, 4H, e), 4.70 (s, 2H, g), 4.66 (d, J = 2.4 Hz, 4H, w), 4.57 (d, J = 2.3 Hz,
2H, f), 4.12-410 (m, 4H, h), 4.06-4.04 (m, 2H, i), 3.85-382 (m, 4H, j), 3.72-3.70 (m, 5H, k),
3.68-3.56 (m, 37H, k), 3.55-3.51 (m, 13H, k), 3.37 (s, 6H, u), 3.36 (s, 3H, y), 2.52 (d, J = 2.4
Hz, 2H, v), 2.47 (d, J = 2.3 Hz, 1H, n).

13

C NMR (CDCl3-100MHz)  160.1, 159.0, 158.8,

157.1, 155.6, 142.2, 139.7, 135.6, 120.0, 110.3, 106.7, 106.2, 105.5, 105.0, 101.3, 101.2,
78.9, 78.4, 77.2, 75.8, 75.6, 71.9, 71.9, 70.8, 70.6, 70.6, 70.5, 70.5, 70.5, 69.6, 67.5, 65.3,
59.0, 59.0, 56.4, 56.0, 53.4. ESI-MS m/z calculated for C69H96O24 + H+: 1311.0; found:
1311.0 for (C27H36O10 + H)+.
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4.5.1.12 Synthesis of compound 14 (DA-3-41)

According to the procedure for click chemistry, compound 12 (185 mg, 0.145
mmol), compound 13 (124 mg, 0.463 mmol), CuSO4.5H2O (33 mg, 0.13 mmol), and
sodium ascorbate (52 mg, 0.261 mmol) were mixed in 2 mL of THF and 2 mL of water.
After purification of the reaction the product 14 was obtained (51 mg, 22%). 1H NMR
(CDCl3-400MHz)  8.44 (d, J = 4.7 Hz, 2H, x), 8.41 (d, J = 3.8 Hz, 1H, w), 7.70-7.58 (m, 7H,
a, z), 7.19 (s, 1H, y), 7.08-7.03 (m, 3H, a), 6.77 (d, J = 5.8 Hz, 2H, a), 6.67-6.49 (m, 10H, a),
5.15 (s, 4H, b), 5.09 (s, 2H, c), 4.94 (s, 4H, d), 4.69 (s, 2H, e), 4.31 (t, J = 7.2 Hz, 4H, f),
4.18-4.04 (m, 8H, f, h), 3.83-3.81 (m, 4H, g), 3.70-3.48 (m, 57H, f, g), 3.36 (s, 6H, i), 3.34
(s, 3H, j), 2.76 (t, J = 7.2 Hz, 4H, k), 2.69 (t, J = 7.2 Hz, 2H, n), 1.91-1.84 (m, 6H, p), 1.761.56 (m, 12H, p), 1.45-0.89 (m, 19H, p). MALDI-ToF m/z expected for C102H144N12O24S6:
2114.69; found 2152.66 for C102H144N12O24S6 + K+, 2136.69 for C102H144N12O24S6 + Na+,
2114.73 for C102H144N12O24S6 + H+.
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4.5.1.13 Synthesis of compound 20 (DA-3-2)

The compounds 6-mercaptoetanol 18 (1 g, 7.45 mmol) and 2-aldrithiol 19 (2.46
g, 11.17 mmol) were dissolved in methanol (10 mL). Stirring, and under Ar atmosphere
250 µL of glacial acetic acid were added. The reaction was left 18 hours. The solvent was
evaporated and NaHCO3 solution was added, to be extracted with dichoromethane.
After purification by column chromatography CombiFlash, the product 20 was obtained
(1.53 g, 85%). 1H NMR (CDCl3-400MHz)  8.46 (ddd, J = 4.9, 1.8, 0.9 Hz, 1H, a), 7.74 (dt, J
= 8.1, 1.0 Hz, 1H, d), 7.66 (ddd, J = 8.1, 7.4, 1.8 Hz, 1H, c), 7.09 (m, 1H, b), 3.62 (t, J = 6.5
Hz, 2H, e), 2.79 (t, J = 7.2 Hz, 2H, f), 1.71 (dd, J = 7.2, 7.1 Hz, 2H, g), 1.54 (dd, J = 5.0, 6.7
Hz, 2H, h), 1.38 (m, 4H, i, j).

13

C NMR (CDCl3-100MHz)  160.5, 149.3, 137.3, 120.6,

119.8, 62.8, 38.9, 32.5, 28.8, 28.2, 25.3. . ESI-MS m/z calculated for C11H17NOS2 + H+:
244.39; found: 266.07 for (C11H17NOS2 + Na)+, 244.09 for (C11H17NOS2 + H)+.

4.5.1.14 Synthesis of compound 21 (DA-3-4)

Compound 20 (4.67g, 19.20 mmol) and triethylamine (3.88 g, 38.39 mol) were
solubilized in 120 mL of anhydrous THF. Under Ar atmosphere and stirring, the mesyl
chloride (4.40 g, 38.39 mmol) was added. The reaction was left overnight, the THF was
evaporated without heating the flask, water was added to the remaining mass, and then
180

extracted with dichloromethane. The organic layers were dried on Na2SO4, filtrated,
concentrated, and purified through column chromatography to get product 21 (5.51 g,
90%). 1H NMR (CDCl3-400MHz)  8.47 (ddd, J = 4.9, 1.7, 0.9 Hz, 1H, a), 7.74 (s, 1H, d),
7.72 (s, 1H, c), 7.67 (ddd, J = 7.7, 1.8 Hz, 1H, b), 4.20 (t, J = 6.5 Hz, 2H, f), 3.00 (s, 3H, k),
2.80 (t, J = 7.3 Hz, 2H, e), 1.77-168 (m, 4H, g, h), 1.46-1.38 (m, 4H, i, j). 13C NMR (CDCl3100MHz)  160.4, 149.3, 137.3, 121.0, 119.9, 69.8, 38.7, 37.4, 29.0, 28.6, 27.8, 25.0. ESIMS m/z calculated for C12H19NO3S3 + H+: 322.48; found: 344.05 for (C12H19NO3S3 + Na)+,
322.06 for (C12H19NO3S3 + H)+.

4.5.1.15 Synthesis of compound 13 (DA-3-6)

Compound 21 (6.11 g, 19.00 mmol) was solubilized in 30 mL of anhydrous DMF
mixing it with NaN3 (1.85 g, 28.50 mmol). Stirring and under Ar atmosphere the reaction
was left for 24 h. Then, more NaN3 was added and left reacting 6 more hours.
Afterwards, 250 mL of water were added to next extract with diethyl ether (3 x 100 mL).
The organic layers were dried on Na2SO4, filtered and purified by column
chromatography to get the product 13 (4.38 g, 86%). 1H NMR (CDCl3-400MHz)  8.46
(ddd, J = 4.9, 1.7, 0.8 Hz, 1H, a), 7.72 (dt, J = 8.1, 0.9 Hz, 1H, d), 7.65 (m, 1H, c), 7.30
(ddd, J = 7.3, 4.9, 1.1 Hz, 1H, b), 3.24 (t, J = 6.9 Hz, 2H, f), 2.80 (m, 2H, e), 1.71 (dt, J =
14.7, 7.2 Hz, 2H, g), 1.58 (dt, J = 14.24, 7.0 Hz, 2H, h), 1.45-1.36 (m, 4H, i, j).
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13

C NMR

(CDCl3-100MHz)  160.5, 149.4, 137.1, 120.6, 119.7, 51.3, 38.8, 28.7, 28.7, 27.9, 26.3.
FAB-MS m/z calculated for C11H16N4S2 + H+: 269.2.

4.5.1.16 Synthesis of compound 23 (DA-3-132)

MTX Compound 22 (0.050 g, 0.11 mmol) was mixed with the 2-(2aminoethoxy)ethanol (0.058 g, 0.55 mmol) in NMP (2 mL). Followed by the addition of
DIPEA (0.071 g, 0.55 mmol). HATU (0.188 g, 0.495 mmol) was previously dissolved in
NMP (2 mL) and this solution was poured into the MTX solution. Stirring and under Ar
atmosphere, the reaction was left to complete for 5 days at room temperature. Diethyl
ether was added to the reaction mass to precipitate a brown oil, which was washed
once more with diethyl ether. The solution was separated from the oil, which was
washed two more times with dichloromethane. The organic solution was separated
from the oil. Then, the oil was mixed with acetone and sonicated. The product 25 (0.017
g, 25%) precipitated as a yellow solid that was vacuum filtered and dried. 1H NMR
(DMSO-d6-400MHz)  8.55 (d, J = 5.1, Hz, 1H, a), 7.73 (d, J = 9.0 Hz, 2H, b), 6.82 (d, J =
8.9 Hz, 2H, c), 6.61 (s, 2H, y), 4.78 (s, 2H, d), 4.59 (s, 2H, z), 4.31 (dd, J = 13.6, 8.4 Hz, 1H,
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e), 3.60-3.35 (m, 16H, h), 3.21 (s, 3H, w), 217-2.11 (m, 2H, g), 2.10-2.08 (m, 2H, f). ESIMS m/z calculated for C28H40N10O7 + H+: 329.68; found: 329.32 for (C28H40N10O7 + H)+.

4.5.1.17 Synthesis of compound 24 (DA-3-134)

To a stirring mixture of dendron 12 (20 mg, 0.015 mmol) and DMAP (7.5 mg,
0.061 mmol) in anhydrous dichloromethane (1.2 mL), was added Tf-Cl (7.7 mg, 0.046
mmol) inside the previous solution. After 48 h the reaction was stopped, more
dichloromethane (10 mL) and brine (10 mL) were added. It was extracted three times
with dichloromethane. The organic extracts were dried over anhydrous Na 2SO4. The
solution was purified by flash chromatography to get the pure product 24 (7.47 mg,
34%). 19F NMR (CDCl3-300MHz)  -78.26 (3F).
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4.5.1.18 Synthesis of compound 25 (DA-3-136)

The dendron 24 (7.47 mg, 5.18 µmol) was dissolved in dichloromethane (1 mL),
in a vial. The ligand 23 (3.26 mg, 5.18 µmol) was added followed by a drop of DBU (10
mg, 77.7 µmol). Stirring, the reaction was left in the capped vial. After 65 hours, water
was added (2 mL), and then, extracted three times with dichloromethane. Then, the
aqueous solution was saturated with NaCl to be extracted three more times with
dichloromethane. The organic layers were dried over anhydrous Na 2SO4. After
purification by flash chromatography, the product 25 was obtained (3 mg, 30%). 1H NMR
(DMSO-d6-400MHz)  8.56 (d, J = 5.1 Hz, 1H, a) 7.73 (d, J = 8.9 Hz, 2H, b), 6.83-6.49 (m,
11H, c), 4.98 (s, 4H, d), 4.77 (s, 2H, e), 4.68-466 (m, 6H, f, g), 4.59-4.57 (m, 4H, h), 4.344.29 (m, 2H, i), 4.12-4.04 (m, 9H, j, k), 3.73 (m, 6H, j, k), 3.58-3.35 (m, 80H, j, k), 3.223.21 (m, 16H, n, p, j), 2.60-2.45 (m, 3H, x). MALDI-ToF m/z expected for C97H134N10O30:
1920.15; found 1943.70 for C97H134N10O30 + Na+.
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4.5.1.19 Synthesis of compound 26 (DA-3-138)

According to the procedure for click chemistry, compounds 25 (3 mg, 1.56 µmol)
and compound 13 (2.52 mg, 9.37 µmol) were mixed in presence of CuSO4.5H2O (0.58
mg, 2.34 µmol) and sodium ascorbate (0.58 mg, 2.34 V) to get the target dendron 26
(1.0 mg, 23%). 1H NMR (DMSO-d6-400MHz)  8.55 (s, 1H, a), 8.43-8.41 (m, 3H, b), 7.827.61 (m, 9H, c), 7.22-7.19 (m, 4H, c), 6.86 (s, 1H, c), 6.71 (s, 1H, c), 6.67 (s, 2H, c), 6.61 (s,
2H, c), 6.57 (m, 2H), 6.53 (m, 3H, c), 5.10 (s, 4H, d), 5.06 (s, 2H, e), 4.94 (s, 4H, f), 4.78 (s,
2H, g), 4.50 (d, , J = 5.6 Hz, 2H, h), 4.31 (t, J = 5.6 Hz, 4H, h), 4.33-4.30 (m, 3H, i), 4.063.90 (m, 5H, i, h), 3.71 (m, 5H, h), 3.57-3.35 (m, 65H, h), 3.20-3.18 (m, 11H, k), 2.80 (t, J =
7.1 Hz, 4H, n), 2.74 (t, 7.2 Hz, 2H, p), 1.78-1.03 (m, 34H, h, q).
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4.5.2 Determination of Size of Self-Assembly and Crosslinked Nanoparticulates
4.5.2.1 Preparation of G1 Dendron Aggregates and DLS Measurements
The samples of dendrons were prepared in solutions of 25 µM and sonicated for
2 hours or until the solution looked clear. Next, the samples were stirred for 2 hours at
room temperature before the DLS measurements were taken. The samples were not
micro-filtered unless DLS revealed aggregate sizes higher than 1000 nm in diameter.

4.5.2.2 Preparation of Crosslinked Aggregates
A sample of dendron 25 µM in solution was taken a UV-Vis spectrum at 343nm
and then, since this dendron concentration makes a PDS concentration of 75 µM, the
sample was exposed to 75 µM of DTT by adding the corresponding microliters from a
DTT stock solution 2 mM. After exposure to the crosllinking agent, the UV-Vis spectrum
of the sample was taken. The absorbance at 343 nm was measured after 28 hours to
verify cleavage of pyridothione groups.
With the objective of cleaving all the PDS functionalities in the dendron, a
second sample with the same concentration of dendron as before was exposed to an
excess concentration of DTT in such a way that the ratio PDS:DTT was at least 1:20. UVVis spectra were taken before and after exposure to DTT to check the highest
absorbance for the sample.
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4.5.2.3 DLS Measurements for Crosslinked Aggregates and Exposure to Organic
Solvent
The samples from the crosslinking procedure were analyzed by DLS to make sure
that the particulate size remains mono-dispersed. Micro-filtered was not necessary
unless there were particulates with sizes larger than 1000 nm. However, the samples
were micro-filtered before exposure to methanol. For that, 500 µL of the crosslinked
dendron sample at 25 µM were diluted to 12.5 µM by adding 500 µL of methanol. The
samples were allowed to equilibrate before DLS measurements.
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CHAPTER 5
SUMMARY AND FUTURE DIRECTIONS

5.1 Introduction
This thesis focused mainly on the importance of ligand availability for
supramolecular interactions between macromolecules, such as proteins and small
molecules or between proteins and synthetic macromolecules, such as dendrons. Using
the knowledge on protein-ligand interactions that has been reported up to date, we
chemically modified a few ligands with the aim of, upon binding to a specific protein,
incorporating in our systems some of the characteristics shown by those proteins such
as hydrophilic surface, globular shape, deep binding pockets, strong non-covalent
interactions, etc.
An interesting and innovative system for screening of small molecules against a
target protein was described in Chapter 2. There, we used the binding pocket of hCA1 to
hinder, upon binding of a probe bearing an enzyme cleavable bond, the action of an
enzyme on the probe. Such action would cleave and activate an otherwise silent
fluorophore. The probe is displaced out of the protein binding pocket and made
available for the enzyme, only in the presence of a small molecule (competitor) with
affinity for the binding site.1 This concept could be used in the screening of small
molecules looking for “hits”, and also to find relative binding constants for proteinligand systems that are difficult to deal with using traditional methods.2
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In Chapter 3, we took advantage of the ligand-protein interaction and great
binding affinity of the system biotin-extravidin, to study the best location to install a
hydrophilic ligand on a dendron. Given the self-assembly property of our biotinmodified dendrons in aqueous solution, we encapsulated a fluorescent probe and
studied dendron-disassembly and release efficiency upon protein binding. We found
that installing a ligand at the periphery of these dendrons makes the ligand more
available for the protein in solution, which gives better release profiles than when the
ligand is tethered to the other locations.
Based on the knowledge gained from studying these supramolecular systems, in
Chapter 4 we proposed the synthesis of a dendron modified with a particular ligand for
targeting the intracellular enzyme DHFR, and endowed the dendron with redoxsensitive crosslinkable functionalities with the objective of de-crosslink in the
intracellular reducing environment, and disassembly in the intracellular milieu upon
protein binding.
Based on the research described in this thesis, there are some modifications that
would be as interesting as pertinent to accomplish and that could give a deeper insight
into the systems introduced by our group.

5.2 Supramolecular Displacement Conditions for Analytical Applications
As shown in Chapter 2, the length of the probe linker influenced the availability
of the ligand for the enzyme. However, the shallowness or deepness of the binding
pocket will have similar impact on such availability. To better understand this, and in
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order to propose a better and more general probe design aimed to target a wider range
of binding sites, it would be useful to study a few more systems.
An interesting target protein for this study is the protein β-lactoglobulin, which
has a binding pocket that could bind either retinol at the rim of the binding site or a

Figure 5.1. Retinoic acid- and fatty acids- based probe for β-lactoglobulin

fatty acid at the bottom of the site.3 Results suggesting that bound retinol is more
exposed to the environment make a retinol-based probe an interesting molecule to test.
As shown in Figure 5.1, a retinol-based probe has a long linker that leaves the enzyme
cleavable bond more exposed to the solvent than in the probes for hCA1, as shown by
our preliminary results (Figure 5.2). Despite the good binding affinity of retinoic acid to
β-lactoglobulin (39 nM),4 a probe synthesized with a linker between retinoic acid and 4methylumbelliferone was not effectively protected by β-lactoglobulin from PLE
cleavage. In our preliminary results, as shown in Figure 5.2, 125 µM of β-lactoglobulin
was not enough to hinder esterase action on the probe linker. Compare to the 20 µM of
hCA1 needed in Chapter 2 to protect Probe A, which means that further experiments
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are required to find the proper conditions to hinder enzymatic action on the βlactoglobulin-probe complex.

Figure 5.2. Finding β-lactoglobulin (B-LG) concentration for esterase (PLE) activity
inhibition. Probe at 5 µM, PLE at 50 nM.
However, palmitic acid has been found to coil in the β-lactoglobulin binding
site.3,4 Hence, a probe based on the fatty acid could present a better inhibition profile
than a retinol-based probe. Additionally, given the high propensity of hydrophobic small
molecules to bind this target protein, it would be interesting to compare a hexanoic acid
based probe to the previous two probes in terms of linker length and hindrance
provided by β-lactoglobulin.5
From a different perspective, but complementary to the interest of testing
probes for a protein with a shallow binding site described above, it would be relevant to
test this supramolecular displacement and activation of a silent fluorescence probe
method against a disease relevant protein. To address this point, a good target would be
the factor-inhibiting hypoxia-inducible factor (FIH), which is known to have a binding
pocket 15 Å wide and to inhibit the hypoxic responses in the cell.6 Also, the screening
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assays for FIH are scarce, and the preparation of the reagents requires high levels of
expertise.7 A probe design could consist simply of 8-hydroxyquinoline as the ligand and
4-methylumbelliferone as the reporter, both linked through an ester bond. There is a set
of ligands known to bind FIH, mostly quinoline derivatives such as clioquinol, which are
commercially accessible ligands that would help the method to be easily transferred to
HTS.8 This would be an excellent fire-proof test for our screening method.

5.3 Using Supramolecular Dendron Exchange to Improve Ligand Diversity
It was demonstrated recently that the dynamics of dendron exchange between
dendritic aggregates involves only assemblies formed by G1 dendrons.9 This means that
if we were to synthesize dendrons with the objective of exchanging them in solution to
form aggregates with both dendrons, our synthetic efforts should be focused only on G1
dendrons. Given the synthetic challenge that implies functionalizing biaryl amphiphilic
dendrons and the risk of precipitation involved in replacing more than one PEG chain in
a G1 dendron, as mentioned in Chapter 3 and Chapter 4, the dynamic exchange could be
used to achieve aggregates with two different kinds of ligands, avoiding design and
synthetic problems.10
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Figure 5.3. Dendron exchange to increase ligand diversity in a dendritic aggregate.

In Chapter 4, we showed a dendron design that incorporates a single ligand and
potentially, could target an intracellular protein. The dendron was endowed with
crosslinkable functionalities that also work as hydrophobic moieties. These
functionalities could be de-crosslinked as response to a reducing environment, which is
found in the intracellular media. However, a crosslinked dendritic aggregate would have
more chance of reaching the intracellular milieu if it could go easily through the cell
membrane.11
It would be relevant to endow a system with three different responsive features
towards three different targets (i) an overexpressed protein receptor in the cell
membrane, (ii) a reducing intracellular environment, and (iii) an overexpressed protein
in the intracellular milieu. Figure 5.3 depicts the characteristics of a dendritic couple that
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merge their properties into a single assembly. Then, the action of a reducing agent such
as DTT could lock those properties in the crosslinked nanoparticulate.
The dendron design in Chapter 4 already incorporates a redox responsive feature
and a ligand for intracellular targeting, methotrexate (MTX). Since MTX shares structural
features with folic acid, the incorporation of the latter into the dendron structure could
be achieve utilizing similar conditions.12 The final structure of the dendrons will only
differ in the ligand moieties.

5.4 Summary
In this final chapter a short summary for the previous chapters has been
presented, highlighting the main features and properties of the systems described in
this thesis. As a complement to that research, general ideas about molecular designs
have been presented with the potential to take further what has been done and shown
in Chapter 2 and Chapter 4.
We expect that the whole set of designs and ideas explored and proposed here,
will help to improve the future molecular designs, and to understand better
supramolecular systems involving proteins, dendrons, polymers, and small molecules.
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